KEY OPINION LEADERS
Find out who has spoken at Galien Foundation
meetings and events
We are determined to ensure that Galien Foundation events are second-to-none in caliber. Our forums, meetings and digital events bring together the world’s thought leaders in one singular mission - to improve the human condition. Discover who has spoken at our events by searching below.
Who are you looking for?
| NAME | COMPANY | TITLE | EVENT | TOPIC | COUNTRY | |
|---|---|---|---|---|---|---|
| 2022 | Juan Camilo Arjona Ferreira | Myovant Sciences | CMO | Galien Week of Innovation | Anti-Viral Drugs and Women’s Health With a global pandemic raising awareness of the importance of vaccines and anti-viral/anti-microbial drugs, are private-sector R&D incentives aligned to meet future contagion threats? Gauging unmet needs in women’s health therapeutics and promising new drugs in the development stage | |
| 2022 | Javier Boix | Novartis | Global Head, Communications & Engagement, Novartis Pharmaceuticals | Galien Webinars Series | Golden Jubilee - Best Pharmaceutical Category | |
| 2020 | Jeremy Abbate | Scientific American | Vice President & Publisher | Jerusalem Ethics Forum | Tracking bioethics: transparency, trust & the industry’s social imperatives | |
| 2018 | Salim Abdool Karim | Columbia University | Professor | Galien Forum Africa | managing infectious diseases & pandemics | |
| 2018 | Salim Abdool Karim | Columbia University | Professor for Global Health | Galien Forum Africa | Remarkable women engage for humanity | |
| 2018 | Papa Abdoulaye Seck | Senegal | Minister of Agriculture | Galien Forum Africa | Addressing chronic malnutrition | |
| 2020 | Amy Abernethy | FDA | Principal Deputy Commissioner | Galien Webinars Series | Digital health improving research & care | |
| 2021 | Imodoye Abioro | Healthbotics | Chief Executive Officer | Galien Forum Africa | Leadership & innovation, meet the winners of the africa young innovators award for health | |
| 2018 | Anna K. Abram | FDA | Deputy Commissioner for Policy, Planning, Legislation & Analysis. | Galien Forum USA | Keynote | |
| 2022 | Michael D. Abramoff | Digital Diagnostics Inc | Digital Diagnostics | Galien Week of Innovation | Digital Health Solution - Disease Management In what ways can these new technologies contribute to the realization of better outcomes for patients at less cost to overburdened health systems? | |
| 2022 | Paul Adam | Boehringer | Head Cancer Immuno MOD | Galien Week of Innovation | Hematologic Cancers and Gene-based “Tumor Agnostic” Therapies How much more mileage is in store for blood-based cancer survival rates, which have been increasing steadily in recent years? And what is being done about the flip side of this success, expressed in more treatment-related morbidities, disease relapse and higher incidence | |
| 2018 | Isaac Adewole | Nigeria | Minister of Health | Galien Forum Africa | Which plan for non communicable diseases? | |
| 2021 | Nanahemaa Adjoa Awindor | Development Queenmother Afigya-Kwabre District – Ghana | Professor | Galien Forum Africa | Women’s leadership in global health security | |
| 2021 | Desmond Adler | Glaukos Corporation | General Manager & Vice President R&D, Corneal Health | Galien Week of innovation | What is med tech innovation doing for patients with specialized needs for treatment? | |
| 2018 | Sultana Afdhal | WISH, Qatar | Chief Executive Officer | Galien Forum Africa | Plenary Panel - women in stem in africa | |
| 2014 | Mohammad Afshar | Ariana pharma | CEO | Galien Foum Monaco | Beyond the Pill : The digital transformation of the biopharmaceutical industry in progress | |
| 2021 | Shefali Agarwal | Epizyme | Chief Medical & Development Officer & trained medical oncologist | Galien Week of innovation | Will the success of novel, gene-based therapies in advancing survival timelines in blood & bone marrow cancers be repeated in the solid tumor setting, with therapies that address each tumor’s individual genetic profile rather than association with its geographic location in the body? | |
| 2018 | Cinzia Akbaraly | Akbaraly Foundation - Madagascar | Founder & President | Galien Forum Africa | Plenary Panel - women in stem in africa | |
| 2022 | Sarah Akerman | Alkermes, Inc | Executive Medical Director | Galien Week of Innovation | Chronic and Autoimmune Disorders Chronic non-communicable diseases now account for three quarters of annual deaths worldwide, with a fast rising percentage taking place in low and middle income countries. With this in mind, how important is incentivizing more industry investment in costly clinical trials and other research targeting key areas of unmet need in major chronic conditions like CVD? Will a better understanding of the common molecular signatures that underlie many serious autoimmune disorders result in more progress in therapeutic interventions, including prevention? | |
| 2018 | Sarah Akerman | Alkermes | Senior Medical Director | Galien Forum USA | Novel approaches to combatting opioid addiction | |
| 2021 | Bola Akinlade | Regeneron | Vice President, Clinical Sciences, Immunology & Inflammation | Galien Week of innovation | Given that many chronic diseases have an infectious origin, what learnings can be had by the most recent innovations in vaccine development technology in raising the bar on innovations to address the huge unmet need against chronic conditions that kill millions? | |
| 2021 | Chrispin Akuzwe | Patient Monitoring System – Rwanda | Smart Chair | Galien Forum Africa | Meeting of young innovators with investors | |
| 2021 | David E. Albert | AliveCor Inc. | Founder & Chief Medical Officer | Galien Week of innovation | In what ways can these new technologies contribute to the realization of better outcomes for patients at less cost to overburdened health systems? | |
| 2016 | Charles Albright | Editas | Journalist | Galien Forum USA | Molecular scissors: what can we expect from gene editing? | |
| 2022 | Alexey Aleshin | Natera, Inc. | MD, MBA | Galien Week of Innovation | Disease Diagnostics and Digital Therapeutics How far are we from achieving the health system world of the connected patient? | |
| 2022 | Sally Allain | Johnson & Johnson Innovation, LLC | Head of Innovation | Galien Week of Innovation | Best Incubator/Accelerator/ equity - Disease Management Incubators and accelerators are pivotal in developing innovative solutions to address humanity’s most pressing health challenges. Why are academic institutions, major medical centers, and significant life science companies launching incubators and accelerators to offer guidance to biotech, digital health, health information, and medical device start-ups? Beyond financial resources, how are these groups working to advance ideas into the marketplace, and what is their impact? | |
| 2013 | David Altshuler | Massachusetts General Hospital & Broad Institute | Professor | Galien Forum USA | Personalized medicine: effect on drug r&d & patient care | |
| 2021 | Yele Aluko | EY Americas Business Consulting Health Sector | Chief Medical Officer | Jerusalem Ethics Forum | Inclusive medicine: how modern research amplifies outcomes for patient access, inclusion & diversity | |
| 2021 | Pape Amadou Sarr | Delegation à l’Entreprenariat Rapid– Senegal | Director General | Galien Forum Africa | Meeting of young innovators with investors | |
| 2021 | Samuel Amo Tobbin | TOBINCO Group of Companies – Ghana | Executive Director | Galien Forum Africa | Meeting of young innovators with investors | |
| 2021 | Samuel Amo Tobbin | TOBINCO Group of Companies – Ghana | Executive Director | Galien Forum Africa | Closing ceremony | |
| 2022 | Aseem Anand | Lantheus | VP Digi Imaging Biomarkers Lantheus | Galien Week of Innovation | Disease Diagnostics and Digital Therapeutics How far are we from achieving the health system world of the connected patient? | |
| 2022 | David E. Anderson | VBI Vaccines Inc. | Chief Scientific Officer | Galien Week of Innovation | Biotech - Chronic/Autoimmune Disorders and Vaccines Given that many chronic diseases have an infectious origin, what learnings can be had by the most recent innovations in vaccine development technology in raising the bar on innovations to address the huge unmet need against conditions that kill millions? | |
| 2022 | Emily Anderson | Boston Scientific Corp. | Director, Global Corporate Communications | Galien Webinars Series | Golden Jubilee - Best MedTech Category | |
| 2014 | David J. Anderson | Howard Hughes Medical Institute, California Institute of Technology | Seymour Benzer Professor of Biology, | Galien Forum USA | The brain initiative | |
| 2018 | John Andrianarisata | Benin Country Office African Development Bank | Country Manager | Galien Forum Africa | Addressing chronic malnutrition | |
| 2021 | Mert Aral | Huma | Head of R&D & Clinical Strategy | Galien Week of innovation | Are insurers & health systems ready to embrace & reward these new self-care technologies, particularly in recognizing prevention & wellness as an integral element of service provision? | |
| 2021 | Juan Camilo Arjona Ferreira | Myovant Sciences Ltd., Myovant Sciences, Inc. | Chief Medical Officer | Galien Week of innovation | What is the state of progress in building new therapeutic & diagnostic platforms to fight major cancers & address their prevalence in vulnerable populations, including the aged, minorities, & pediatric patients? | |
| 2022 | Katrina Armstrong | Faculties of health sciences and the Vagelos college of physicians and surgeons & Columbia university Irving medical center Harold and Margaret hatch professor in the faculty of medicine | Executive vice president for health and biomedical sciences - Dean & CEO | Galien Forum USA - Chair | Diversity and health equity in the future creation of medicine | |
| 2021 | Scott A. Armstrong | Dana-Farber Cancer Institute | President, Boston Children’s Cancer & Blood Disorders Center; Chairman, Department of Pediatric Oncology, | Galien Forum USA | New breakthroughs in the biology of cancer: pioneering novel ways to enhance & restore the body’s ability to fight cancer | |
| 2015 | David Artis | Jill Roberts Institute for Research in Inflammatory Bowel Disease, Weill Cornell Medical College Cornell University, Joan & Sanford I. Weill | Michael Kors Professor of Immunology Director, Department of Medicine | Galien Forum USA | Microbiota in human diseases | |
| 2021 | El Hadji As Sy | Kofi Annan Foundation International – Senegal | President | Galien Forum Africa | Symposium one health – one africa : a new agenda for governance & the growth of a post-covid continent | |
| 2018 | El Hadji As Sy | International Federation of Red Cross & Red Crescent Societies | Secretary General | Galien Forum Africa | Financing africa’s healthcare | |
| 2022 | Simon Ashwell | GSK | Global Corporate Affairs and Sustainability | Galien Webinars Series | Golden Jubilee - Best Vaccine Category | |
| 2020 | Paul Atlan | University Paris-Descartes, France | Director of Teaching of Transcultural Biomedical Ethics | Jerusalem Ethics Forum | Up-to-date reflection on society, medicine & reproduction | |
| 2019 | Paul Atlan | University Paris-Descartes, France | Director of Teaching of Transcultural Biomedical Ethics | Jerusalem Ethics Forum | Personalized genomics medicine: the value of knowing | |
| 2013 | Christopher Austin | National Center for Advancing Translational Sciences, National Institutes of Health | Director | Galien Forum USA | The promise of gene therapy | |
| 2015 | Richard Axel | the Kavli Institute for Brain Science, Columbia University Medical Center, New York | Nobel Laureate, Co-Director | Galien Forum USA | Untangling the web of neurodegeneration: how far & how soon? | |
| 2014 | Richard Axel | the Kavli Institute for Brain Science, Columbia University Medical Centre, New York | Nobel Laureate, Co-Director | Galien Forum USA | The brain initiative | |
| 2021 | Maëlle Ba | Speak Up Africa | Strategic Communications Manager, | Galien Forum Africa | Leadership & innovation, meet the winners of the africa young innovators award for health | |
| 2021 | Doudou Ba | Academy of Sciences & Techniques of Senegal | President | Galien Forum Africa | Conference on reform in health training | |
| 2021 | Mamadou Ba | Leadership & Management – Senegal | Institutional Capacity Building Advisor | Galien Forum Africa | Youth leadership training (part 1) | |
| 2021 | Mamadou Ba | Leadership & Management – Senegal | Institutional Capacity Building Advisor | Galien Forum Africa | Youth leadership training | |
| 2020 | Alassane Ba | Humanitarian Center for Pharmacy Trades (CHMP France) | Director | Galien Forum Africa | Covid 19 drug supply chain in africa: challenges & perspectives | |
| 2015 | Peter Bach | Center for Health Policy & Outcomes, Memorial Sloan-Kettering Cancer Center | Director | Galien Forum USA | Keynote: drug pricing & access in the trump administration: consensus or confrontation? | |
| 2020 | Junaid Bajwa | Microsoft | Chief Medical Scientist | Galien Webinars Series | Digital health in the aftermath of covid-19 | |
| 2014 | Andre-Michel Ballester | Sorin group | CEO | Galien Foum Monaco | Beyond the Pill : The digital transformation of the biopharmaceutical industry in progress | |
| 2021 | Jeffrey Balser | Vanderbilt University Medical Center | President & Chief Executive Officer | Galien Webinars Series | The incubators of innovation: academic medical centers as digital health champions | |
| 2021 | Stephane Bancel | Moderna | Chief Executive Officer | Galien Forum USA | Covid-19 vaccine development & the enduring impact on life sciences innovation – speed, collaboration, clinical trial advancement & manufacturing | |
| 2020 | Stephane Bancel | Moderna | Chief Executive Officer | Galien Forum USA | Covid-19 vaccines: the path to the holy grail | |
| 2014 | Cori Bargmann | The Rockefeller University, New York | Professor | Galien Forum USA | Keynote: fixed circuits & flexible behaviors | |
| 2022 | Eliav Barr | Merck research laboratories | head, global clinical development & chief medical officer, | Galien Forum USA | Diversity and health equity in the future creation of medicine | |
| 2018 | Françoise Barre-Sinoussi | Director of the Regulation Retroviral Infections Division Professor Institut Pasteur Paris, France | Nobel Prize for Medicine | Galien Forum Africa | Remarkable women engage for humanity | |
| 2018 | Françoise Barre-Sinoussi | Institut Pasteur - France | Nobel Prize for Medicine | Galien Forum Africa | Plenary Panel - women in stem in africa | |
| 2018 | Françoise Barre-Sinoussi | Institut Pasteur - France | Nobel Prize for Medicine | Galien Forum Africa | managing infectious diseases & pandemics | |
| 2021 | Danny Bar-Zohar | Merck KGaA | Global Head of Development | Galien Forum USA | New breakthroughs in the biology of cancer: pioneering novel ways to enhance & restore the body’s ability to fight cancer | |
| 2017 | Jose Baselga | Memorial Sloan Kettering Cancer Center GRAIL, Inc. | Physician-in-Chief & Chief Medical Officer, Director, Board of Directors, | Galien Forum USA | Addressing unmet medical needs with early-stage life science venture capital | |
| 2021 | Gil Bashe | Finn Partners | Managing Partner, Chair Global Health | Galien Week of innovation | With a global pandemic raising awareness of the importance of vaccines & anti-viral/anti-microbial drugs, are private-sector r&d incentives aligned to meet these unmet medical needs? | |
| 2021 | Gil Bashe | Finn Partners | Managing Partner, Chair Global Health | Galien Webinars Series | The incubators of innovation: academic medical centers as digital health champions | |
| 2021 | Gil Bashe | Finn Partners | Managing Partner, Chair Global Health | Galien Week of innovation | In what ways can these new technologies contribute to the realization of better outcomes for patients at less cost to overburdened health systems? | |
| 2021 | Gil Bashe | Finn Partners | Managing Partner, Chair Global Health | Galien Webinars Series | Data governance in a converging world: public & private sector approaches to the management of emerging health technologies. | |
| 2020 | Gil Bashe | Finn Partners | Managing Partner, Chair Global Health | Galien Webinars Series | The digital health enterprise: start-up trends & the culture of big pharma | |
| 2020 | Gil Bashe | Finn Partners | Managing Partner, Chair Global Health | Galien Webinars Series | Digital health webinar – presentation of the nominees in the 2020 prix galien digital health category | |
| 2020 | Gil Bashe | Finn Partners | Managing Partner, Chair Global Health | Galien Webinars Series | Digital health in the aftermath of covid-19 | |
| 2022 | Gil Bashe | Finn | Chair Glob. Health&Purp. Moderator: | Galien Week of Innovation | Best Incubator/Accelerator/ equity - Disease Management Incubators and accelerators are pivotal in developing innovative solutions to address humanity’s most pressing health challenges. Why are academic institutions, major medical centers, and significant life science companies launching incubators and accelerators to offer guidance to biotech, digital health, health information, and medical device start-ups? Beyond financial resources, how are these groups working to advance ideas into the marketplace, and what is their impact? | |
| 2020 | Emmanuel Bassene | Ministry of Health & Social Action (Senegal) | Associate of Pharmacognosy & Head of the Traditional Medicine Division | Galien Forum Africa | Contribution of traditional medicine in the response against covid 19: state of play, challenges & prospects sub-theme 5: | |
| 2020 | Nathan Belete | Senegal, Mauritania, Guinea Bissau, Gambia & Republic of Cape Verde, World Bank | Director of Operations | Galien Forum Africa | Socio-economic impact of the covid 19 pandemic sub-theme 3 | |
| 2021 | Karim Bendhaou | IFPMA | Representative | Galien Forum Africa | Leadership & innovation, meet the winners of the africa young innovators award for health | |
| 2021 | Christoph Benn | Global Health Diplomacy | Director | Galien Forum Africa | Innovations & ethic for global health security | |
| 2015 | Frank Bennett | Ionis Pharmaceuticals | Senior Vice-President of Research, | Galien Forum USA | Spinal muscular atrophy: charting the pathway to clinical progress | |
| 2019 | Zion Ben-Rafael | Rabin Maj Center’s Campus Beilinson & Golda, Israel | Director of the Department of Obstetrics & Gynecology | Jerusalem Ethics Forum | Human reproduction: technical limit, ethical limit | |
| 2020 | Bjarne Bergheim | Sonendo, Inc | President & Chief Executive Officer | Galien Week of innovation | What is medtech innovation doing for patients with specialized needs for treatment? | |
| 2011 | Jeffrey Berkowitz | Walgreens | Senior Vice President Pharmaceutical Development & Market Access | Galien Forum USA | What is "value" & how can it be measured & demonstrated in therapeutic innovations? breaking down the barriers of the past | |
| 2014 | Emily Bernstein | Icahn School of Medicine at Mount Sinai | Prize Winner & Associate Professor of Oncological Sciences & Dermatology, | Galien Forum USA | Pioneers for a cure: the role of innovation & entrepreneurship in cancer research | |
| 2021 | Rachele Berria | AstraZenica | Vice President & Medical Heads US Biopharmaceuticals | Galien Webinars Series | The impact of digital technologies in transforming & accelerating vaccine trials, development & delivery – lessons from covid-19 part 2 | |
| 2021 | Rachele Berria | AstraZenica US | Vice President & Medical Head | Galien Webinars Series | The impact of digital technologies in transforming & accelerating vaccine trials, development & delivery – lessons from covid-19 | |
| 2020 | Uri Bettesh | Datos-Health | Chief Executive Officer | Galien Webinars Series | Digital health in the aftermath of covid-19 | |
| 2020 | Sailaja Bhaskar | Adlon Therapeutics L.P., a subsidiary of Purdue Pharma L.P. | Executive Director, Clinical Operations Planning | Galien Week of innovation | The ability to claim larger health system productivity benefits from the introduction of chronic disease medicines looms in importance as these therapeutic segments become more crowded & competitive. | |
| 2022 | Sangeeta Bhorade | Natera, Inc. | CMO, Organ Health Division | Galien Week of Innovation | Disease Diagnostics and Digital Therapeutics How far are we from achieving the health system world of the connected patient? | |
| 2020 | Satasuk Joy Bhosai | Duke Clinical Research Institute | Chief of Digital Health & Strategy | Galien Webinars Series | Digital health improving research & care | |
| 2014 | Francis Bidault | Esmt European Xchool of Management and Technology | Professor | Galien Foum Monaco | Beyond the Pill : The digital transformation of the biopharmaceutical industry in progress | |
| 2021 | Agnes Binagwaho | Global Health Equity University, The Global Health Equity University, Former Minister of Health of Rwanda | Chancellor | Galien Forum Africa | Conference on reform in health training | |
| 2021 | Agnes Binagwaho | Global Health Equity University, Former Minister of Health of Rwanda | Chancellor | Galien Forum Africa | Symposium one health – one africa : a new agenda for governance & the growth of a post-covid continent | |
| 2020 | Fatou Binetou Sarr | UFR Thies; Laureate of the Macky SALL Gr& Prize for Innovation (Senegal) | Teacher & Researcher | Galien Forum Africa | Place of women in innovation related to covid 19 sub-theme 2: | |
| 2018 | Kathie M. Bishop | Otonomy | Chief Executive Officer | Galien Forum USA | Spinal muscular atrophy: charting the pathway to clinical progress | |
| 2022 | Andy Blackwell | Ieso Digital Health | Chief Science & Strategy Officer | Galien Forum UK | Digital health innovation: a key driver of next generation healthcare – what & when? | |
| 2015 | Cheryl R. Blanchard | Microchips Biotech, Inc. | Chief Executive Officer | Galien Forum USA | Us health reform: partnering, pricing & politics | |
| 2015 | Cheryl R. Blanchard | Microchips Biotech, Inc. | Chief Executive Officer | Galien Forum USA | Bioengineering for better health: what future for targeted drug delivery? | |
| 2022 | Robert O. Blaustein | Merck & Co., Inc | AVP Global Clinical Devt | Galien Week of Innovation | Chronic and Autoimmune Disorders Chronic non-communicable diseases now account for three quarters of annual deaths worldwide, with a fast rising percentage taking place in low and middle income countries. With this in mind, how important is incentivizing more industry investment in costly clinical trials and other research targeting key areas of unmet need in major chronic conditions like CVD? Will a better understanding of the common molecular signatures that underlie many serious autoimmune disorders result in more progress in therapeutic interventions, including prevention? | |
| 2017 | Carina Blomström-Lundqvist | Uppsala University | Professor of Cardiology | Galien Forum USA | Atrial fibrillation | |
| 2014 | Jeff Bluestone | Provost at UCSF | Immunology & Head of the Diabetes Center, | Galien Forum USA | Cancer immunotherapeutics | |
| 2021 | Boris Bogdan | Accenture | Global Lead Medical | Galien Week of innovation | What can patients with chronic conditions expect from medicines advances within the next five to ten years? how is chronic disease research moving from incremental & maintenance therapies to real breakthroughs toward cure & prevention? | |
| 2022 | François-Henri Boissel | Novadiscovery | Cofounder CEO Novadiscovery | Galien Week of Innovation | Digital Health Solution - Clinical Trial Management and Wellness Care Are researchers, physicians and regulators ready to embrace advanced, low-touch approaches to streamline the cumbersome infrastructure of clinical trials? And are insurers and health systems prepared to reward software- driven patient self-care technologies, particularly by recognizing prevention and wellness as an integral element of service provision? | |
| 2016 | Michael W. Bonney | Cubist Pharmaceuticals Inc.; Advisor, UK Review on Antimicrobial Resistance | Retired Chief Executive Officer, | Galien Forum USA | Next generation antimicrobials – shaping policy to develop new business models | |
| 2022 | Marc Bonten | Royal Netherlands Academy of Arts and Sciences (KNAW) | Professor | Galien Forum Netherlands | #VALUE! | |
| 2018 | Alexis Borisy | Third Rock Ventures | Partner | Galien Forum USA | Cancer in a time of disruption | |
| 2015 | Alexis Borisy | Third Rock Ventures | Partner | Galien Forum USA | Autism - the next decade | |
| 2021 | Ouided Bouchamaoui | Tunisian Union of Industry, Commerce & Handicrafts | Peace Nobel Prize | Galien Forum Africa | Socio-economic consequences, equity & gender in the global health security | |
| 2021 | Ouided Bouchamaoui | Honorary Committee of the Prix Galien Afrique | Nobel Prize for Peace | Galien Forum Africa | Closing ceremony | |
| 2020 | Ouided Bouchamaoui | Tunisian Union of Industry, Commerce & Handicrafts | Peace Nobel Prize | Galien Forum Africa | Gender & innovations facing covid 19 sub-theme 1: gender & response to covid 19. | |
| 2018 | Ouided Bouchamaoui | Tunisian Union of Industry, Commerce & Handicrafts | Peace Nobel Prize | Galien Forum Africa | Plenary Panel - women in stem in africa | |
| 2019 | Albert Bourla | Pfizer Inc. | Chairman & Chief Executive Officer | Galien Forum USA | How will we be paying for medicine 10 years from now? (Chief Executive Officers panel) | |
| 2021 | Albert Bourla | Pfizer Inc. | Chairman & Chief Executive Officer | Galien Forum USA | Covid-19 vaccine development & the enduring impact on life sciences innovation – speed, collaboration, clinical trial advancement & manufacturing | |
| 2020 | Abdoulaye Bousso | Senegal Emergency Health Operations Center | Director | Galien Forum Africa | Current situation of the response, challenges & prospects.sub-theme 1: | |
| 2013 | Marc M. Boutin | National Health Council | Chief Executive Officer | Galien Forum USA | What’s holding back the technology revolution in clinical trials? | |
| 2014 | Gilles Bouvenot | National Academy of Medicine | Member | Galien Foum Monaco | Innovation at what cost? make the voice of science and reason heard | |
| 2013 | Robert Bradway | Amgen | Chairman & Chief Executive Officer | Galien Forum USA | Drugging the undruggable» with novel approaches to small molecule design | |
| 2021 | Vincent Bretin | UNITAID International, France | Director of Results | Galien Forum Africa | « one health » & « global health » approaches: are they complementaries or contradictories in the global health security context? | |
| 2013 | Karin Briner | Novartis | Vice President & Head, Global Discovery Chemistry, | Galien Forum USA | Drugging the undruggable» with novel approaches to small molecule design | |
| 2020 | Sabine Brookman-May | Janssen Research & Development, LLC | Executive Medical Director, Late Development, Solid Tumor | Galien Week of innovation | What are the prospects – & limitations – behind the new approaches to cancer treatments from our increased knowledge of the underlying biology behind tumor growth & proliferation? | |
| 2022 | Melissa Brotz | Abbott Laboratories | Chief Marketing & Communications Officer | Galien Webinars Series | Golden Jubilee - Best MedTech Category | |
| 2018 | Denis Broun | CIPLA | Head of Government Affairs, | Galien Forum Africa | Universal access to essential & others medicines | |
| 2014 | Michael S. Brown | UT Southwestern Medical Center at Dallas | Nobel Laureate, Professor of Molecular Genetics & Internal Medicine | Galien Forum USA | Heart attack guidelines | |
| 2013 | Michael S. Brown | UT Southwestern Medical Center at Dallas | Nobel Laureate, Professor of Molecular Genetics & Internal Medicine | Galien Forum USA | Gender & innovations facing covid 19 sub-theme 1: gender & response to covid 19. | |
| 2013 | Paula Brown | Novan, Inc. University of North Carolina, Chapel Hill, Co-Founder of Habergeon LLC | Chief Development Officer,Professor of Public Health Leadership | Galien Forum USA | What’s holding back the technology revolution in clinical trials? | |
| 2021 | Jason Brubaker | Blueprint Medicines | Vice President Medicinal Chemistry | Galien Week of innovation | What is the state of progress in building new therapeutic & diagnostic platforms to fight major cancers & address their prevalence in vulnerable populations, including the aged, minorities, & pediatric patients? | |
| 2021 | Anne Bruinvels | Px HealthCare | Chief Executive Officer | Galien Week of innovation | In what ways can these new technologies contribute to the realization of better outcomes for patients at less cost to overburdened health systems? | |
| 2021 | James Kyle Bryan | IQVIA Biotech | Chief Medical Officer | Galien Week of innovation | What is the state of progress in building new therapeutic & diagnostic platforms to fight major cancers & address their prevalence in vulnerable populations, including the aged, minorities, & pediatric patients? | |
| 2022 | Aby Buchbinder | Global Program Head | Galien Week of Innovation | Laureates Media Presentation | ||
| 2022 | Ulrike K Buchwald | Merck & Co., Inc | Executive Director, Global Clinical Development, Vaccine | Galien Week of Innovation | Biotech - Chronic/Autoimmune Disorders and Vaccines Given that many chronic diseases have an infectious origin, what learnings can be had by the most recent innovations in vaccine development technology in raising the bar on innovations to address the huge unmet need against conditions that kill millions? | |
| 2013 | Samantha Budd | Neuroscience iMed at AstraZeneca R&D | Vice President | Galien Forum USA | Neurodegenerative disease drug progress | |
| 2022 | Heather Bukant | Edwards Lifesciences | Director, Global Communications | Galien Webinars Series | Golden Jubilee - Best MedTech Category | |
| 2022 | Koos Burggraaf | Centre for Human Drug Research (CHDR) | CEO | Galien Forum Netherlands | #VALUE! | |
| 2022 | Paul Burton | Moderna | Chief Medical Officer | Galien Forum USA | Covid pandemic science 2022: current vaccines and treatments and the future outlook | |
| 2021 | Amy K. Butler | Thermo Fisher Scientific | Vice President & General Manager of Cell Biology, | Galien Forum USA | The marriage of technology & medicine: bringing out the best in each other | |
| 2016 | Sean Caffey | Replenish, Inc. | Co-Founder, Chairman, & Chief Executive Officer of Auricle, LLC. Co-Founder & Chairman | Galien Forum USA | Next generation antimicrobials – shaping policy to develop new business models | |
| 2015 | Sean Caffey | Replenish, Inc. | Co-Founder, Chairman, & Chief Executive Officer of Auricle, LLC. Co-Founder & Chairman | Galien Forum USA | Bioengineering for better health: what future for targeted drug delivery? | |
| 2022 | Giovanni Caforio | Bristol Myers Squibb | Chairman & Chief Executive Officer | Galien Forum USA | CEO Panel | |
| 2022 | Robert M. Califf | Food and drug administration | Commissioner | Galien Forum USA | Keynote | |
| 2021 | Robert M Califf | Verify & Google Health; Adjunct Professor, Duke University & Stanford University; Former FDA Deputy Commissioner to President Barack Obama | Head of Clinical Policy & Strategy, | Galien Forum USA | The future is decentralized -- how the paradigm has changed & what it means for modern trials | |
| 2013 | Robert M. Califf | Clinical & Translational Medicine, Director of the Duke Translational Medicine Institute (DTMI), & Professor of Medicine in the Division of Cardiology Duke University | Vice Chancellor | Galien Forum USA | The promise of gene therapy | |
| 2017 | John Camm | St George’s, University of London | Professor of Clinical Cardiology | Galien Forum USA | Atrial fibrillation | |
| 2020 | Monique Canto-Sperber | CNRS, France | Director of Research | Jerusalem Ethics Forum | Up-to-date reflection on society, medicine & reproduction | |
| 2019 | Monique Canto-Sperber | CNRS, France | Director of Research | Jerusalem Ethics Forum | Human reproduction: technical limit, ethical limit | |
| 2022 | Renaud Capdeville, MD | Novartis | Global Program Head AML | Galien Week of Innovation | Laureates Media Presentation | |
| 2012 | John Castellani | Pharmaceutical Research Manufacturers of America (PhRMA) | President & Chief Executive Officer | Galien Forum USA | 21st century science: building partnerships, managing for success | |
| 2021 | Jeffrey P. Castelli | Amicus Therapeutics | Chief Development Officer | Galien Week of innovation | Will clinical progress in therapies that promise a genetics-based cure for devastating rare diseases lead to similar downstream progress in patient access to these high-cost, high-touch treatments? | |
| 2021 | Cecile Cecile | Association of Burkinabe Women Lawyers | Lawyers | Galien Forum Africa | Socio-economic consequences, equity & gender in the global health security | |
| 2021 | Eric Chan | Teva Pharmaceuticals | Director of Product Management in Digital Health | Galien Week of innovation | How far are we from achieving the health system world of the connected patient? | |
| 2010 | Paul Chew | Sanofi-Aventis US Safety Signal Detection: The Promise & the Pitfalls“ | Senior Vice President,Chief Scientific Officer/Chief Medical Officer, Dr. | Galien Forum USA | The changing l& scape of pharmacovigilance: the impact on medical innovation & human health | |
| 2020 | Moredreck Chibi | WHO Africa Regional Office | Innovations Program Officer | Galien Forum Africa | Youth forum: leadership & young people facing covid-19 | |
| 2020 | Moredreck Chibi | WHO Africa Regional Office | Innovation Program Officer | Galien Forum Africa | What place for digital health & innovations? sub-theme 3: | |
| 2019 | Beatrice Childs | France | Psychoanalyst | Jerusalem Ethics Forum | Personalized genomics medicine: the value of knowing | |
| 2021 | Herve Chneiweiss | CNRS | Neurolugue Director de Resercher | Galien Webinars Series | The impact of digital technology in clinical trials: ethical considerations (french edition) | |
| 2020 | Mohamed Khaled Chouli | Large Social Organizations (Morocco) | Head of Department of Pre-clinical Sciences & Manager | Galien Forum Africa | Covid 19 drug supply chain in africa: challenges & perspectives | |
| 2021 | Khady Cisse | Organization for the Health of Children & Women – Cote d’Ivoire | President | Galien Forum Africa | The power of youth: how can young leaders contribute to sustainable change for healthier communities? | |
| 2021 | Alessio Ciulli | University of Dundee | Professor of Chemical & Structural Biology, School of Life Sciences, | Galien Forum USA | Drugging the undruggable» with novel approaches to small molecule design | |
| 2021 | Tony Clapsis | CVS Clinical Trial Services | Vice President | Galien Forum USA | The future is decentralized -- how the paradigm has changed & what it means for modern trials | |
| 2020 | Helen Clark | EITI International | President | Galien Forum Africa | Impact of the covid 19 pandemic on the natural resources sector sub-theme 2: | |
| 2022 | Christine Clemson | Albireo Pharma, Inc. | SVP, Global Head of Medical Affairs | Galien Week of Innovation | BioTech – Rare Diseases What is the underlying science behind clinical progress in therapies that promise a genetics-based cure for devastating rare diseases and how will this contribute to the next wave of innovations? What are the implications for continued patient access to these high-cost, high-touch 2 treatments – does the ROI calculation for rare diseases still add up? | |
| 2021 | Ron Cohen | Acorda Therapeutics, Inc. | President & Chief Executive Officer | Jerusalem Ethics Forum | The ethical obligations of pharmaceutical companies in a global health emergency – case study: covid-19 vaccines | |
| 2021 | Bruno Cohen | The Galien Foundation | Chairman | Galien Forum Africa | Youth leadership training (part 1) | |
| 2021 | Bruno Cohen | The Galien Foundation | Chairman | Galien Forum Africa | Youth leadership training | |
| 2021 | Bruno Cohen | The Galien Foundation | Chairman | Galien Forum Africa | Inaugural Panel | |
| 2021 | Bruno Cohen | The Galien Foundation | Chairman | Galien Forum Africa | Closing ceremony | |
| 2020 | Brigitte Fanny Cohen | Media | Journalist | Jerusalem Ethics Forum | Science, intelligence, ethics: a multi-faceted response to the challenges of covid-19 | |
| 2010 | Ron Cohen | Acorda Therapeutics | President & Chief Executive Officer | Galien Forum USA | Biomedical innovation: funding challenges & developing public/private partnership incentives | |
| 2022 | Ron Cohen | Acorda | President & CEO - Moderator | Galien Week of Innovation | Best Incubator/Accelerator/ equity - Clinical Trial Management and Wellness Care An innovator’s connection to a leadership accelerator, incubator or private equity organization is a strong indicator of success. Financial support is part of the commitment, as are experience and connections. How do these investment and counseling groups help start-ups with their clinical trial design, navigate regulatory and payer system complexities or build a go-to marketing plan? Beyond access to cash, what makes the innovator’s connection to an accelerator, incubator or private equity group success critical? | |
| 2022 | Heidi Cole | GT Medical Technologies, Inc. | Ass VP, R&D GT Medical Technologies | Galien Week of Innovation | Medical Devices and Implants – Cardiovascular and Cancer How are systems design, electronics and engineering making invasive, high-risk surgical procedures a thing of the past for these two major killers? | |
| 2021 | Awa Marie Coll Seck | CN-ITIE | Minister of State, President of the CN-ITIE, President of the Scientific Committee | Galien Forum Africa | Youth leadership training (part 1) | |
| 2021 | Awa Marie Coll Seck | CN-ITIE | Minister of State, President of the CN-ITIE, President of the Scientific Committee | Galien Forum Africa | Youth leadership training | |
| 2021 | Awa Marie Coll Seck | Minister of State (Senegal) | Minister of State, President of the CN-ITIE, President of the Scientific Committee | Galien Forum Africa | Women & stem in the global health security context | |
| 2021 | Awa Marie Coll Seck | President of NC-EITI, President of the Scientific Committee | Minister of State, President of the CN-ITIE, President of the Scientific Committee | Galien Forum Africa | Symposium one health – one africa : a new agenda for governance & the growth of a post-covid continent | |
| 2021 | Awa Marie Coll Seck | President of NC-EITI, President of the Scientific Committee | Minister of State, President of the CN-ITIE, President of the Scientific Committee | Galien Forum Africa | Inaugural Panel | |
| 2021 | Awa Marie Coll Seck | NC-EITI, | Minister of State, President of the CN-ITIE, President of the Scientific Committee | Galien Forum Africa | Closing ceremony | |
| 2018 | Awa Marie Coll Seck | CN-ITIE | Minister of State, President of the CN-ITIE, President of the Scientific Committee | Galien Forum Africa | Which plan for non communicable diseases? | |
| 2018 | Awa Marie Coll Seck | CN-ITIE | Minister of State, President of the CN-ITIE, President of the Scientific Committee | Galien Forum Africa | Remarkable women engage for humanity | |
| 2022 | Steven Collens | MATTER | CEO | Galien Week of Innovation | Best Incubator/Accelerator/ equity - Clinical Trial Management and Wellness Care An innovator’s connection to a leadership accelerator, incubator or private equity organization is a strong indicator of success. Financial support is part of the commitment, as are experience and connections. How do these investment and counseling groups help start-ups with their clinical trial design, navigate regulatory and payer system complexities or build a go-to marketing plan? Beyond access to cash, what makes the innovator’s connection to an accelerator, incubator or private equity group success critical? | |
| 2020 | Beth-Ann Coller | Merck & Co., Inc | Executive Director, Global Clinical Development | Galien Week of innovation | Can the foundational biologic understandings now being brought to cancer care be leveraged to secure a targeted, more personalized approach to other conditions? | |
| 2014 | Rory Collins | the University of Oxford's Clinical Trials Unit | Co-Director | Galien Forum USA | Heart attack guidelines | |
| 2018 | Bernard Colombo | Roche Diagnostics France | Chairman | Galien Forum Africa | Which plan for non communicable diseases? | |
| 2012 | Meryl Comer | Geoffrey Beene Foundation Alzheimer's Initiative | President | Galien Forum USA | Alzheimer's innovation & the white house 2025 m& ate:what will it take to find a treatment? | |
| 2021 | Celestin Compaore | DMPA-SC Project, Jhpiego 6 International | Regional Director | Galien Forum Africa | The power of youth: how can young leaders contribute to sustainable change for healthier communities? | |
| 2020 | Brian S. Conklin | Edwards Lifesciences | Senior Distinguished Engineer | Galien Week of innovation | How much are new technologies & engineering efficiencies contributing to progress against the world’s biggest killer? | |
| 2021 | Vlad Coric | Biohaven Pharmaceuticals | Chief Executive Officer | Galien Week of innovation | What can patients with chronic conditions expect from medicines advances within the next five to ten years? how is chronic disease research moving from incremental & maintenance therapies to real breakthroughs toward cure & prevention? | |
| 2022 | Mark Cornfeld | Incyte Corp. | VP Hemato. Onco. Clinical Det | Galien Week of Innovation | Solid Tumor Cancers What is the state of progress in extending cell-based gene therapies to fight solid tumor cancers? How successful has the pharma industry been in building new therapeutic and diagnostic platforms to fight major cancers and address their prevalence in vulnerable populations, including the aged, minorities, and pediatric patients? | |
| 2020 | Toumani Corrah | African Research Excellence Fund (AREF) (London - Gambia- USA) | Executive Director | Galien Forum Africa | Research facing covid 19 | |
| 2018 | Tumani Corrah | AREF, Gambie | Chief Executive Officer | Galien Forum Africa | Financing africa’s healthcare | |
| 2022 | Christopher Corsico | GSK | Global Head of Development | Galien Forum UK | Clinical trials & regulations: what have we learned from covid? | |
| 2020 | Sophie Coulbary | Association of Women Doctors of Senegal AFEMS (Senegal) | President | Galien Forum Africa | Professional women & covid 19 sub-theme 3: contribution of professional women in the response against covid 19: state of play, challenges & perspectives | |
| 2022 | Joseph Coulloc'h | AAZ-LMb | Founder & President | Galien Webinars Series | Golden Jubilee - Best MedTech Category | |
| 2022 | Angela Coxon, | Amgen | VP Research | Galien Week of Innovation | Laureates Media Presentation | |
| 2012 | Craig Crews | John C. Malone Professor of Molecular, Cellular, & Developmental Biology, Yale University | Galien Forum USA | Drugging the undruggable» with novel approaches to small molecule design | ||
| 2020 | Dan Cua | Janssen Biotech, Inc. | Vice President IL-23 Pathway Area Leader for the Immunology Therapeutic Area | Galien Week of innovation | Where is the growing science & its link to disease leading us in terms of new treatments for patients with unresolved chronic conditions? | |
| 2022 | Tom Daniel | Scripps Research Institute | MD Board of Directors | Galien Week of Innovation | Best Incubator/Accelerator/ equity - Disease Management Incubators and accelerators are pivotal in developing innovative solutions to address humanity’s most pressing health challenges. Why are academic institutions, major medical centers, and significant life science companies launching incubators and accelerators to offer guidance to biotech, digital health, health information, and medical device start-ups? Beyond financial resources, how are these groups working to advance ideas into the marketplace, and what is their impact? | |
| 2011 | Stephen Daniels | Hospital Colorado | Pediatrician-in-Chief, University of Colorado School of Medicine, L Joseph, Butterfield Chair in Pediatrics | Galien Forum USA | A global health challenge: the obesity & diabetes epidemic where are the innovations & who will pay for them? | |
| 2012 | Alice Dautry | Institut Pasteur | President | Galien Forum USA | Infectious diseases: a global healthcare challenge | |
| 2019 | Benjamin David | Pouah Center Israel | Medical Ethics Doctor | Jerusalem Ethics Forum | Personalized genomics medicine: the value of knowing | |
| 2019 | Benjamin David | Pouah Center Israel | Medical Ethics Doctor | Jerusalem Ethics Forum | Ethical considerations around patient choice & human enhancement in healthcare? | |
| 2011 | Brett Davis | Oracle Corporation, | Senior Director, Personalized Healthcare, Health Sciences Global Business Unit | Galien Forum USA | The next generation of health & research informatics accelerating translational research & personalized medicine at moffitt cancer center | |
| 2022 | Rob Davis | Merck & co. | CEO & president, | Galien Forum USA | CEO Panel | |
| 2015 | Geraldine Dawson | Duke Center for Autism & Brain Development, Duke University School of Medicine | Professor, Department of Psychiatry & Behavioral Sciences & Director, | Galien Forum USA | Autism - the next decade | |
| 2021 | Steph De Bono | Eli Lilly & Company | Senior Medical Director | Galien Week of innovation | What can patients with chronic conditions expect from medicines advances within the next five to ten years? how is chronic disease research moving from incremental & maintenance therapies to real breakthroughs toward cure & prevention? | |
| 2012 | Neil De Crescenzo | Oracle Health Sciences | Senior Vice President & General Manager, | Galien Forum USA | Welcome Remarks | |
| 2022 | Adam De la Zerda | Visby Medical, Inc. | Founder and CEO | Galien Week of Innovation | Disease Diagnostics and Digital Therapeutics How far are we from achieving the health system world of the connected patient? | |
| 2021 | Rui De Passos Sousa | Sanofi | Global Medical Head for the TTP program | Galien Week of innovation | Can the foundational biologic underst& ings now being brought to cancer care be leveraged to secure a targeted, more personalized approach to other rare conditions, particularly blood-based hematologic disorders? | |
| 2020 | Darryl De Vivo | Columbia University Medical Center | Sidney Carter Professor of Neurology & Pediatrics, | Galien Forum USA | Spinal muscular atrophy: charting the pathway to clinical progress | |
| 2014 | Laurent Degos | University of Paris Diderot & National Academy of Medicine | Member | Galien Foum Monaco | Innovation at what cost? make the voice of science and reason heard | |
| 2014 | Karl Deisseroth | Stanford University | Chen Professor of Bioengineering & of Psychiatry & Behavioral Sciences, | Galien Forum USA | The brain initiative | |
| 2020 | Bernard Delaey | Sanofi | Regulatory Therapeutic Area Lead | Galien Week of innovation | Can the foundational biologic underst& ings now being brought to cancer care be leveraged to secure a targeted, more personalized approach to other conditions? | |
| 2018 | George D. Demetri | Dana-Farber Cancer Institute Ludwig Center, Harvard Medical School; Associate Director for Clinical Sciences, Dana | Senior Vice President for Experimental Therapeutics, Professor of Medicine & Director | Galien Forum USA | Cancer in a time of disruption | |
| 2022 | Bela Denes | Lantheus | VP Global Medical Affairs | Galien Week of Innovation | Disease Diagnostics and Digital Therapeutics How far are we from achieving the health system world of the connected patient? | |
| 2011 | Alex Depaoli | NGM Biopharmaceuticals | Vice President of Translational Research, | Galien Forum USA | A global health challenge: the obesity & diabetes epidemic where are the innovations & who will pay for them? | |
| 2015 | Nancy-Ann Deparle | Consonance Capital Partners | Partner | Galien Forum USA | Us health reform: partnering, pricing & politics | |
| 2021 | Sue Desmond-Hellmann | Bill & Melinda Gates Foundation | Prix Galien Committee Chair & Former Chief Executive Officer | Galien Forum USA | Vaccines, drugs & the future of pandemics - - lessons from covid-19 | |
| 2020 | Sue Desmond-Hellmann | Bill & Melinda Gates Foundation | Prix Galien Committee Chair & Former Chief Executive Officer | Galien Forum USA | The next 50 years of innovation: where will it come from & how do we secure it? | |
| 2020 | Sue Desmond-Hellmann | Bill & Melinda Gates Foundation | Prix Galien Committee Chair & Former Chief Executive Officer | Galien Forum Africa | Research funding: state of play & perspectives sub-theme 4: | |
| 2020 | Sue Desmond-Hellmann | Bill & Melinda Gates Foundation | Prix Galien Committee Chair & Former Chief Executive Officer | Galien Forum Africa | Professional women & covid 19 sub-theme 3: contribution of professional women in the response against covid 19: state of play, challenges & perspectives | |
| 2020 | Sue Desmond-Hellmann | Bill & Melinda Gates Foundation | Prix Galien Committee Chair & Former Chief Executive Officer | Galien Forum USA | Closing remarks | |
| 2018 | Sue Desmond-Hellmann | Bill & Melinda Gates Foundation | Prix Galien Committee Chair & Former Chief Executive Officer | Galien Forum Africa | Remarkable women engage for humanity | |
| 2021 | Deepika Devadas | Grand Challenges Canada | Senior Program Advisor | Galien Forum Africa | Meeting of young innovators with investors | |
| 2022 | Nina Devlin | Vertex | SVP & Chief Communciations Officer | Galien Webinars Series | Golden Jubilee - Best Orphan Rare Category | |
| 2020 | Djiby Diagne | Emerging Senegal Plan (BOS - PSE) (Senegal) | Operational Monitoring Office | Galien Forum Africa | Place of local production in the pharmaceutical sector sub-theme 4: | |
| 2021 | Djiby Diakhate | National Council for Audiovisual Regulation CNRA – Senegal | Sociologist teacher | Galien Forum Africa | Communication of crisis or risk communication & community engagement (rcce) : what respective roles ? | |
| 2021 | Adja Diakhou Ndiaye | High Council on Health Security, One Health – Senegal | Permanent Secretary | Galien Forum Africa | Women’s leadership in global health security | |
| 2021 | Ndeye Fatou Diallo | Neighborhood godmother (Senegal), | Neighborhood godmother | Galien Forum Africa | Women’s leadership in global health security | |
| 2021 | Mohamadou Diallo | CIO Mag | Founder & Editor in Chief | Galien Forum Africa | Women & stem in the global health security context | |
| 2021 | Abdourahmane Diallo | Roll Back Malaria International – Guinea | Director | Galien Forum Africa | « one health » & « global health » approaches: are they complementaries or contradictories in the global health security context? | |
| 2018 | Abdourahmane Diallo | Presidency of the Republic of Guinea, Minister Counselor in charge of Health Issues | Director, Minister Counselor | Galien Forum Africa | Universal access to essential & others medicines | |
| 2017 | Marc Diamond | Center for Alzheimer’s & Neurodegenerative Disease, the University of Texas, Southwestern Medical Center | Distinguished Chair in Basic Brain Injury & Repair & Director, | Galien Forum USA | Closing symposium: treating neurodegenerative disease: the potential of prion-based therapies | |
| 2020 | Oley Dibba Wadda | GAM African Leadership Institute (Gambia) | President | Galien Forum Africa | Professional women & covid 19 sub-theme 3: contribution of professional women in the response against covid 19: state of play, challenges & perspectives | |
| 2013 | Andrew Dillon | National Institute for Health & Care Excellence (NICE), | Chief Executive | Galien Forum USA | Making medicines affordable | |
| 2021 | Ibrahima Cheikh Diong | United NationsDirector General of ARC – International – Senegal | Assistant Secretary-General | Galien Forum Africa | Communication of crisis or risk communication & community engagement (rcce) : what respective roles ? | |
| 2021 | Amadou Gallo Diop | Research & Innovation – MESRI Platform | Director General | Galien Forum Africa | Innovations & ethic for global health security | |
| 2020 | Amadou Gallo Diop | Research Ministry of Higher Education, Research & Innovation (Senegal) | Director General | Galien Forum Africa | Research funding: state of play & perspectives sub-theme 4: | |
| 2021 | Waly Diouf | DANGOTE Cement Senegal | Director of Human Resources | Galien Forum Africa | Meeting of young innovators with investors | |
| 2021 | Abdoulaye Diouf Sarr | Minister of Health & Social Action Senegal | Minister of Health | Galien Forum Africa | « one health » & « global health » approaches: are they complementaries or contradictories in the global health security context? | |
| 2018 | Abdoulaye Diouf Sarr | Senegal | Minister of Health | Galien Forum Africa | Financing africa’s healthcare | |
| 2022 | Graham Dixon | Mayne Pharma | Chief Scientific Officer | Galien Week of Innovation | Anti-Viral Drugs and Women’s Health With a global pandemic raising awareness of the importance of vaccines and anti-viral/anti-microbial drugs, are private-sector R&D incentives aligned to meet future contagion threats? Gauging unmet needs in women’s health therapeutics and promising new drugs in the development stage | |
| 2021 | Yacine Djibo | Speak Up Africa | Founder & Executive Director | Galien Forum Africa | Women & stem in the global health security context | |
| 2020 | Yacine Djibo | Speak Up Africa | Founder & Executive Director | Galien Forum Africa | Multisectoral & community participation: strengths, weaknesses & recommendations sub-theme 4: | |
| 2022 | Mikael Dolsten | Pfizer Inc | Chief Scientific Officer & President, Worldwide Research | Galien Forum USA - Chair | Covid pandemic science 2022: current vaccines and treatments and the future outlook | |
| 2021 | Mikael Dolsten | Pfizer Inc | Chief Scientific Officer & President, Worldwide Research | Galien Forum USA | Where will new therapies & vaccines come from? | |
| 2020 | Mikael Dolsten | Pfizer Inc | Chief Scientific Officer & President, Worldwide Research | Galien Forum USA | The promise of gene therapy | |
| 2020 | Mikael Dolsten | Pfizer Inc | Chief Scientific Officer & President, Worldwide Research | Galien Forum USA | The future of therapeutics: what novel modalities will be drugs? what vaccines & technologies will we need? | |
| 2020 | Mikael Dolsten | Pfizer Inc | Chief Scientific Officer & President, Worldwide Research | Galien Forum USA | Drugging the undruggable» with novel approaches to small molecule design | |
| 2017 | Mikael Dolsten | Pfizer Inc. | Chief Scientific Officer & President, Worldwide Research | Galien Forum USA | Inflammatory skin diseases & mechanistic interconnections to other inflammation disorders | |
| 2016 | Mikael Dolsten | Pfizer Inc. | Chief Scientific Officer & President, Worldwide Research | Galien Forum USA | Precision medicine: delivering on the promise | |
| 2014 | Mikael Dolsten | Pfizer Inc. | Chief Scientific Officer & President, Worldwide Research | Galien Forum USA | A new agenda for global health | |
| 2013 | Mikael Dolsten | Pfizer Inc | Chief Scientific Officer & President, Worldwide Research | Galien Forum USA | Improving efficiency in drug development | |
| 2021 | Habib Douagui | Algerian Society of Asthmology, Allergology & Clinical Immunology (SAAIC); Member of the Executive Committee of Respiratory Diseases & Allergies at the World Allergy Organization (WAO) International – Algeria | President | Galien Forum Africa | « one health » & « global health » approaches: are they complementaries or contradictories in the global health security context? | |
| 2020 | Philippe Douste-Blazy | United Nations | Deputy General Secretary | Jerusalem Ethics Forum | Science, intelligence, ethics: a multi-faceted response to the challenges of covid-19 | |
| 2019 | Philippe Douste-Blazy | United Nations | Deputy General Secretary | Jerusalem Ethics Forum | Health policy & financing innovation: ethical considerations, cost & the role of the patient | |
| 2019 | Philippe Douste-Blazy | United Nations | Deputy General Secretary | Jerusalem Ethics Forum | 2020/2030 agenda “facing the next ethical challenges” | |
| 2018 | Philippe Douste-Blazy | United Nations | Deputy General Secretary | Galien Forum Africa | Which health insurance for the african continent? | |
| 2018 | Philippe Douste-Blazy | United Nations | Deputy General Secretary | Galien Forum Africa | Which health insurance for the african continent? | |
| 2022 | Cristal Downing | Merck & Co | Executive Vice President & Chief Communications and Public Affairs Officer | Galien Webinars Series | Golden Jubilee - Best Pharmaceutical Category | |
| 2015 | William F. Doyle | NovoCure, Ltd. | Executive Chairman | Galien Forum USA | Bioengineering for better health: what future for targeted drug delivery? | |
| 2019 | Nancy Dreyer | IQVIA | Chief Scientific Officer | Galien Forum USA | Digital health -orchestrating patient- centricity from molecule to market | |
| 2016 | Daniel J. Drucker | Research Institute Mt. Sinai Hospital Toronto Ontario, Canada | Senior Scientist, Lunenfeld Tanenbaum | Galien Forum USA | Diabetes mellitus & cardiovascular risk – on the rise, fall & novel possibilities with glucose lowering drugs | |
| 2020 | Philippe Duneton | United Nations | Executive Director | Galien Forum Africa | Place of local production in the pharmaceutical sector sub-theme 4: | |
| 2018 | Philippe Duneton | UNITAID | Director | Galien Forum Africa | Universal access to essential & others medicines | |
| 2022 | Adam Dunki-Jacobs | Standard Bariatrics, Inc. | Titan SGS® | Galien Week of Innovation | Medical Devices and Implants - Other Therapeutic Areas What is Med Tech innovation doing for patients with specialized needs for treatment? | |
| 2021 | Cristina Duran | AstraZeneca | Chief Digital Health Officer, R&D | Galien Forum USA | The future is decentralized -- how the paradigm has changed & what it means for modern trials | |
| 2022 | Tim Durst | Accenture | Global Medical Technology Sector Lead - Moderator | Galien Week of Innovation | Medical Devices and Implants – Cardiovascular and Cancer How are systems design, electronics and engineering making invasive, high-risk surgical procedures a thing of the past for these two major killers? | |
| 2014 | Gerard Duru | CNRS | Honorary Research Director | Galien Foum Monaco | Innovation at what cost? make the voice of science and reason heard | |
| 2021 | Mette Dyhrberg | Mymee | Founder & Chief Executive Officer | Galien Week of innovation | In what ways can these new technologies contribute to the realization of better outcomes for patients at less cost to overburdened health systems? | |
| 2022 | Craig Eagle | Guardant Health | CMO | Galien Week of Innovation | Disease Diagnostics and Digital Therapeutics How far are we from achieving the health system world of the connected patient? | |
| 2021 | Jamey Edwards | Cloudbreak Health | Chief Executive Officer | Galien Webinars Series | Data governance in a converging world: public & private sector approaches to the management of emerging health technologies. | |
| 2020 | Mark Milton Edwards | Teva Pharmaceutical Industries | Head of Product & Health Solutions – Digital Health | Galien Week of innovation | How far are we from achieving the health system world of the connected patient? | |
| 2020 | Pierre Effa | Pan-African Ethics & Bioethics Congress (COPAB) | President | Galien Forum Africa | Current situation of the response, challenges & prospects.sub-theme 1: | |
| 2020 | Serge Eholie | Ivory Coast | Head of the ALERRT work platform | Galien Forum Africa | Management of patients positive for sars-cov2: management, challenges & perspectives sub-theme 3: | |
| 2010 | Paul Eisenberg | Amgen Strategies for Incorporating Continuous Benefit: Risk into Drug Developmen | Global Regulatory Affairs & Safety | Galien Forum USA | The changing l& scape of pharmacovigilance: the impact on medical innovation & human health | |
| 2022 | Sathya Elumalai | Aidar Health | President & CEO Aidar Health | Galien Week of Innovation | Digital Health Solution - Clinical Trial Management and Wellness Care Are researchers, physicians and regulators ready to embrace advanced, low-touch approaches to streamline the cumbersome infrastructure of clinical trials? And are insurers and health systems prepared to reward software- driven patient self-care technologies, particularly by recognizing prevention and wellness as an integral element of service provision? | |
| 2021 | Ezekiel J. Emanuel | University of Pennsylvania | Vice Provost for Global Initiatives & Professor & Co-Director, Healthcare Transformation Institute | Jerusalem Ethics Forum | The ethical obligations of pharmaceutical companies in a global health emergency – case study: covid-19 vaccines | |
| 2014 | Ezekiel J. Emanuel | University Professor Perelman School of Medicine & The Wharton School University of Pennsylvania | Vice Provost for Global Initiatives, Chair, Department of Medical Ethics & Health Policy Levy | Galien Forum USA | Us health reform | |
| 2019 | David R. Epstein | Flagship Pioneering | Executive Partner | Galien Forum USA | What’s holding back the technology revolution in clinical trials? | |
| 2017 | David Epstein | Novartis Pharmaceuticals | Former Chief Executive Officer & Division Head | Galien Forum USA | Moderator | |
| 2016 | David Epstein | Novartis Pharmaceuticals | Former Chief Executive Officer & Division Head | Galien Forum USA | Promise - & politics - in the fight against cancer | |
| 2016 | David Epstein | Novartis Pharmaceuticals | Former Chief Executive Officer & Division Head | Galien Forum USA | Promise - & politics - in the fight against cancer | |
| 2011 | Robert S. Epstein | Medco Health Solutions, Inc. | Chief Clinical Research & Development Officer | Galien Forum USA | What is "value" & how can it be measured & demonstrated in therapeutic innovations? breaking down the barriers of the past | |
| 2021 | Barış Erdoğan | Clinerion | Chief Executive Officer | Galien Week of innovation | Will the success of novel, gene-based therapies in advancing survival timelines in blood & bone marrow cancers be repeated in the solid tumor setting, with therapies that address each tumor’s individual genetic profile rather than association with its geographic location in the body? | |
| 2020 | Daniel Everitt | TB Alliance | Vice President & Chief Medical Officer | Galien Week of innovation | Will the coronavirus pandemic finally lead to an upswing in r&d to tackle neglected areas like antibiotic resistance, zoonotic transmission of pathogens & a more globally-coordinated approach to infectious diseases overall? | |
| 2021 | Ibrahima Soce Fall | Emergency Response at WHO International – Senegal | Assistant Director-General | Galien Forum Africa | Covid 19 lessons learned, autonomy & sovereignty of africa sub topic 6 | |
| 2020 | Ibrahima Soce Fall | Emergency Response (WHO-Geneva) | Assistant Director-General | Galien Forum Africa | Health break | |
| 2021 | Barbara Fant | Clinical Research Consultants, Inc. | President | Galien Week of innovation | What is med tech innovation doing for patients with specialized needs for treatment? | |
| 2020 | Barbara Fant | Clinical Research Consultants, Inc. | President | Galien Week of innovation | How far are we from achieving the health system world of the connected patient? | |
| 2021 | Anthony S. Fauci | NIAID & Chief Advisor to the President of the United States | Director | Galien Forum USA | Keynote | |
| 2021 | Anthony S. Fauci | NIAID & Chief Advisor to the President of the United States | Director | Galien Forum USA | Galien golden jubilee special address | |
| 2022 | Anthony S. Fauci | NIAID & chief advisor to the president of the united states | Director | Galien Forum USA | Special Address Galien Golden Jubilee | |
| 2021 | Olufunmilayo Fawole | Faculty of Public Health at the University of Ibadan – Nigeria | Epidemiologist & Dean | Galien Forum Africa | Involvement of women researchers in the mhw | |
| 2021 | Jessica Federer | Bayer | Partner Boston Millenia Partners Former CDO | Galien Week of innovation | Will progress in therapies that promise a genetic cure for devastating rare diseases lead to similar innovations in patient access to these high-cost, high-touch treatments? | |
| 2021 | Jessica Federer | Bayer | Partner Boston Millenia Partners Former CDO | Galien Webinars Series | The impact of digital technologies in transforming & accelerating vaccine trials, development & delivery – lessons from covid-19 part 3 | |
| 2021 | Jessica Federer | Bayer | Partner Boston Millenia Partners Former CDO | Galien Webinars Series | The impact of digital technologies in transforming & accelerating vaccine trials, development & delivery – lessons from covid-19 | |
| 2021 | Jessica Federer | Bayer, HUMA | Managing Director; HUMA Former Chief Digital Officer | Galien Webinars Series | Data governance in a converging world: public & private sector approaches to the management of emerging health technologies. | |
| 2020 | Jessica Federer | Bayer | Partner Boston Millenia Partners Former CDO | Galien Webinars Series | Digital health improving research & care | |
| 2022 | Jessica Federer | Supernode Ventures | MP - Moderator | Galien Week of Innovation | Disease Diagnostics and Digital Therapeutics How far are we from achieving the health system world of the connected patient? | |
| 2022 | Jessica Federer | Supernode Ventures | MP - Moderator | Galien Week of Innovation | Rare Genetic Diseases Will progress in therapies that promise a genetic cure for devastating rare diseases lead to similar innovations in patient access to these high-cost, high-touch treatments? | |
| 2014 | Mark Feinberg | IAVI | Chief Executive Officer | Galien Forum USA | Preparing for the next pandemic: development & delivery of new wave innovations in vaccines | |
| 2020 | Marc Fellous | Bayer | Global Medical Affairs Head | Galien Week of innovation | What are the prospects – & limitations – behind the new approaches to cancer treatments from our increased knowledge of the underlying biology behind tumor growth & proliferation? | |
| 2016 | David Feltquate | Bristol-Myers Squibb | Vice President, Immuno-Oncology Development, | Galien Forum USA | Precision medicine: delivering on the promise | |
| 2014 | Adolfo Ferrando | Institute for Cancer Genetics,Columbia University Medical Center | Prize Winner & Associate Professor of Pediatrics & Pathology, | Galien Forum USA | Pioneers for a cure: the role of innovation & entrepreneurship in cancer research | |
| 2018 | Mauro Ferrari | Houston Methodist Research Institute,Houston Methodist Hospital System | Ernest Cockrell Jr. Presidential Distinguished Chair, President & Chief Executive Officer, Executive Vice President, | Galien Forum USA | What’s holding back the technology revolution in clinical trials? | |
| 2019 | Michael Fischbach | Stanford University | Associate Professor of Bioengineering | Galien Forum USA | The gut microbiome: opportunities & challenges | |
| 2021 | Senait Fisseha | Susan Thompson Buffett Foundation International – Ethiopia | Director of International Programs | Galien Forum Africa | Socio-economic consequences, equity & gender in the global health security | |
| 2021 | Senait Fisseha | Susan Thompson Buffett Foundation International – Ethiopia | Director of International Programs | Galien Forum Africa | Closing ceremony | |
| 2020 | Senait Fisseha | Susan Thompson Buffett Foundation International – Ethiopia | Director of International Programs | Galien Forum Africa | Place of women in innovation related to covid 19 sub-theme 2: | |
| 2011 | Martin Fitchet | Johnson & Johnson, Pharmaceutical Research & Development | Chief Operating Officer | Galien Forum USA | A global health challenge: the obesity & diabetes epidemic where are the innovations & who will pay for them? | |
| 2018 | Julian Fleet | START-International (USA) | Ethical specialist | Galien Forum Africa | The health consequences of climate change | |
| 2019 | Emmanuel Fombu | The Future of Healthcare | Medical Futurist | Galien Forum USA | Digital health -orchestrating patient- centricity from molecule to market | |
| 2019 | Emmanuel Fombu | The Future of Healthcare | Medical Futurist | Jerusalem Ethics Forum | “artificial intelligence & ethics” | |
| 2021 | Joanne Micale Foody | Esperion | Chief Medical Officer | Galien Week of innovation | Will progress in therapies that promise a genetic cure for devastating rare diseases lead to similar innovations in patient access to these high-cost, high-touch treatments? | |
| 2017 | Jean Francois Formela | Atlas Ventures | Partner | Galien Forum USA | Addressing unmet medical needs with early-stage life science venture capital | |
| 2014 | Richard N. Foster | Healthcare Innovation, Yale University;Director Emeritus, McKinsey & Company | Venture Partner, Lux Capital; Special Advisor to the President | Galien Forum USA | The future of digital health | |
| 2021 | Jacqualyn Fouse | Agios | Chief Executive Officer | Galien Forum USA | How will we be paying for medicine 10 years from now? (Chief Executive Officers panel) | |
| 2020 | Susannah Fox | U.S. Department of Health & Human Services | Independent Consultant & Health Care Innovation Leader & Former Chief Technology Officer | Galien Week of innovation | How far are we from achieving the health system world of the connected patient? | |
| 2021 | Kenneth C. Frazier | Merck & Co., Inc | Chairman of the Board - President & Chief Executive Officer | Galien Forum USA | Keynote remarks & a discussion with | |
| 2020 | Kenneth C. Frazier | Merck & Co., Inc | Chairman of the Board - President & Chief Executive Officer | Galien Forum USA | Combating the opioid crisis in america | |
| 2015 | Bud Frazier | Baylor College of Medicine & the University of Texas Health Science Center, Chief of the Center for Cardiac Support at The Texas Heart Institute | Professor of Surgery | Galien Forum USA | Confronting the crisis of heart failure: innovation in pharmacology & medical devices | |
| 2015 | Kenneth C. Frazier | Merck & Co., Inc | Chairman of the Board - President & Chief Executive Officer | Galien Forum USA | Us health reform: partnering, pricing & politics | |
| 2013 | Kenneth C. Frazier | Merck & Co., Inc | Chairman of the Board - President & Chief Executive Officer | Galien Forum USA | Affordable care act us healthcare in transition: the stakes for industry | |
| 2016 | Maria C. Freire | Foundation for the National Institutes of Health | President & Executive Director | Galien Forum USA | Next generation antimicrobials – shaping policy to develop new business models | |
| 2012 | Maria C. Freire | Albert & Mary Lasker Foundation | President | Galien Forum USA | Infectious diseases: a global healthcare challenge | |
| 2022 | Greg Friberg | Amgen Inc. | VP Medical Affairs ELMAC Region | Galien Week of Innovation | Solid Tumor Cancers What is the state of progress in extending cell-based gene therapies to fight solid tumor cancers? How successful has the pharma industry been in building new therapeutic and diagnostic platforms to fight major cancers and address their prevalence in vulnerable populations, including the aged, minorities, and pediatric patients? | |
| 2011 | Jeffrey Friedman | Investigator Howard Hughes Medical Institute, Laboratory of Genetics, The Rockefeller University | Marilyn M Simpson Professor | Galien Forum USA | A global health challenge: the obesity & diabetes epidemic where are the innovations & who will pay for them? | |
| 2022 | Johannes Fruehauf | BioLabs | Founder, President | Galien Week of Innovation | Laureates Media Presentation | |
| 2022 | Johannes Fruehauf | BioLabs and LabCentral | Founder President | Galien Week of Innovation | Best Incubator/Accelerator/ equity - Disease Management Incubators and accelerators are pivotal in developing innovative solutions to address humanity’s most pressing health challenges. Why are academic institutions, major medical centers, and significant life science companies launching incubators and accelerators to offer guidance to biotech, digital health, health information, and medical device start-ups? Beyond financial resources, how are these groups working to advance ideas into the marketplace, and what is their impact? | |
| 2020 | Rene Frydman | Antoine Beclere Hospital, France | Head of the Department of Gynecology & Obstetrics | Jerusalem Ethics Forum | Up-to-date reflection on society, medicine & reproduction | |
| 2020 | Rene Frydman | Antoine Beclere Hospital, France | Head of the Department of Gynecology & Obstetrics | Jerusalem Ethics Forum | Science, intelligence, ethics: a multi-faceted response to the challenges of covid-19 | |
| 2019 | Rene Frydman | Antoine Beclere Hospital, France | Head of the Department of Gynecology & Obstetrics | Jerusalem Ethics Forum | Human reproduction: technical limit, ethical limit | |
| 2019 | Rene Frydman | Antoine Beclere Hospital, France | Head of the Department of Gynecology & Obstetrics | Jerusalem Ethics Forum | 2020/2030 agenda “facing the next ethical challenges” | |
| 2012 | Les Funtleyder | Polliwog | Fund Manager | Galien Forum USA | The changing face of chinese healthcare | |
| 2011 | Les Funtleyder | Miller Tabak | Healthcare Strategist & Portfolio Manager, Health Care Transformation Fund | Galien Forum USA | Funding innovation new trends in the healthcare m&a l& scape | |
| 2012 | John Furey | Spark Therapeutics Inc. | Chief Operating Officer | Galien Forum USA | Making medicines affordable | |
| 2019 | Gilles Gade | Cross River | Founder, President & Chief Executive Officer | Jerusalem Ethics Forum | Health policy & financing innovation: ethical considerations, cost & the role of the patient | |
| 2019 | Gilles Gade | Cross River | Founder, President & Chief Executive Officer | Jerusalem Ethics Forum | 2020/2030 agenda “facing the next ethical challenges” | |
| 2018 | Priya Gajraj | PNUD - Dakar | Resident Representative | Galien Forum Africa | Which health insurance for the african continent? | |
| 2012 | Diana Gallagher | Biogen | Head of External Innovation, | Galien Forum USA | Infectious diseases: a global healthcare challenge | |
| 2021 | Pushkal Garg | Alnylam | Chief Medical Officer | Galien Week of innovation | Will clinical progress in therapies that promise a genetics-based cure for devastating rare diseases lead to similar downstream progress in patient access to these high-cost, high-touch treatments? | |
| 2020 | Pushkal Garg | Alnylam | Chief Medical Officer | Galien Week of innovation | Will progress in therapies that promise a genetic cure for devastating rare diseases lead to similar innovations in patient access to these highcost, high-touch treatments? | |
| 2021 | Diane Gashumba | Former Minister of Health of Rwanda | Ambassador | Galien Forum Africa | Women’s leadership in global health security | |
| 2020 | Diane Gashumba | Former Minister of Health of Rwanda | Ambassador | Galien Forum Africa | Health & socio-economic impact of the covid 19 pandemic in africa sub-theme 1: resilience of health systems & continuity of care: state of play, challenges & rerspectives | |
| 2018 | Diane Gashumba | Former Minister of Health of Rwanda | Ambassador | Galien Forum Africa | Which health insurance for the african continent? | |
| 2022 | Natacha Gassenbach | Biogen | Head of Corporate Affairs, Chief Communications Officer | Galien Webinars Series | Golden Jubilee - Best Orphan Rare Category | |
| 2022 | Judy Gawlik Brown | Amgen | SVP, Corporate Affairs | Galien Webinars Series | Golden Jubilee - Best Orphan Rare Category | |
| 2021 | Julie Louise Gerberding | Merck & Co., Inc. | Chief Patient Officer & Executive Vice President, Population Health & Sustainability | Jerusalem Ethics Forum | Highly prevalent neglected diseases: developing medicines & building infrastructure for the rest of the world | |
| 2016 | Julie Louise Gerberding | Merck & Co., Inc. | Executive Vice-President, Chief Patient Officer & Head of Policy | Galien Forum USA | Keynote | |
| 2015 | Julie Louise Gerberding | Merck & Co., Inc. | Executive Vice-President, Chief Patient Officer & Head of Policy | Galien Forum USA | Preparing for the next pandemic: development & delivery of new wave innovations in vaccines | |
| 2012 | Julie Louise Gerberding | Merck Vaccines, Merck & Co., Inc.; Former Director, Centers for Disease Control & Prevention (CDC) | President | Galien Forum USA | Infectious diseases: a global healthcare challenge | |
| 2011 | Barry Gertz | Merck | Senior Vice President, & head of clinical research & regulatory affairs | Galien Forum USA | What is "value" & how can it be measured & demonstrated in therapeutic innovations? breaking down the barriers of the past | |
| 2021 | Ken Getz | Tufts Center for the Study of Drug DevelopmentTufts University School of Medicine | Director | Jerusalem Ethics Forum | Inclusive medicine: how modern research amplifies outcomes for patient access, inclusion & diversity | |
| 2021 | Tedros A. Ghebreyesus | WHO | Director General | Galien Forum Africa | Inaugural Panel | |
| 2021 | Tedros A. Ghebreyesus | WHO | Director General | Galien Forum Africa | Closing ceremony | |
| 2018 | Tedros A. Ghebreyesus | WHO (World Health Organization) | Director General | Galien Forum Africa | Which health insurance for the african continent? | |
| 2018 | Tedros A. Ghebreyesus | World Health Organization | Director General | Galien Forum Africa | Which health insurance for the african continent? | |
| 2020 | Gargee Ghosh | Bill & Melinda Gates Foundation | Director of Development Policy & Finance | Galien Forum Africa | Financing the response to covid 19 | |
| 2018 | Gambie Gargee Ghosh | Bill & Melinda Gates Foundation | Director of Development Policy & Finance | Galien Forum Africa | Financing africa’s healthcare | |
| 2022 | Mati Gill | AION Labs | CEO | Galien Week of Innovation | Best Incubator/Accelerator/ equity - Disease Management Incubators and accelerators are pivotal in developing innovative solutions to address humanity’s most pressing health challenges. Why are academic institutions, major medical centers, and significant life science companies launching incubators and accelerators to offer guidance to biotech, digital health, health information, and medical device start-ups? Beyond financial resources, how are these groups working to advance ideas into the marketplace, and what is their impact? | |
| 2014 | Michael Giordano | Oncology & Immunoscience at Bristol-Myers Squibb | Senior Vice President, Head of Development, | Galien Forum USA | Cancer immunotherapeutics | |
| 2020 | Nicanor Giorgio Austriaco | Providence College | Biology & Theology | Jerusalem Ethics Forum | Societal, legal & ethical challenges around access to covid-19 vaccines | |
| 2019 | Nicanor Giorgio Austriaco | Providence College | Biology & Theology | Jerusalem Ethics Forum | Ethical considerations around patient choice & human enhancement in healthcare? | |
| 2020 | Sophie Gladima | Senegal | Minister of Petroleum & Energy | Galien Forum Africa | Professional women & covid 19 sub-theme 3: contribution of professional women in the response against covid 19: state of play, challenges & perspectives | |
| 2018 | Sophie Gladima Siby | Senegal | Minister of Industries | Galien Forum Africa | Plenary Panel - women in stem in africa | |
| 2021 | Laurie H. Glimcher | Harvard Medical School | President & Chief Executive Officer, Dana-Farber Cancer Institute, Richard & Susan Smith, Professor of Medicine, | Galien Forum USA | New breakthroughs in the biology of cancer: pioneering novel ways to enhance & restore the body’s ability to fight cancer | |
| 2015 | Laurie H. Glimcher | Cornell University, New York | Dean of Weill Cornell Medical College & Provost for Medical Affairs | Galien Forum USA | Microbiota in human diseases | |
| 2014 | Laurie H. Glimcher | Cornell University | Dean of Weill Cornell Medical College & Provost for Medical Affairs | Galien Forum USA | Cancer immunotherapeutics | |
| 2021 | Claire Gloeckner | Becton-Dickinson | Senior Staff Scientist | Galien Week of innovation | What is med tech innovation doing for patients with specialized needs for treatment? | |
| 2014 | Joseph Goldstein | UT, Southwestern Medical Center at Dallas | Nobel Laureate, Professor of Molecular Genetics & Internal Medicine, | Galien Forum USA | Heart attack guidelines | |
| 2013 | Joseph Goldstein | UT, Southwestern Medical Center at Dallas | Nobel Laureate, Professor of Molecular Genetics & Internal Medicine, | Galien Forum USA | Personalized medicine: effect on drug r&d & patient care | |
| 2015 | Jeff Gordon | Robert Glaser University Center for Genome Sciences & Systems Biology at Washington University in St. Louis | Professor & Director | Galien Forum USA | Microbiota in human diseases | |
| 2015 | Jeff Gordon | Robert Glaser University Center for Genome Sciences & Systems Biology at Washington University in St. Louis | Professor & Director | Galien Forum USA | Keynote | |
| 2016 | Alex Gorsky | Johnson & Johnson | Chairman of the Board - President & Chief Executive Officer | Galien Forum USA | Promise - & politics - in the fight against cancer | |
| 2013 | Alex Gorsky | Johnson & Johnson | Chairman of the Board - President & Chief Executive Officer | Galien Forum USA | Affordable care act us healthcare in transition: the stakes for industry | |
| 2016 | Scott Gottlieb | Food & Drug Administration | Former Commissioner of the U.S. | Galien Forum USA | Keynote dialogue life science companies: public health institutions or black hats? | |
| 2021 | Raymonde Goudou Coffie | Lakes District Former Minister of Health Ivory Coast | Minister Governor | Galien Forum Africa | Women’s leadership in global health security | |
| 2020 | Raymonde Goudou Coffie | Lakes District Former Minister of Health Ivory Coast | Minister Governor | Galien Forum Africa | Professional women & covid 19 sub-theme 3: contribution of professional women in the response against covid 19: state of play, challenges & perspectives | |
| 2021 | Ann M. Graybiel | MIT | Institute Professor, Department of Brain & Cognitive Science, | Galien Forum USA | Future pathways in translational medicine -- academic-industry collaborations in cns diseases | |
| 2010 | Paul Greengard | Rockefeller University | Nobel Laureate Professor | Galien Forum USA | Translational neuroscience: academic-industrial collaborations in cns diseases | |
| 2016 | Philip D. Gregory | Bluebird | Chief Scientific Officer | Galien Forum USA | The promise of gene therapy | |
| 2020 | Jessica Grossman | Medicines360 | Chief Executive Officer | Galien Week of innovation | Where is the growing science & its link to disease leading us in terms of new treatments for patients with unresolved chronic conditions? | |
| 2014 | Dan Grossman | Boston Consulting Group | Managing Director & Senior Partner. Health Care Practice Area, | Galien Forum USA | A new agenda for global health | |
| 2014 | Scott Grundy | Texas Southwestern Medical Center; Center for Human Nutrition University | Professor | Galien Forum USA | Heart attack guidelines | |
| 2021 | Henri Gueye | EYONEInvestors | Founder & Chief Executive Officer | Galien Forum Africa | Meeting of young innovators with investors | |
| 2021 | Arame Gueye Sene | Social Change Factory – Senegal | Executive Director | Galien Forum Africa | The power of youth: how can young leaders contribute to sustainable change for healthier communities? | |
| 2022 | Vishal Gulati | Deeptech / Healthtech VC | Director | Galien Forum UK | Digital health innovation: a key driver of next generation healthcare – what & when? | |
| 2021 | Ira Gupta | GSK | Vice President, Medicines Development Leader – Global Oncology Therapy Area | Galien Week of innovation | Can the foundational biologic understandings now being brought to cancer care be leveraged to secure a targeted, more personalized approach to other rare conditions, particularly blood-based hematologic disorders? | |
| 2020 | Fred Guterl | The Fate of the Species | Author | Jerusalem Ethics Forum | Tracking bioethics: transparency, trust & the industry’s social imperatives | |
| 2021 | Sebastian Guth | Bayer Pharmaceuticals, Americas Region | President | Galien Forum USA | The future is decentralized -- how the paradigm has changed & what it means for modern trials | |
| 2020 | Shwen Gwee | Bristol Myers Squibb | Vice President & Head of Global Digital Strategy | Galien Webinars Series | Digital health in the aftermath of covid-19 | |
| 2012 | Kimberly Ha | Biopharm Insight | Global Editor | Galien Forum USA | The changing face of chinese healthcare | |
| 2011 | Kimberly Ha | Biopharm Insight | Global Editor | Galien Forum USA | Funding innovation new trends in the healthcare m&a l& scape | |
| 2021 | Amir Aman Hagos | Health of Ethiopia International – Ethiopia | GFF Strategic Advisor | Galien Forum Africa | Covid 19 lessons learned, autonomy & sovereignty of africa sub topic 1 | |
| 2022 | William N. Hait | Johnson & Johnson | Global Head, Research & Development | Galien Forum USA | Diversity and health equity in the future creation of medicine | |
| 2014 | William N. Hait | Janssen Research & Development | Global Head, Research & Development | Galien Forum USA | A new agenda for global health | |
| 2015 | John Hambor | Research Administration Boehringer Ingelheim Pharmaceuticals, Inc. | Distinguished Research Fellow | Galien Forum USA | Microbiota in human diseases | |
| 2016 | Margaret A. Hamburg | Food & Drug Administration | Former Commissioner of the U.S. | Galien Forum USA | Promise - & politics - in the fight against cancer | |
| 2015 | Margaret A. Hamburg | Food & Drug Administration | Former U.S. Commissioner | Galien Forum USA | Delivering on the patient promise of gene therapy | |
| 2012 | Margaret A. Hamburg | U.S. Food & Drug Administration | Commissioner, | Galien Forum USA | Ethics of innovation, under the auspices of the elie wiesel foundation for humanity | |
| 2012 | Margaret A. Hamburg | Food & Drug Administration | Commissioner | Galien Forum USA | Infectious diseases: a global healthcare challenge | |
| 2018 | Patrice A. Harris | American Medical Association | President-elect, | Galien Forum USA | Novel approaches to combatting opioid addiction | |
| 2021 | Fatima Hassan | Health Justice Initiative HJI – South Africa | Founder | Galien Forum Africa | Innovations & ethic for global health security | |
| 2012 | Fred Hassan | Bausch & Lomb | Chairman of the Board - President & Chief Executive Officer | Galien Forum USA | “looking back, moving forward” | |
| 2020 | Richard Hatchett | Coalition for Epidemic Preparedness Innovations | Chief Executive Officer | Galien Forum Africa | Vaccine production: state of play & perspectives sub-theme 3 | |
| 2020 | Richard Hatchett | Coalition for Epidemic Preparedness Innovations | Chief Executive Officer | Jerusalem Ethics Forum | Societal, legal & ethical challenges around access to covid-19 vaccines | |
| 2019 | Richard Hatchett | Coalition for Epidemic Preparedness Innovations | Chief Executive Officer | Galien Forum USA | Preparing for the next pandemic: development & delivery of new wave innovations in vaccines | |
| 2018 | Richard Hatchett | Coalition for Epidemic Preparedness Innovations | Chief Executive Officer | Galien Forum Africa | Universal access to essential & others medicines | |
| 2022 | Richard M. Haupt | Merck | Vice President | Galien Week of Innovation | Laureates Media Presentation | |
| 2020 | David Hayes | Biotronik | Chief Medical Officer | Galien Week of innovation | How much are new technologies & engineering efficiencies contributing to progress against the world’s biggest killer? | |
| 2020 | Penny M. Heaton | Bill & Melinda Gates Gates Medical Research Institute | Chief Executive Officer | Galien Forum USA | The future of therapeutics: what novel modalities will be drugs? what vaccines & technologies will we need? | |
| 2018 | Michael Heffernan | Collegium Pharmaceutical | Chairman | Galien Forum USA | Novel approaches to combatting opioid addiction | |
| 2016 | Michael Heffernan | Collegium Pharmaceutical | Chairman | Galien Forum USA | Next generation antimicrobials – shaping policy to develop new business models | |
| 2010 | Thomas Heffner | Pfizer | Executive Director of Worldwide Business Development , | Galien Forum USA | Translational neuroscience: academic-industrial collaborations in cns diseases | |
| 2022 | Kristen Hege | Bristol Myers Squibb | SVP Onco/Hemato /Cell Therapy | Galien Week of Innovation | Biotech - Cancer Can the foundational biologic understandings now being brought to cancer care be leveraged to secure a targeted, more personalized approach to treatment, particularly in solid tumors? | |
| 2022 | Nicky Hekster | The Netherlands | Independent freelance teacher | Galien Forum Netherlands | #VALUE! | |
| 2021 | Marie-Pierre Hellio Le Graverand | Pfizer | Senior Vice President, Head of Clinical Development & Operations | Galien Webinars Series | The impact of digital technologies in transforming & accelerating vaccine trials, development & delivery – lessons from covid-20 | |
| 2021 | Marie-Pierre Hellio Le Graverand | Pfizer | Senior Vice President, Head of Clinical Development & Operations | Galien Webinars Series | The impact of digital technologies in transforming & accelerating vaccine trials, development & delivery – lessons from covid-19 part 4 | |
| 2011 | Hunt Henrie | Ferghana Partners | Managing Director a specialist investment banking group | Galien Forum USA | Funding innovation new trends in the healthcare m&a l& scape | |
| 2012 | Karl Hick | Takeda | Chief Digital & Information Officer | Galien Forum USA | The promise of gene therapy | |
| 2013 | Kathy A. High | Spark Therapeutics | President & Head of Research & Development | Galien Forum USA | Fireside chat | delivering on the patient promise of gene therapy | |
| 2012 | Kathy High | Spark Therapeutics | President & Head of Research & Development | Galien Forum USA | The promise of gene therapy | |
| 2021 | Samit Hirawat | Bristol Myers Squibb | Executive Vice President, Chief Medical Officer, Global Drug Development | Galien Forum USA | New breakthroughs in the biology of cancer: pioneering novel ways to enhance & restore the body’s ability to fight cancer | |
| 2012 | R.T. (Terry) Hisey | Deloitte LLP | Vice Chairman & US Life Sciences Leader | Galien Forum USA | The changing face of chinese healthcare | |
| 2021 | Colin Hislop | Eiger Biopharmaceuticals Inc. | Senior Vice President of Clinical & Development Operations | Galien Week of innovation | Will progress in therapies that promise a genetic cure for devastating rare diseases lead to similar innovations in patient access to these high-cost, high-touch treatments? | |
| 2022 | Colin Hislop | Eiger BioPharmaceuticals, Inc. | Sr VP Clinical&Devt Operations | Galien Week of Innovation | Rare Genetic Diseases Will progress in therapies that promise a genetic cure for devastating rare diseases lead to similar innovations in patient access to these high-cost, high-touch treatments? | |
| 2022 | John Hoekman | Impel Pharmaceuticals Inc. | Chf Technology & Devt Officer | Galien Week of Innovation | Medical Devices and Implants - Other Therapeutic Areas What is Med Tech innovation doing for patients with specialized needs for treatment? | |
| 2021 | Michelle Hoiseth | Parexel International | Chief Data Officer & Corporate Vice President Medical & Scientific Services | Galien Webinars Series | Data governance in a converging world: public & private sector approaches to the management of emerging health technologies. | |
| 2020 | Michelle Hoiseth | Parexel International | Chief Data Officer & Corporate Vice President Medical & Scientific Services | Galien Webinars Series | Digital health improving research & care | |
| 2022 | Alison Holland | Medable | Head of Decentralized Clinical Trials | Galien Forum UK | Clinical trials & regulations: what have we learned from covid? | |
| 2022 | Ali Holland | Medable | Head of Decentralised Clinical Trials - Moderator | Galien Week of Innovation | Anti-Viral Drugs and Women’s Health With a global pandemic raising awareness of the importance of vaccines and anti-viral/anti-microbial drugs, are private-sector R&D incentives aligned to meet future contagion threats? Gauging unmet needs in women’s health therapeutics and promising new drugs in the development stage | |
| 2013 | David Holtzman | Disease Research Center, Washington University | Andrew B. & Gretchen P. Jones Professor & Chairman, Neurology, Professor of Developmental Biology, Associate Director of the Alzheimer‘s | Galien Forum USA | Neurodegenerative disease drug progress | |
| 2010 | Peter Honig | Astra Zeneca The New Postmarketing Pharmacovigilance Toolbox | Head,Global Regulatory Affairs, | Galien Forum USA | The changing l& scape of pharmacovigilance: the impact on medical innovation & human health | |
| 2022 | Andrew Hopkins, | Exscientia | CEO | Galien Week of Innovation | Laureates Media Presentation | |
| 2013 | Herve Hoppenot | Novartis Oncology, Novartis Pharmaceuticals Corporation | President | Galien Forum USA | Oncology: newer therapies | |
| 2020 | Amadou Hott | Planning & International Cooperation of Senegal | Minister of Economy, Planning & Cooperation | Galien Forum Africa | Socio-economic impact of the covid 19 pandemic sub-theme 4 | |
| 2021 | Amadou Hott | Planning & International Cooperation of Senegal | Minister of Economy | Galien Forum Africa | Symposium one health – one africa : a new agenda for governance & the growth of a post-covid continent | |
| 2016 | John G. Houston | Arvinas | President & Chief Executive Officer | Galien Forum USA | Promise - & politics - in the fight against cancer | |
| 2022 | Mary Howard | Design Technologies LLC | Program Director | Galien Week of Innovation | Best Incubator/Accelerator/ equity - Disease Management Incubators and accelerators are pivotal in developing innovative solutions to address humanity’s most pressing health challenges. Why are academic institutions, major medical centers, and significant life science companies launching incubators and accelerators to offer guidance to biotech, digital health, health information, and medical device start-ups? Beyond financial resources, how are these groups working to advance ideas into the marketplace, and what is their impact? | |
| 2016 | Scott Howell | Novartis Pharmaceuticals Inc. | Vice-President & Head, US Market Access, | Galien Forum USA | Making medicines affordable | |
| 2021 | Dennis E. Hruby | SIGA Technologies, Inc. | Chief Scientific Officer | Galien Week of innovation | With a global pandemic raising awareness of the importance of vaccines & anti-viral/anti-microbial drugs, are private-sector r&d incentives aligned to meet these unmet medical needs? | |
| 2020 | Dennis E. Hruby | SIGA Technologies, Inc. | Chief Scientific Officer | Galien Week of innovation | Will the coronavirus pandemic finally lead to an upswing in r&d to tackle neglected areas like antibiotic resistance, zoonotic transmission of pathogens & a more globally-coordinated approach to infectious diseases overall? | |
| 2016 | Clifford A. Hudis | the American Society of Clinical Oncology | Chief Executive Officer | Galien Forum USA | Promise - & politics - in the fight against cancer | |
| 2020 | Mimi Huizinga | Novartis | Vice President & Head, US Oncology Medical | Galien Week of innovation | What are the prospects – & limitations – behind the new approaches to cancer treatments from our increased knowledge of the underlying biology behind tumor growth & proliferation? | |
| 2020 | Mimi Huizinga | Novartis | Vice President & Head, US Oncology Medical | Galien Week of innovation | Are there common links in advancing research on hematologic cancers & other rare diseases associated with uncontrolled vascular system inflammation, such as sickle cell anemia? | |
| 2012 | Mark Hulse | Moffitt Cancer Center | RN, Vice President Information Technology & Chief Information Officer, | Galien Forum USA | The next generation of health & research informatics accelerating translational research & personalized medicine at moffitt cancer center | |
| 2012 | Stephen Hume | Psy.D., Clinician & patient with early onset Alzheimer's disease | Galien Forum USA | Alzheimer's innovation & the white house 2025 m& ate:what will it take to find a treatment? | ||
| 2022 | Robert Iannone | Jazz Pharmaceuticals | Global Head of R&D | Galien Week of Innovation | Biotech - Cancer Can the foundational biologic understandings now being brought to cancer care be leveraged to secure a targeted, more personalized approach to treatment, particularly in solid tumors? | |
| 2021 | Joseph Illa | Ordre des Medecins - Burkina Faso | Doctor | Galien Forum Africa | Conference on reform in health training | |
| 2021 | Lucile Imboua | WHO Senegal | Resident Representative | Galien Forum Africa | Communication of crisis or risk communication & community engagement (rcce) : what respective roles ? | |
| 2020 | Lucile Imboua | WHO | Resident Representative | Galien Forum Africa | Current situation of the response, challenges & prospects.sub-theme 1: | |
| 2022 | Bev Incledon | Ironshore Pharmaceuticals Inc. | CSO and Executive VP | Galien Week of Innovation | Chronic and Autoimmune Disorders Chronic non-communicable diseases now account for three quarters of annual deaths worldwide, with a fast rising percentage taking place in low and middle income countries. With this in mind, how important is incentivizing more industry investment in costly clinical trials and other research targeting key areas of unmet need in major chronic conditions like CVD? Will a better understanding of the common molecular signatures that underlie many serious autoimmune disorders result in more progress in therapeutic interventions, including prevention? | |
| 2020 | Alon Iron | THERANICA | President & Chief Executive Officer, Co-founder | Galien Webinars Series | The digital health enterprise: start-up trends & the culture of big pharma | |
| 2021 | Melanie Ivarsson | Moderna | Chief Development Officer | Galien Webinars Series | The impact of digital technologies in transforming & accelerating vaccine trials, development & delivery – lessons from covid-19 part 5 | |
| 2012 | Andrew Jack | Financial Times, | Journalist | Galien Forum USA | Moderator | |
| 2021 | David Jacoby | BioMarin | Fellow for Clinical Sciences & Vice President Discovery Medicine | Galien Week of innovation | Will clinical progress in therapies that promise a genetics-based cure for devastating rare diseases lead to similar downstream progress in patient access to these high-cost, high-touch treatments? | |
| 2014 | Sachin H. Jain | Merck & Co Inc.; Lecturer in Healthcare Policy, Harvard Medical School | Chief Medical information & Innovation Officer | Galien Forum USA | The future of digital health | |
| 2022 | Petra Jantzer | Accenture | Senior managing director, global life sciences lead, | Galien Forum USA - Chair | CEO Panel | |
| 2021 | Ted W. Johnson | Medicinal Chemistry, Pfizer Oncology Pfizer Inc | Research Fellow | Galien Week of innovation | What is the state of progress in building new therapeutic & diagnostic platforms to fight major cancers & address their prevalence in vulnerable populations, including the aged, minorities, & pediatric patients? | |
| 2020 | Ted W. Johnson | Medicinal Chemistry, Pfizer Oncology Pfizer Inc. | Research Fellow | Galien Week of innovation | What are the prospects – & limitations – behind the new approaches to cancer treatments from our increased knowledge of the underlying biology behind tumor growth & proliferation? | |
| 2021 | Russ Joseph | Edwards Lifesciences | Senior Director, Product Development, Transcatheter Heart Valves | Galien Week of innovation | How are systems design, electronics & engineering making invasive, high-risk surgical procedures a thing of the past? | |
| 2013 | Kris Joshi | Oracle Health Sciences | Global Vice President, Healthcare | Galien Forum USA | Welcome & intro | |
| 2012 | Kris Joshi | Healthcare, Oracle Health Sciences | Global Vice President, | Galien Forum USA | Addressing big datachallenges in genomics & personalized healthcare | |
| 2021 | Marc Julien | Diabeloop | Co-Chief Executive Officer | Galien Week of innovation | In what ways can these new technologies contribute to the realization of better outcomes for patients at less cost to overburdened health systems? | |
| 2021 | Carl H. June | Director of Translational Research at the Abramson Cancer Center | the University of Pennsylvania | Galien Forum USA | Where will new therapies & vaccines come from? | |
| 2021 | Carl H. June | Center for Cellular - Immunotherapies - UPenn | Director | Galien Forum USA | The future is decentralized -- how the paradigm has changed & what it means for modern trials | |
| 2021 | Anne-Maryse K’Habore | CAMEG | General Manager of CAMEG – SG of ACAME – Burkina Faso | Galien Forum Africa | Youth leadership training (part 1) | |
| 2021 | Anne-Maryse K’Habore | CAMEG | General Manager of CAMEG – SG of ACAME – Burkina Faso | Galien Forum Africa | Youth leadership training | |
| 2021 | William G. Kaelin | Harvard Medical School & Dana-Farber Cancer Institute | Sidney Farber Professor of Medicine, | Galien Forum USA | New breakthroughs in the biology of cancer: pioneering novel ways to enhance & restore the body’s ability to fight cancer | |
| 2021 | Jeanne Kagame | Rwanda | 1st Lady of Rwanda | Galien Forum Africa | Closing ceremony | |
| 2020 | Kenneth Kaitin | Tufts Center for the Study of Drug Development, Tufts University School of Medicine | Director | Jerusalem Ethics Forum | Societal, legal & ethical challenges around access to covid-19 vaccines | |
| 2010 | Kenneth Kaitin | Tufts Center for the Study of Drug Development | Director | Galien Forum USA | Biomedical innovation: funding challenges & developing public/private partnership incentives | |
| 2021 | Amir Kalali | CNS Summit; Decentralized Trials & Researched Alliance; | Chief Currator & Chairman | Galien Webinars Series | Data governance in a converging world: public & private sector approaches to the management of emerging health technologies. | |
| 2020 | Amir Kalali | CNS Summit; Decentralized Trials & Researched Alliance; | Chief Currator & Chairman | Galien Webinars Series | Digital health in the aftermath of covid-19 | |
| 2020 | Milind Kamkolkar | CELLARITY | Chief Digital & Data Officer | Galien Webinars Series | The digital health enterprise: start-up trends & the culture of big pharma | |
| 2020 | Eugene Kandel | Start Up Nation Central | Chief Executive Officer | Galien Webinars Series | Digital health in the aftermath of covid-19 | |
| 2012 | Eric Kandel | Department of Neuroscience, Columbia University, New York | Nobel Laureate, Professor & Fred Kavli Professor, | Galien Forum USA | Closing symposium: treating neurodegenerative disease: the potential of prion-based therapies | |
| 2010 | Eric Kandel | Columbia University | Nobel Laureate Professor | Galien Forum USA | Translational neuroscience: academic-industrial collaborations in cns diseases | |
| 2021 | Barinder Kang | Novartis | Vice President & Head, US Oncology Medical (Radio lig& Therapy) | Galien Week of innovation | What is the state of progress in building new therapeutic & diagnostic platforms to fight major cancers & address their prevalence in vulnerable populations, including the aged, minorities, & pediatric patients? | |
| 2021 | Amadou Kanoute | CICODEV NGO – Senegal | President | Galien Forum Africa | Communication of crisis or risk communication & community engagement (rcce) : what respective roles ? | |
| 2020 | Salim Abdool Karim | CAPRISA (South Africa) | Director | Galien Forum Africa | Clinical trials in africa sub-theme 2: | |
| 2011 | Brian Kaspar | AveXis, Inc | Scientific Founder & Chief Scientific Officer | Galien Forum USA | The promise of gene therapy | |
| 2022 | Nobuko Kato | Takeda | Vice President, Global Head of External Communications, Corporate Communications & Public Affairs | Galien Webinars Series | Golden Jubilee - Best Orphan Rare Category | |
| 2022 | Ariel Katz | H1 | Co-Founder & CEO | Galien Forum USA | Diversity and health equity in the future creation of medicine | |
| 2012 | Russell Katz | Division of Neurology Products, Center for Drug Evaluation & Research, Food & Drug Administration | Director | Galien Forum USA | Alzheimer's innovation & the white house 2025 m& ate:what will it take to find a treatment? | |
| 2020 | Michael Kauffman | Karyopharm Therapeutics Inc | Chief Executive Officer Co-Founder | Galien Week of innovation | Are there common links in advancing research on hematologic cancers & other rare diseases associated with uncontrolled vascular system inflammation, such as sickle cell anemia? | |
| 2022 | Paramjit Kaur | Servier Pharmaceuticals | Asset Leader | Galien Week of Innovation | Hematologic Cancers and Gene-based “Tumor Agnostic” Therapies How much more mileage is in store for blood-based cancer survival rates, which have been increasing steadily in recent years? And what is being done about the flip side of this success, expressed in more treatment-related morbidities, disease relapse and higher incidence | |
| 2022 | Patrick J. Kennedy | The Kennedy Forum; Former Member, President’s Commission on Combating Drug Addiction & the Opioid Crisis; Co-Founder, One Mind; Co-Chair, Mental Health for US | Former U.S. Representative (D-RI); Founder | Galien Forum USA | Mental health in America, a public health crisis | |
| 2019 | Patrick J. Kennedy | The Kennedy Forum; Former Member, President’s Commission on Combating Drug Addiction & the Opioid Crisis; Co-Founder, One Mind; Co-Chair, Mental Health for US | Former U.S. Representative (D-RI); Founder | Galien Forum USA | The changing l& scape of pharmacovigilance: the impact on medical innovation & human health | |
| 2018 | Admasu Kesete | RBM end malaria | Chief Executive Officer | Galien Forum Africa | Financing africa’s healthcare | |
| 2010 | Mark Kessel | Symphony Capital LLC | Managing Director | Galien Forum USA | Biomedical innovation: funding challenges & developing public/private partnership incentives | |
| 2021 | Ibrahima Khalilou Dia | e-health Dpt of Ministery of Health & Social Welfare – Senegal | Coordinator | Galien Forum Africa | Innovations & ethic for global health security | |
| 2020 | Ibrahima Khalilou Dia | e-health Dpt of Ministery of Health & Social Welfare – Senegal | MSAS digital health unit | Galien Forum Africa | What place for digital health & innovations? sub-theme 3: | |
| 2010 | Kostas Kidos | Oracle Corporation Pharmacovigilance in the Intersection of Healthcare & Life Sciences | Vice President, Safety & PV Strategy | Galien Forum USA | The changing l& scape of pharmacovigilance: the impact on medical innovation & human health | |
| 2021 | George Kimathi | Capacity Building Institute, Amref Health Africa | Director | Galien Forum Africa | Communication of crisis or risk communication & community engagement (rcce) : what respective roles ? | |
| 2022 | Robert Kissling | Bausch + Lomb | VP Medical&Scientific Affairs | Galien Week of Innovation | Medical Devices and Implants - Other Therapeutic Areas What is Med Tech innovation doing for patients with specialized needs for treatment? | |
| 2014 | William E. Klitgaard | Covance | Senior Vice President et Information Director | Galien Foum Monaco | Beyond the Pill : The digital transformation of the biopharmaceutical industry in progress | |
| 2021 | Stephanie Klocke | Becton, Dickinson & Company | Vice President of Research & Development | Galien Week of innovation | How are systems design, electronics & engineering making invasive, high-risk surgical procedures a thing of the past? | |
| 2020 | Stephanie Klocke | Becton, Dickinson & Company | Vice President of Research & Development | Galien Week of innovation | What is medtech innovation doing for patients with specialized needs for treatment? | |
| 2022 | Volker Knappertz | Aurinia Pharmaceuticals Inc. | Executive VP R&D | Galien Week of Innovation | Chronic and Autoimmune Disorders Chronic non-communicable diseases now account for three quarters of annual deaths worldwide, with a fast rising percentage taking place in low and middle income countries. With this in mind, how important is incentivizing more industry investment in costly clinical trials and other research targeting key areas of unmet need in major chronic conditions like CVD? Will a better understanding of the common molecular signatures that underlie many serious autoimmune disorders result in more progress in therapeutic interventions, including prevention? | |
| 2012 | Jean-Pierre A. Kocher | The Bioinformatics Core (BIC) of the Mayo Clinic | Head | Galien Forum USA | Addressing big datachallenges in genomics & personalized healthcare | |
| 2020 | Robert Kowal | Medtronic | Chief Medical Officer, Vice President of Medical Affairs & Business Development | Galien Week of innovation | How much are new technologies & engineering efficiencies contributing to progress against the world’s biggest killer? | |
| 2015 | Adrian R. Krainer | Cold Spring Harbor Laboratory, Watson School of Biological Sciences | St. Giles Foundation Professor of Molecular Genetics, Program Chair, Cancer & Molecular Biology, | Galien Forum USA | Spinal muscular atrophy: charting the pathway to clinical progress | |
| 2022 | Nikolaus Krall | Exscientia | VP, Precision Medicine | Galien Week of Innovation | Digital Health Solution - Disease Management In what ways can these new technologies contribute to the realization of better outcomes for patients at less cost to overburdened health systems? | |
| 2022 | Florian Krammer | Icahn school of medicine at mount Sinai | Pofessor of microbiology, pathology, molecular and cell based medicine, | Galien Forum USA | Covid pandemic science 2022: current vaccines and treatments and the future outlook | |
| 2022 | Daniella Kranjac | Dynamk Capital LLC | Founding Partner | Galien Week of Innovation | Best Incubator/Accelerator/ equity - Disease Management Incubators and accelerators are pivotal in developing innovative solutions to address humanity’s most pressing health challenges. Why are academic institutions, major medical centers, and significant life science companies launching incubators and accelerators to offer guidance to biotech, digital health, health information, and medical device start-ups? Beyond financial resources, how are these groups working to advance ideas into the marketplace, and what is their impact? | |
| 2017 | Jörg Kreuzer | Boehringer Ingelheim Pharma GmbH & Co. KG | Therapeutic Area Head Medicine CV | Galien Forum USA | Atrial fibrillation | |
| 2012 | Health Sciences Global Business Unit Kridel | Ferghana Partners | Partner | Galien Forum USA | The changing face of chinese healthcare | |
| 2013 | Mark Kris | Memorial Sloan-Kettering Cancer Center | Chair Chief, Thoracic Oncology Services, | Galien Forum USA | Oncology: newer therapies | |
| 2017 | Jim Krueger | Rockefeller University | Laboratory for Investigative Dermatology, | Galien Forum USA | Inflammatory skin diseases & mechanistic interconnections to other inflammation disorders | |
| 2018 | Seema Kumar | Johnson & Johnson | Vice President | Galien Forum Africa | Plenary Panel - women in stem in africa | |
| 2021 | Pradip Kumar Sasmal | Dr. Reddy’s Laboratories | Vice President & Head of CMC, Differentiated Products | Galien Week of innovation | What can patients with chronic conditions expect from medicines advances within the next five to ten years? how is chronic disease research moving from incremental & maintenance therapies to real breakthroughs toward cure & prevention? | |
| 2021 | Angella Kyomugisha | Women Innovators Incubator program | Participant | Galien Forum Africa | Women & stem in the global health security context | |
| 2018 | Paul Lalvani | Empower School of Health, India | Dean & Director | Galien Forum Africa | Universal access to essential & others medicines | |
| 2016 | Story Landis | National Institute of Neurological Disorders & Stroke, National Institutes of Health (NIH), NIH BRAIN Initiative | Former Director, & Co-Founder | Galien Forum USA | Spinal muscular atrophy: charting the pathway to clinical progress | |
| 2022 | Martin Landray | Oxford University | Professor of Medicine & Epidemiology | Galien Forum UK | Clinical trials & regulations: what have we learned from covid? | |
| 2021 | Robert S. Langer | David H. Koch Institute MIT | Professor | Galien Week of innovation | What is med tech innovation doing for patients with specialized needs for treatment? | |
| 2020 | Robert S. Langer | David H. Koch Institute MIT | Professor | Galien Week of innovation | What is medtech innovation doing for patients with specialized needs for treatment? | |
| 2018 | Robert S. Langer | Massachusetts Institute of Technology | Professor | Galien Forum USA | Novel approaches to combatting opioid addiction | |
| 2015 | Robert S. Langer | Massachusetts Institute of Technology | Professor | Galien Forum USA | Bioengineering for better health: what future for targeted drug delivery? | |
| 2021 | Peter Langmuir | Incyte | Group Vice President of Oncology Targeted Therapeutics | Galien Week of innovation | What is the state of progress in building new therapeutic & diagnostic platforms to fight major cancers & address their prevalence in vulnerable populations, including the aged, minorities, & pediatric patients? | |
| 2022 | Jacob LaPorte | Novartis Pharmaceuticals Corporation | Co-Founder, Global Head | Galien Week of Innovation | Best Incubator/Accelerator/ equity - Clinical Trial Management and Wellness Care An innovator’s connection to a leadership accelerator, incubator or private equity organization is a strong indicator of success. Financial support is part of the commitment, as are experience and connections. How do these investment and counseling groups help start-ups with their clinical trial design, navigate regulatory and payer system complexities or build a go-to marketing plan? Beyond access to cash, what makes the innovator’s connection to an accelerator, incubator or private equity group success critical? | |
| 2020 | Margaret Lartey | Ghana | Dean of the Faculty of Medicine | Galien Forum Africa | Place of women in innovation related to covid 19 sub-theme 2: | |
| 2012 | Martin Leach | Broad Institute, MIT & Harvard | Chief Information Officer, | Galien Forum USA | Addressing big datachallenges in genomics & personalized healthcare | |
| 2013 | John Lechleiter | Eli Lilly & Company | Chairman & Chief Executive Officer | Galien Forum USA | Affordable care act us healthcare in transition: the stakes for industry | |
| 2022 | Matthieu Leclerc-Chalvet | Therapixel | CEO | Galien Week of Innovation | Digital Health Solution - Disease Management In what ways can these new technologies contribute to the realization of better outcomes for patients at less cost to overburdened health systems? | |
| 2021 | Matthieu Leclerc-Chalvet | Therapixel | Chief Executive Officer | Galien Week of innovation | In what ways can these new technologies contribute to the realization of better outcomes for patients at less cost to overburdened health systems? | |
| 2022 | Melissa Lederer | mHUB | Chief Experience Officer | Galien Week of Innovation | Best Incubator/Accelerator/ equity - Clinical Trial Management and Wellness Care An innovator’s connection to a leadership accelerator, incubator or private equity organization is a strong indicator of success. Financial support is part of the commitment, as are experience and connections. How do these investment and counseling groups help start-ups with their clinical trial design, navigate regulatory and payer system complexities or build a go-to marketing plan? Beyond access to cash, what makes the innovator’s connection to an accelerator, incubator or private equity group success critical? | |
| 2022 | Myrto Lee | BCG | Managing Director & Partner | Galien Forum UK | Clinical trials & regulations: what have we learned from covid? | |
| 2022 | Patrice A. Lee | Pfizer Inc. | VP Pharmaco Exploratory Devt | Galien Week of Innovation | Solid Tumor Cancers What is the state of progress in extending cell-based gene therapies to fight solid tumor cancers? How successful has the pharma industry been in building new therapeutic and diagnostic platforms to fight major cancers and address their prevalence in vulnerable populations, including the aged, minorities, and pediatric patients? | |
| 2021 | Philina Lee | Blueprint Medicines | Senior Vice President, Head of Portfolio Strategy | Galien Week of innovation | Will progress in therapies that promise a genetic cure for devastating rare diseases lead to similar innovations in patient access to these high-cost, high-touch treatments? | |
| 2016 | Jonathan S. Leff | Deerfield Institute | Partner, Deerfield Management; Chairman, | Galien Forum USA | Next generation antimicrobials – shaping policy to develop new business models | |
| 2013 | Jeffrey Leiden | Vertex | Chairman, President & Chief Executive Officer | Galien Forum USA | Improving efficiency in drug development | |
| 2022 | Arjen Lemmen | Argenx | VP, Corporate Devt & Strategy | Galien Week of Innovation | BioTech – Rare Diseases What is the underlying science behind clinical progress in therapies that promise a genetics-based cure for devastating rare diseases and how will this contribute to the next wave of innovations? What are the implications for continued patient access to these high-cost, high-touch 2 treatments – does the ROI calculation for rare diseases still add up? | |
| 2020 | David J. Lennon | Novartis Gene Therapies | President | Galien Week of innovation | Will progress in therapies that promise a genetic cure for devastating rare diseases lead to similar innovations in patient access to these highcost, high-touch treatments? | |
| 2016 | John Leonard | Intellia Therapeutics | President and Chief Executive Officer | Galien Forum USA | Molecular scissors: what can we expect from gene editing? | |
| 2020 | Jean Leonetti | Sophia Antipolis Urban Community | President | Jerusalem Ethics Forum | Science, intelligence, ethics: a multi-faceted response to the challenges of covid-19 | |
| 2015 | Nick Leschly | Bluebird | President & Chief Executive Officer | Galien Forum USA | Delivering on the patient promise of gene therapy | |
| 2021 | Steven J. Lester | Mayo Clinic-ASU MedTech Accelerator & Professor of Medicine | Chief Medical Officer | Galien Week of innovation | How are systems design, electronics & engineering making invasive, high-risk surgical procedures a thing of the past? | |
| 2020 | Steven J. Lester | Mayo Clinic-ASU MedTech Accelerator | Chief Medical Officer | Galien Week of innovation | How much are new technologies & engineering efficiencies contributing to progress against the world’s biggest killer? | |
| 2021 | Franck Leveiller | Alcon | Senior Vice President, Head, Global Research & Development | Galien Week of innovation | What is med tech innovation doing for patients with specialized needs for treatment? | |
| 2022 | Gail D. Lewis | Genentech | Senior Principal Scientist | Galien Week of Innovation | Laureates Media Presentation | |
| 2020 | Tanya Lewis | Scientific American | Associate Editor for Health & Medicine | Galien Week of innovation | Will progress in therapies that promise a genetic cure for devastating rare diseases lead to similar innovations in patient access to these highcost, high-touch treatments? | |
| 2020 | Dean Y Li | Merck & Co., Inc. | Senior Vice President - Discovery Sciences & Translational Medicine - | Galien Forum USA | The future of therapeutics: what novel modalities will be drugs? what vaccines & technologies will we need? | |
| 2013 | Richard Lifton | Yale University School of Medicine | Professor | Galien Forum USA | Personalized medicine: effect on drug r&d & patient care | |
| 2018 | Dan R. Littman | Vedanta Biosciences | Co-Founder | Galien Forum USA | The gut microbiome: opportunities & challenges | |
| 2017 | Dan R. Littman | American Association of Immunology | Former President | Galien Forum USA | Inflammatory skin diseases & mechanistic interconnections to other inflammation disorders | |
| 2010 | Rodolfo R. Lliná S | New York University | Chairman Department of Physiology & Neuroscience | Galien Forum USA | Translational neuroscience: academic-industrial collaborations in cns diseases | |
| 2014 | Donald Lloyd-Jones | Northwestern University in Chicago. | Chairman of the Department of Preventive Medicine | Galien Forum USA | Heart attack guidelines | |
| 2011 | Peter D. Loftus | contributor to Wall Street Journal | Dow Jones Newswires reporter covering pharmaceutical industry; | Galien Forum USA | Perspectives on innovation, patient safety & global access thinking beyond laboratories & clinical trials | |
| 2022 | Sylvie Lombardi | BD | Director of R&D | Galien Week of Innovation | Medical Devices and Implants – Cardiovascular and Cancer How are systems design, electronics and engineering making invasive, high-risk surgical procedures a thing of the past for these two major killers? | |
| 2012 | Roger Longman | Real Endpoints | Chief Executive Officer | Galien Forum USA | Moderator | |
| 2011 | Roger Longman | Real Endpoints | Chief Executive Officer | Galien Forum USA | What is "value" & how can it be measured & demonstrated in therapeutic innovations? breaking down the barriers of the past | |
| 2010 | Roger Longman | Real Endpoints | Chief Executive Officer | Galien Forum USA | Biomedical innovation: funding challenges & developing public/private partnership incentives | |
| 2022 | Michelle Longmire | Medable | Chair of the Board - President & Chief Executive Officer | Galien Forum USA | Covid pandemic science 2022: current vaccines and treatments and the future outlook | |
| 2021 | Michelle Longmire | Medable | Chair of the Board - President & Chief Executive Officer | Galien Webinars Series | The incubators of innovation: academic medical centers as digital health champions | |
| 2021 | Michelle Longmire | Medable | Chair of the Board - President & Chief Executive Officer | Galien Week of innovation | In what ways can these new technologies contribute to the realization of better outcomes for patients at less cost to overburdened health systems? | |
| 2022 | Michelle Longmire | Medable | Co-founder & CEO, Moderator | Galien Week of Innovation | Digital Health Solution - Disease Management In what ways can these new technologies contribute to the realization of better outcomes for patients at less cost to overburdened health systems? | |
| 2022 | Carole Longson | Medicines Discovery Catapult | Vice Chair | Galien Forum UK | Access to innovation: optimizing health for patient populations | |
| 2012 | William Looney | Executive Magazine | Editorial Director Pharmaceutical | Galien Forum USA | Ethics of innovation, under the auspices of the elie wiesel foundation for humanity | |
| 2013 | Jan Lundberg | Lilly Research Labs, Lilly & Co. | Executive Vice President, Science & Technology & President | Galien Forum USA | Improving efficiency in drug development | |
| 2022 | Lusong Luo | BeiGene | Senior VP, External Innovation | Galien Week of Innovation | Biotech - Cancer Can the foundational biologic understandings now being brought to cancer care be leveraged to secure a targeted, more personalized approach to treatment, particularly in solid tumors? | |
| 2021 | Crystal L. Mackall | Ernest & Amelia Gallo Family, Stanford University | Professor of Pediatrics & Internal Medicine | Galien Forum USA | New breakthroughs in the biology of cancer: pioneering novel ways to enhance & restore the body’s ability to fight cancer | |
| 2015 | Charles R. Mackay | Pfizer Inc. | Inflammation & Immunology, | Galien Forum USA | Microbiota in human diseases | |
| 2016 | Sandi Macrae | Sangamo BioSciences | President & Chief Executive Officer | Galien Forum USA | Molecular scissors: what can we expect from gene editing? | |
| 2021 | Serigne Magueye Gueye | Campus franco-senegalais – Senegal | Director General | Galien Forum Africa | Conference on reform in health training | |
| 2021 | Sadiqa Mahmood | Health Catalyst | General Manager & Senior Vice President Life Science Business | Galien Webinars Series | Data governance in a converging world: public & private sector approaches to the management of emerging health technologies. | |
| 2021 | Aliou Maïga | West & Central Africa of the International Finance Corporation IFC | Regional Director | Galien Forum Africa | Symposium one health – one africa : a new agenda for governance & the growth of a post-covid continent | |
| 2020 | Hilary Malone | Valo Health | Chief Operating Officer | Galien Webinars Series | Digital health improving research & care | |
| 2021 | El Hadji Mamadou Ndiaye | Prevention at the Ministry of Health & Social Action – Senegal | Director | Galien Forum Africa | Communication of crisis or risk communication & community engagement (rcce) : what respective roles ? | |
| 2020 | Flavio Manetlli | Dompe U.S. Inc. | Chief Medical Officer | Galien Week of innovation | Can the foundational biologic underst& ings now being brought to cancer care be leveraged to secure a targeted, more personalized approach to other conditions? | |
| 2021 | Carl Manlan | ECOBANK Foundation – International – Ivory Coast | Director of Operations | Galien Forum Africa | Meeting of young innovators with investors | |
| 2020 | Carl Manlan | ECOBANK Foundation – International – Ivory Coast | Director of Operations | Galien Forum Africa | Financing the response to covid 19 | |
| 2020 | John Maraganore | Alnylam | Chief Executive Officer | Galien Forum USA | The future of therapeutics: what novel modalities will be drugs? what vaccines & technologies will we need? | |
| 2022 | Joel S. Marcus | Alexandria real estate equities, inc./Alexandria venture investments | Executive Chairman & Founder Co-Founder, | Galien Forum USA | Mental health in America, a public health crisis | |
| 2021 | Joel S. Marcus | Alexandria Real Estate Equities, Inc./ Alexandria Venture Investments ; Alexandria Summit | Chairman, Chief Executive Officer & Founder, Co-Founder | Galien Forum USA | Combating the opioid crisis in america | |
| 2020 | Joel S. Marcus | Alexandria Real Estate Equities, Inc./ Alexandria Venture Investments ; Alexandria Summit | Chairman, Chief Executive Officer & Founder, Co-Founder | Galien Forum USA | Covid-19 vaccines: the path to the holy grail | |
| 2019 | Joel S. Marcus | Alexandria Real Estate Equities, Inc./ Alexandria Venture Investments ; Co-Founder, Alexandria Summit | Executive Chairman & Founder Co-Founder, | Galien Forum USA | Can disruptive innovation positively impact healthcare costs? | |
| 2018 | Joel S. Marcus | Alexandria Real Estate Equities, Inc./Alexandria Venture Investments; Alexandria Summit | Executive Chairman & Founder Co-Founder, | Galien Forum USA | Cancer in a time of disruption | |
| 2017 | Joel S. Marcus | Alexandria Real Estate Equities, Inc./ Alexandria Venture Investments ; Co-Founder, Alexandria Summit | Co-Moderator, Chairman, Chief Executive Officer & Founder, Co-Founder | Galien Forum USA | Addressing unmet medical needs with early-stage life science venture capital | |
| 2014 | Joel S. Marcus | Alexandria Real Estate Equities, Inc./ Alexandria Venture Investments ; Alexandria Summit | Chairman, Chief Executive Officer & Founder, Co-Founder | Galien Forum USA | The future of digital health | |
| 2013 | Joel S. Marcus | Alexandria Real Estate Equities, Inc./ Alexandria Venture Investments ; Co-Founder, Alexandria Summit | Chairman | Galien Forum USA | Welcome & intro | |
| 2012 | Joel S. Marcus | Alexandria Real Estate Equities, Inc./ Alexandria Venture Investments ; Alexandria Summit | Chairman, Chief Executive Officer & Founder, Co-Founder | Galien Forum USA | Welcome Remarks | |
| 2021 | Yuri Maricich | Pear Therapeutics | Chief Medical Officer & Head of Development | Galien Week of innovation | How far are we from achieving the health system world of the connected patient? | |
| 2020 | Yuri Maricich | Pear Therapeutics | Chief Medical Officer & Head of Development | Galien Week of innovation | How far are we from achieving the health system world of the connected patient? | |
| 2016 | Michael Mark | Research Boehringer Ingelheim Pharma GmbH & Co. KG Research | Vice President & Global Head of Cardio Metabolic Diseases | Galien Forum USA | Diabetes mellitus & cardiovascular risk – on the rise, fall & novel possibilities with glucose lowering drugs | |
| 2021 | Wanda Markotter | Centre for Viral Zoonoses Pretoria – South Africa | Director | Galien Forum Africa | Covid 19 lessons learned, autonomy & sovereignty of africa sub topic 2 | |
| 2018 | Peter Marks | Center for Biologics Evaluation & Research, FDA | Director | Galien Forum USA | The promise of gene therapy | |
| 2014 | Peter Marks | Center for Biologics Evaluation & Research, FDA | Director | Galien Forum USA | Fireside chat | delivering on the patient promise of gene therapy | |
| 2012 | Lynn Marks | Clinical Platforms & Sciences, GlaxoSmithKline plc | Senior Vice President, Projects | Galien Forum USA | Infectious diseases: a global healthcare challenge | |
| 2022 | Peter Marks | Center for Biologics Evaluation & Research, FDA | Director | Galien Forum USA | Covid pandemic science 2022: current vaccines and treatments and the future outlook | |
| 2022 | John Martin | Butterfly Network Inc | Chief Medical Officer | Galien Week of Innovation | Digital Health Solution - Clinical Trial Management and Wellness Care Are researchers, physicians and regulators ready to embrace advanced, low-touch approaches to streamline the cumbersome infrastructure of clinical trials? And are insurers and health systems prepared to reward software- driven patient self-care technologies, particularly by recognizing prevention and wellness as an integral element of service provision? | |
| 2018 | Kelsey C. Martin | Simons Foundation Autism Research Initiative (SFARI) | Director | Galien Forum USA | Cancer in a time of disruption | |
| 2010 | Sharon Mates | Intra-Cellular Therapies | Chairman & Chief Executive Officer | Galien Forum USA | Translational neuroscience: academic-industrial collaborations in cns diseases | |
| 2021 | Eric Mayes | Endomagnetics Ltd. | Chief Executive Officer | Galien Week of innovation | How far are we from achieving the health system world of the connected patient? | |
| 2020 | Eric Mayes | Endomag Ltd. | Chief Executive Officer | Galien Week of innovation | How far are we from achieving the health system world of the connected patient? | |
| 2015 | Sarkis K. Mazmanian | California Institute of Technology | Louis & Nelly Soux Professor of Microbiology | Galien Forum USA | The gut microbiome: opportunities & challenges | |
| 2015 | Sarkis K. Mazmanian | California Institute of Technology | Louis & Nelly Soux Professor of Microbiology | Galien Forum USA | Microbiota in human diseases | |
| 2020 | Aminata Mbengue Ndiaye | Territorial Communities HCCT (Senegal) | President High Council | Galien Forum Africa | Africa post covid 19 | |
| 2021 | Souleymane Mboup | IRESSEF (Institute for Health Research, Epidemiological Surveillance & Training) | Executive Director | Galien Forum Africa | Communication of crisis or risk communication & community engagement (rcce) : what respective roles ? | |
| 2021 | Souleymane Mboup | IRESSEF (Institute for Health Research, Epidemiological Surveillance & Training) | Co-President | Galien Forum Africa | Closing ceremony | |
| 2020 | Souleymane Mboup | IRESSEF (Institute for Health Research, Epidemiological Surveillance & Training) | President & Chief Executive Officer | Galien Forum Africa | Research facing covid 19 | |
| 2018 | Souleymane Mboup | IRESSEF (Institute for Health Research, Epidemiological Surveillance & Training) | Chief Executive Officer | Galien Forum Africa | Remarkable women engage for humanity | |
| 2018 | Souleymane Mboup | IRESSEF (Institute for Health Research, Epidemiological Surveillance & Training) | Chief Executive Officer | Galien Forum Africa | managing infectious diseases & pandemics | |
| 2021 | Cheikh Mbow | Future Africa University of Pretoria – South Africa | Director | Galien Forum Africa | Youth leadership training (part 1) | |
| 2021 | Cheikh Mbow | Future Africa University of Pretoria – South Africa | Director | Galien Forum Africa | Youth leadership training | |
| 2020 | Cheikh Mbow | Future Africa University of Pretoria (South Africa) | Inaugural Director | Galien Forum Africa | Environmental impact of the covid 19 pandemic sub-theme 4: | |
| 2018 | Cheikh Mbow | Harvard | Chief Executive Officer | Galien Forum Africa | The health consequences of climate change | |
| 2018 | Corey McCann | Pear Therapeutics | President & Chief Executive Officer | Galien Forum USA | Novel approaches to combatting opioid addiction | |
| 2022 | Chrissa McFarlane | Patientory Inc | CEO | Galien Week of Innovation | Digital Health Solution - Clinical Trial Management and Wellness Care Are researchers, physicians and regulators ready to embrace advanced, low-touch approaches to streamline the cumbersome infrastructure of clinical trials? And are insurers and health systems prepared to reward software- driven patient self-care technologies, particularly by recognizing prevention and wellness as an integral element of service provision? | |
| 2021 | Chrissa McFarlane | Patientory Inc. | Founder & Chief Executive Officer | Galien Week of innovation | Are insurers & health systems ready to embrace & reward these new self-care technologies, particularly in recognizing prevention & wellness as an integral element of service provision? | |
| 2016 | Mark McLellan | Professor of Business, Medicine, & Health Policy, Duke-Robert J. Margolis Center for Health Policy & Robert J. Margolis, Duke University | Director | Galien Forum USA | Next generation antimicrobials – shaping policy to develop new business models | |
| 2014 | Mark McLellan | the Brookings Institution | Senior Fellow & Director of the Health Care Innovation & Value Initiative | Galien Forum USA | Us health reform | |
| 2021 | Sapna McManus | Genentech | Head of Patient Inclusion & Health Equity, Chief Diversity Office | Jerusalem Ethics Forum | Inclusive medicine: how modern research amplifies outcomes for patient access, inclusion & diversity | |
| 2015 | Michelle McMurry-Heath | BIO | President & Chief Executive Officer | Galien Forum USA | What’s holding back the technology revolution in clinical trials? | |
| 2018 | Nicolas Meda | Burkina Faso | Minister ofHealth | Galien Forum Africa | managing infectious diseases & pandemics | |
| 2018 | Nicolas Meda | Burkina Faso | Minister of Health | Galien Forum Africa | Remarkable women engage for humanity | |
| 2022 | Gerold Meinhardt | Daiichi Sankyo | Vice President, Asset & Portfolio Management | Galien Week of Innovation | Biotech - Cancer Can the foundational biologic understandings now being brought to cancer care be leveraged to secure a targeted, more personalized approach to treatment, particularly in solid tumors? | |
| 2015 | Ira Mellman | Genentech | Vice President, Research Oncology, | Galien Forum USA | What’s holding back the technology revolution in clinical trials? | |
| 2022 | Johanna Mercier | Gilead Sciences | Chief Communications Officer | Galien Webinars Series | Golden Jubilee - Best Orphan Rare Category | |
| 2020 | Jane Metcalfe | Neo.Life. Wired Magazine | Chief Executive Officer Co-Founder | Galien Webinars Series | Digital health in the aftermath of covid-19 | |
| 2022 | Philippe Michel | FUTURE4CARE | COO | Galien Week of Innovation | Best Incubator/Accelerator/ equity - Disease Management Incubators and accelerators are pivotal in developing innovative solutions to address humanity’s most pressing health challenges. Why are academic institutions, major medical centers, and significant life science companies launching incubators and accelerators to offer guidance to biotech, digital health, health information, and medical device start-ups? Beyond financial resources, how are these groups working to advance ideas into the marketplace, and what is their impact? | |
| 2020 | Jennifer Miller | Yale School of Medicine | Assistant Professor | Jerusalem Ethics Forum | Tracking bioethics: transparency, trust & the industry’s social imperatives | |
| 2011 | Steve Miller | Express Scripts | Senior Vice President & Chief Medical Officer | Galien Forum USA | Keynote: drug pricing & access in the trump administration: consensus or confrontation? | |
| 2019 | Talya Miron-Shatz | Israel | Decision Scientist | Jerusalem Ethics Forum | Human reproduction: technical limit, ethical limit | |
| 2021 | Kenneth I. Moch | Center for Global Health Innovation & Global Health Crisis Coordination Center | Senior Advisor to the Chairman | Jerusalem Ethics Forum | Highly prevalent neglected diseases: developing medicines & building infrastructure for the rest of the world | |
| 2020 | Kenneth I. Moch | Center for Global Health Innovation & Global Health Crisis Coordination Center | Senior Advisor to the Chairman | Jerusalem Ethics Forum | Societal, legal & ethical challenges around access to covid-19 vaccines | |
| 2021 | Serigne Modou Babou | Cauris technologiesUniversité Cheikh Anta Diop de Dakar | Professor | Galien Forum Africa | Conference on reform in health training | |
| 2022 | Alexandra Moens | H1 | Dir Product Marketing - Moderator | Galien Week of Innovation | Digital Health Solution - Disease Management In what ways can these new technologies contribute to the realization of better outcomes for patients at less cost to overburdened health systems? | |
| 2022 | Alexandra Moens | H1 | Dir Product Marketing - Moderator | Galien Week of Innovation | Biotech - Chronic/Autoimmune Disorders and Vaccines Given that many chronic diseases have an infectious origin, what learnings can be had by the most recent innovations in vaccine development technology in raising the bar on innovations to address the huge unmet need against conditions that kill millions? | |
| 2022 | Alexandra Moens | H1 | Dir Product Marketing Moderator | Galien Week of Innovation | BioTech – Rare Diseases What is the underlying science behind clinical progress in therapies that promise a genetics-based cure for devastating rare diseases and how will this contribute to the next wave of innovations? What are the implications for continued patient access to these high-cost, high-touch 2 treatments – does the ROI calculation for rare diseases still add up? | |
| 2021 | Matshidiso Moeti | WHO Regional Office for Africa | Regional Director | Galien Forum Africa | Covid 19 lessons learned, autonomy & sovereignty of africa sub topic 3 | |
| 2021 | Matshidiso Moeti | WHO Regional Office for Africa | Regional Director | Galien Forum Africa | Closing ceremony | |
| 2020 | Matshidiso Moeti | WHO Regional Office for Africa | Regional Director | Galien Forum Africa | The response of african countries to the covid-19 pandemic | |
| 2020 | Matshidiso Moeti | WHO Regional Office for Africa | Regional Director | Galien Forum Africa | Africa post covid 19 | |
| 2018 | Matshidiso Moeti | WHO Regional Office for Africa | Regional Director | Galien Forum Africa | Which plan for non communicable diseases? | |
| 2021 | Mark Mogul | Servier Pharmaceuticals | Head of Medical Affairs | Galien Week of innovation | Will the success of novel, gene-based therapies in advancing survival timelines in blood & bone marrow cancers be repeated in the solid tumor setting, with therapies that address each tumor’s individual genetic profile rather than association with its geographic location in the body? | |
| 2020 | Briggs Morrison | Syndax | Chief Executive Officer | Jerusalem Ethics Forum | Tracking bioethics: transparency, trust & the industry’s social imperatives | |
| 2020 | Ponda Motsepe – Ditshego | Amgen Bone | Executive Medical Director | Galien Week of innovation | Where is the growing science & its link to disease leading us in terms of new treatments for patients with unresolved chronic conditions? | |
| 2018 | Aaron Motsoaledi | South Africa | Minister of Health | Galien Forum Africa | Financing africa’s healthcare | |
| 2020 | Vanessa Moungar | African Development Bank (Chad) | Director of Gender & Civil Society | Galien Forum Africa | Gender & innovations facing covid 19 sub-theme 1: gender & response to covid 19. | |
| 2022 | Katherine Moyer | Skipta | VP Content & Com - Moderator | Galien Week of Innovation | Medical Devices and Implants - Other Therapeutic Areas What is Med Tech innovation doing for patients with specialized needs for treatment? | |
| 2022 | Shephard Mpofu | Novartis Gene Therapies | SVP, CMO | Galien Week of Innovation | BioTech – Rare Diseases What is the underlying science behind clinical progress in therapies that promise a genetics-based cure for devastating rare diseases and how will this contribute to the next wave of innovations? What are the implications for continued patient access to these high-cost, high-touch 2 treatments – does the ROI calculation for rare diseases still add up? | |
| 2021 | Shephard Mpofu | Novartis | Senior Vice President & Chief Medical Officer | Galien Week of innovation | Will clinical progress in therapies that promise a genetics-based cure for devastating rare diseases lead to similar downstream progress in patient access to these high-cost, high-touch treatments? | |
| 2021 | Arnold Munnich | Hopital Necker Enfants Malades | Chief of Dpeartment | Galien Webinars Series | The impact of digital technology in clinical trials: ethical considerations (french edition) | |
| 2020 | Arnold Munnich | University Paris-Descartes, France | Genetics | Jerusalem Ethics Forum | Science, intelligence, ethics: a multi-faceted response to the challenges of covid-19 | |
| 2019 | Arnold Munnich | University Paris-Descartes, France | Genetics | Jerusalem Ethics Forum | Personalized genomics medicine: the value of knowing | |
| 2019 | Arnold Munnich | University Paris-Descartes, France | Genetics | Jerusalem Ethics Forum | 2020/2030 agenda “facing the next ethical challenges” | |
| 2021 | Terry Murphy | Janssen | COVID-19 Clinical Dev. Relaunch Leader | Galien Webinars Series | The impact of digital technologies in transforming & accelerating vaccine trials, development & delivery – lessons from covid-21 | |
| 2016 | John Mc Murray | Institute of Cardiovascular & Medical Sciences, University of Glasgow | Professor of Medical Cardiology, | Galien Forum USA | Keynote | |
| 2015 | John Mc Murray | Institute of Cardiovascular & Medical Sciences, University of Glasgow | Professor of Medical Cardiology, | Galien Forum USA | Confronting the crisis of heart failure: innovation in pharmacology & medical devices | |
| 2019 | Mordechai Muszkat | Hadassah University Hospital at Mt Scopus, Israel | Head of the Department of Medicine | Jerusalem Ethics Forum | Health policy & financing innovation: ethical considerations, cost & the role of the patient | |
| 2021 | John Mwangi | Daktari Media | Chief Executive Officer | Galien Forum Africa | Leadership & innovation, meet the winners of the africa young innovators award for health | |
| 2021 | Whitney Mwangui | African Union | Advocacy, Partnership & Communication Specialist | Galien Forum Africa | Leadership & innovation, meet the winners of the africa young innovators award for health | |
| 2015 | Elizabeth Nabel | Brigham & Women’s Hospital | President | Galien Forum USA | What’s holding back the technology revolution in clinical trials? | |
| 2021 | Mame Nahe Diouf | Institute of Agricultural Research (ISRA), National Laboratory of Livestock & Veterinary Research (LNERV) – Senegal | Director | Galien Forum Africa | Involvement of women researchers in the mhw | |
| 2015 | Gerard Nahum | Bayer Pharmaceuticals | Vice President, Global Clinical Development for Medical Devices & eHealth, | Galien Forum USA | What’s holding back the technology revolution in clinical trials? | |
| 2021 | Nuriat Nambogo | Women Innovators Incubator program | Participant | Galien Forum Africa | Women & stem in the global health security context | |
| 2014 | Tara Narula | CBS This Morning | Medical Contributor, | Galien Forum USA | Pioneers for a cure: the role of innovation & entrepreneurship in cancer research | |
| 2015 | Ameet Nathwani | Novartis | Senior Vice President & Global Head of Medical Affairs. | Galien Forum USA | Confronting the crisis of heart failure: innovation in pharmacology & medical devices | |
| 2018 | Sidy Ndao | University of Nebraska-Lincoln - USA | Associate Professor, | Galien Forum Africa | Plenary Panel - women in stem in africa | |
| 2021 | Massamba Ndiaye | Ubuntu University, National Digital Debate of the Youth | Founder Executive Chairman | Galien Forum Africa | Youth leadership training (part 1) | |
| 2021 | Massamba Ndiaye | Ubuntu University, National Digital Debate of the Youth | Founder Executive Chairman | Galien Forum Africa | Youth leadership training | |
| 2020 | Youssou Ndiaye | MSAS- Senegal | Director of Planning, Research & Statistics | Galien Forum Africa | Health & socio-economic impact of the covid 19 pandemic in africa sub-theme 1: resilience of health systems & continuity of care: state of play, challenges & rerspectives | |
| 2018 | Alioune Ndiaye | UN | Special Advisor | Galien Forum Africa | The health consequences of climate change | |
| 2021 | Aïta Ndir Dia | WERGU – Senegal | Co-founder | Galien Forum Africa | Meeting of young innovators with investors | |
| 2021 | Babacar Ndoye | WHO Expert-Consultant Senegal | Expert-Consultant | Galien Forum Africa | « one health » & « global health » approaches: are they complementaries or contradictories in the global health security context? | |
| 2018 | Lee N. Newcomer | UnitedHealthcare | Principal, Lee Newcomer Consulting LLC, Former Senior Vice President, Oncology & Genetics, | Galien Forum USA | Cancer in a time of disruption | |
| 2014 | William Newsome | Stanford University of Medicine | Ph.D. Harman Family Provostial Professor & Professor of Neurobiology, | Galien Forum USA | The brain initiative | |
| 2021 | Sobel Ngom | Consortium Jeunesse Senegal | Executive Director | Galien Forum Africa | Meeting of young innovators with investors | |
| 2020 | Sobel Ngom | Social change Factory | Executive Director | Galien Forum Africa | Youth forum: leadership & young people facing covid-19 | |
| 2018 | Mabingue Ngom | WCARO (Western & Central Africa Region), UNFPA | Regional Director | Galien Forum Africa | Universal access to essential & others medicines | |
| 2020 | Marie Khemesse Ngom Ndiaye | National Committee for the Management of Epidemics (Senegal) | Director General of Health & President | Galien Forum Africa | Professional women & covid 19 sub-theme 3: contribution of professional women in the response against covid 19: state of play, challenges & perspectives | |
| 2021 | Catherine Nguila | Winner of the L’Oreal /Unesco Africa Prize for Women in Science – Kenya | Winner of the L’Oreal /Unesco Africa Prize | Galien Forum Africa | Involvement of women researchers in the mhw | |
| 2018 | Mary Teuw Niane | Research & Innovation, Senegal | Minister of Higher Education | Galien Forum Africa | Plenary Panel - women in stem in africa | |
| 2020 | Cheikh Ibrahima Niang | FST | Socio-anthropologis | Galien Forum Africa | Multisectoral & community participation: strengths, weaknesses & recommendations sub-theme 4: | |
| 2011 | Steven Nissen | Clevel& Clinic Lerner School of Medicine at Case Western Reserve U | Chairman, Department of Cardiovascular Medicine Clevel& Clinic Foundation & Professor of Medicine, | Galien Forum USA | Perspectives on innovation, patient safety & global access thinking beyond laboratories & clinical trials | |
| 2022 | Wilfred Njagi | Villgro Africa | CEO | Galien Week of Innovation | Best Incubator/Accelerator/ equity - Clinical Trial Management and Wellness Care An innovator’s connection to a leadership accelerator, incubator or private equity organization is a strong indicator of success. Financial support is part of the commitment, as are experience and connections. How do these investment and counseling groups help start-ups with their clinical trial design, navigate regulatory and payer system complexities or build a go-to marketing plan? Beyond access to cash, what makes the innovator’s connection to an accelerator, incubator or private equity group success critical? | |
| 2021 | John Nkengasong | African Centers for Disease Control & Prevention (CDC Africa) President the Prix Galien Africa Jury International – Cameroon | Director | Galien Forum Africa | Covid 19 lessons learned, autonomy & sovereignty of africa sub topic 4 | |
| 2021 | John Nkengasong | African Centers for Disease Control & Prevention (CDC Africa) President the Prix Galien Africa Jury International – Cameroon | Director | Galien Forum Africa | Closing ceremony | |
| 2021 | John Nkengasong | Prix Galien Africa Jury International – Cameroon | CDC Africa Director | Galien Forum Africa | Symposium one health – one africa : a new agenda for governance & the growth of a post-covid continent | |
| 2020 | John Nkengasong | African Centers for Disease Control & Prevention (Africa CDC) | Director | Galien Forum Africa | The response of african countries to the covid-19 pandemic | |
| 2020 | John Nkengasong | African Centers for Disease Control & Prevention (Africa CDC) | Director | Galien Forum Africa | Current situation of the response, challenges & prospects.sub-theme 1: | |
| 2018 | John Nkengasong | CDC, Centre for Disease Control & Prenvention, Africa | Director | Galien Forum Africa | Remarkable women engage for humanity | |
| 2018 | John Nkengasong | Centre for Disease Control & Prenvention - Africa | Director | Galien Forum Africa | managing infectious diseases & pandemics | |
| 2011 | Larry Norton | Memorial Sloan-Kettering Cancer Center | Deputy physician-in chief for breast cancer programs & medical director, Evelyn H. Lauder Breast Center, | Galien Forum USA | Perspectives on innovation, patient safety & global access thinking beyond laboratories & clinical trials | |
| 2020 | Ngoy Nsenga | COVID 19 & Program Manager for Emergency Response at WHO AFRO | Incident Manager | Galien Forum Africa | Current situation of the response, challenges & prospects.sub-theme 1: | |
| 2021 | Francine Ntoumi | Congolese Foundation for Medical Research (DR Congo) | President & Executive Director | Galien Forum Africa | Involvement of women researchers in the mhw | |
| 2021 | Mwelecele Ntuli Malecela | Deportment of Control of Neglected Tropical Diseases World Health Organization | Director | Jerusalem Ethics Forum | Highly prevalent neglected diseases: developing medicines & building infrastructure for the rest of the world | |
| 2015 | Stephen Oesterle | Medtronic, plc | Senior Vice President Medicine & Technology | Galien Forum USA | Bioengineering for better health: what future for targeted drug delivery? | |
| 2019 | Joshua J. Ofman | GRAIL, Inc | Chief of Corporate Strategy & External Affairs | Galien Forum USA | Digital health -orchestrating patient- centricity from molecule to market | |
| 2021 | Stephen Ogweno | Stowelink Inc. – Kenya | Young Innovators | Galien Forum Africa | Meeting of young innovators with investors | |
| 2021 | Franz Okey | Speak Up Africa Country Coordinator in Benin – Benin | Country Coordinator | Galien Forum Africa | The power of youth: how can young leaders contribute to sustainable change for healthier communities? | |
| 2021 | Ngozi Okonjo-Iweala | World Trade Organization WTO – International – Nigeria | Director General | Galien Forum Africa | Symposium one health – one africa : a new agenda for governance & the growth of a post-covid continent | |
| 2011 | Bernat Olle | Vedanta Biosciences | Chief Executive Officer | Galien Forum USA | The gut microbiome: opportunities & challenges | |
| 2021 | Olayinka Olusola Omigbodun | Representative of the Deans of ECOWAS-Nigeria | Provost University of Ibadan, Representative of the Deans of ECOWAS | Galien Forum Africa | Youth leadership training (part 1) | |
| 2021 | Olayinka Olusola Omigbodun | Representative of the Deans of ECOWAS-Nigeria | Provost University of Ibadan, Representative of the Deans of ECOWAS | Galien Forum Africa | Youth leadership training | |
| 2020 | Olayinka Olusola Omigbodun | University of Ibadan (Nigeria) | Dean of the College of Medicine | Galien Forum Africa | Current situation of the response, challenges & prospects.sub-theme 1: | |
| 2020 | Francis Omaswa | African Center for Global Health & Social Transformation; 2019 NOGUCHI Prize Laureate (Ug& a) | Executive Director | Galien Forum Africa | Multisectoral & community participation: strengths, weaknesses & recommendations sub-theme 4: | |
| 2020 | Jorge Ortiz | Bayer | Global Medical Affairs Head | Galien Week of innovation | What are the prospects – & limitations – behind the new approaches to cancer treatments from our increased knowledge of the underlying biology behind tumor growth & proliferation? | |
| 2021 | Anu Osinusi | Gilead Sciences | Vice President, Clinical Research for Hepatitis, Respiratory & Emerging Viruses | Galien Week of innovation | With a global pandemic raising awareness of the importance of vaccines & anti-viral/anti-microbial drugs, are private-sector r&d incentives aligned to meet these unmet medical needs? | |
| 2021 | Cheikh Oumar Seydi | Bill & Melinda Gates Foundation Africa | Scientific Advisory Committee | Galien Forum Africa | Innovations & ethic for global health security | |
| 2022 | Jackie Pacelli | AbbVie | VP, Communications | Galien Webinars Series | Golden Jubilee - Best BioTech Category | |
| 2012 | Michel Pairet | Boehringer Ingelheim | Member, Board of Managing Directors - Innovation, | Galien Forum USA | Closing symposium: treating neurodegenerative disease: the potential of prion-based therapies | |
| 2020 | Alexandra Palt | L’Oreal FoundationFrance | President | Galien Forum Africa | Place of women in innovation related to covid 19 sub-theme 2: | |
| 2022 | Susan Pandya | Servier Pharmaceuticals | Clin. Devt Head of Cancer | Galien Week of Innovation | Solid Tumor Cancers What is the state of progress in extending cell-based gene therapies to fight solid tumor cancers? How successful has the pharma industry been in building new therapeutic and diagnostic platforms to fight major cancers and address their prevalence in vulnerable populations, including the aged, minorities, and pediatric patients? | |
| 2022 | Menelas (Mene) Pangalos | AstraZeneca | Executive Vice President & President BioPharmaceuticals R&D | Galien Forum UK | Clinical trials & regulations: what have we learned from covid? | |
| 2014 | Ed Park | Athenahealth, Inc | Executive Vice President & Chief Operating Officer | Galien Forum USA | The future of digital health | |
| 2012 | Roy Parker | University of Colorado, Boulder | Professor Cech-Leinwand Endowed Chair of Biochemistry | Galien Forum USA | Closing symposium: treating neurodegenerative disease: the potential of prion-based therapies | |
| 2020 | Amanda Paschke | Merck & Co., Inc. | Executive Director Global Clinical Development | Galien Week of innovation | Will the coronavirus pandemic finally lead to an upswing in r&d to tackle neglected areas like antibiotic resistance, zoonotic transmission of pathogens & a more globally-coordinated approach to infectious diseases overall? | |
| 2011 | Richard C. Pasternak | Merck & Co., Inc | Former Vice-President & Past Director | Galien Forum USA | What is "value" & how can it be measured & demonstrated in therapeutic innovations? breaking down the barriers of the past | |
| 2021 | Muhammad Ali Pate | Harvard University Former Minister of Health (Nigeria/ USA) | Public Health Leadership | Galien Forum Africa | Women’s leadership in global health security | |
| 2020 | Muhammad Pate | World Bank | Public Health Leadership | Galien Forum Africa | Financing the response to covid 19 | |
| 2022 | Kiran Patel | Janssen | VP Clinical Devt, Solid Tumor | Galien Week of Innovation | Solid Tumor Cancers What is the state of progress in extending cell-based gene therapies to fight solid tumor cancers? How successful has the pharma industry been in building new therapeutic and diagnostic platforms to fight major cancers and address their prevalence in vulnerable populations, including the aged, minorities, and pediatric patients? | |
| 2015 | Steven Paul | Voyager Therapeutics | President & Chief Executive Officer | Galien Forum USA | Untangling the web of neurodegeneration: how far & how soon? | |
| 2021 | Eric M Pearlman | Eli Lilly & Company | Senior Medical Director-Migraine/Pain, Neuroscience Medical Affairs | Galien Week of innovation | What can patients with chronic conditions expect from medicines advances within the next five to ten years? how is chronic disease research moving from incremental & maintenance therapies to real breakthroughs toward cure & prevention? | |
| 2020 | Eric M Pearlman | Eli Lilly & Company | Senior Medical Director-Migraine/Pain, Neuroscience Medical Affairs | Galien Week of innovation | Where is the growing science & its link to disease leading us in terms of new treatments for patients with unresolved chronic conditions? | |
| 2020 | Eric M Pearlman | Eli Lilly & Company | Senior Medical Director-Migraine/Pain, Neuroscience Medical Affairs | Galien Week of innovation | The ability to claim larger health system productivity benefits from the introduction of chronic disease medicines looms in importance as these therapeutic segments become more crowded & competitive. | |
| 2011 | Steve Pearson | Institute for Clinical & Economic Review (ICER) | Founder & President | Galien Forum USA | Keynote: drug pricing & access in the trump administration: consensus or confrontation? | |
| 2019 | Renzo Pegoraro | Lanza Foundation, Vatican | Scientific Director | Jerusalem Ethics Forum | Human reproduction: technical limit, ethical limit | |
| 2021 | Louis Penali | Life Sciences Ethics Committee, Cote d’Ivoire, MSF Scientific Advisor (West & Central Africa) International – Côte d’Ivoire | President | Galien Forum Africa | Innovations & ethic for global health security | |
| 2022 | Rodolfo Perini | Merck & Co., Inc | AVP Global Clinical Dvt Onco | Galien Week of Innovation | Rare Genetic Diseases Will progress in therapies that promise a genetic cure for devastating rare diseases lead to similar innovations in patient access to these high-cost, high-touch treatments? | |
| 2021 | Greg Perry | IFPMA | Assistant Director-General | Galien Forum Africa | Women & stem in the global health security context | |
| 2011 | Magnus Persson | The Column Group | Managing Partner | Galien Forum USA | A global health challenge: the obesity & diabetes epidemic where are the innovations & who will pay for them? | |
| 2012 | Jennifer C. Petter | Arrakis | Founder & Chief Scientific Officer | Galien Forum USA | Drugging the undruggable» with novel approaches to small molecule design | |
| 2010 | Seth Pinsky | New York City Economic Development Corporation (NYCEDC) | President | Galien Forum USA | Biomedical innovation: funding challenges & developing public/private partnership incentives | |
| 2011 | Gary Pisano | Harvard Business School | Harry E. Figgie Professor of Business Administration, | Galien Forum USA | Making medicines affordable | |
| 2011 | Peter J. Pitts | Center for Medicine in the Public Interest | President | Galien Forum USA | What is "value" & how can it be measured & demonstrated in therapeutic innovations? breaking down the barriers of the past | |
| 2021 | David Platt | Novartis Pharmaceuticals Corporation | Vice President, Medical Unit Head Cardiovascular, Renal & Metabolism Medical Unit | Galien Week of innovation | What can patients with chronic conditions expect from medicines advances within the next five to ten years? how is chronic disease research moving from incremental & maintenance therapies to real breakthroughs toward cure & prevention? | |
| 2020 | David Platt | Novartis Pharmaceuticals Corporation | Vice President, Medical Unit Head Cardiovascular, Renal & Metabolism Medical Unit | Galien Week of innovation | The ability to claim larger health system productivity benefits from the introduction of chronic disease medicines looms in importance as these therapeutic segments become more crowded & competitive. | |
| 2012 | Andy Plump | Takeda Pharmaceuticals Company Ltd | President, Research & Development, | Galien Forum USA | Ethics of innovation, under the auspices of the elie wiesel foundation for humanity | |
| 2022 | Theresa Podrebarac | Horizon Therapeutics | SVP Clinical Devt | Galien Week of Innovation | Biotech - Chronic/Autoimmune Disorders and Vaccines Given that many chronic diseases have an infectious origin, what learnings can be had by the most recent innovations in vaccine development technology in raising the bar on innovations to address the huge unmet need against conditions that kill millions? | |
| 2018 | Marie-Pierre Poirier | WCA (Western & Central Africa) UNICEF | Regional Director | Galien Forum Africa | Addressing chronic malnutrition | |
| 2022 | Catherine Pollard | Centre for Improving Data Collaboration, NHSX | Director | Galien Forum UK | Digital health innovation: a key driver of next generation healthcare – what & when? | |
| 2012 | Richard F. Pops | Alkermes | Chairman & Chief Executive Officer | Galien Forum USA | Ethics of innovation, under the auspices of the elie wiesel foundation for humanity | |
| 2012 | William Potter | National Institute of Mental Health | Senior Advisor, | Galien Forum USA | Alzheimer's innovation & the white house 2025 m& ate:what will it take to find a treatment? | |
| 2013 | John Thomas Potts, Jr | Massachusetts General Hospital & Harvard Medical School | Distinguished Jackson Professor of Clinical Medicine, | Galien Forum USA | The promise of gene therapy | |
| 2022 | Bernard Poussot | Roche holding & Wyeth | Director & Former Chairman & CEO | Galien Forum USA - Chair | prix Galien awards ceremony categories: > best startup > best digital health solution > inaugural best incubator/accelerator/equity | |
| 2020 | Santosh Prabhu | Abbott Structural Heart | Divisional Vice President, Product Development | Galien Week of innovation | How much are new technologies & engineering efficiencies contributing to progress against the world’s biggest killer? | |
| 2021 | Lisa Prasad | Henry Ford Health System | Vice President & Chief Innovation Officer | Galien Webinars Series | The incubators of innovation: academic medical centers as digital health champions | |
| 2022 | David Prior | NHS England | Lord. | Galien Forum UK | Access to innovation: optimizing health for patient populations | |
| 2012 | Stanley Prusiner | University of California, San Francisco (UCSF) | Nobel Laureate, Professor of Neurology & Biochemistry, | Galien Forum USA | Closing symposium: treating neurodegenerative disease: the potential of prion-based therapies | |
| 2020 | Dee Punungwe | Kenya | researcher | Galien Forum Africa | Place of women in innovation related to covid 19 sub-theme 2: | |
| 2010 | Dennis Purcell | Aisling Capital | Senior Managing Director | Galien Forum USA | Biomedical innovation: funding challenges & developing public/private partnership incentives | |
| 2011 | Mark Pykett | Neoprobe Corporation | President & Chief Executive Officer | Galien Forum USA | Perspectives on innovation, patient safety & global access thinking beyond laboratories & clinical trials | |
| 2011 | Paul I. Rachlin | Proskauer | Partner | Galien Forum USA | Funding innovation new trends in the healthcare m&a l& scape | |
| 2020 | Angela Radcliffe | CAPGEMINI INVENT | R&D Practice Lead,m Founding Member, CoS, IEEE Global Initiative to Standardize Fairness in the Trade of Data; Advisory Board Member to Startups in Life Science; Clinical Research Advocate | Galien Webinars Series | The digital health enterprise: start-up trends & the culture of big pharma | |
| 2014 | Daniel Rader | the University of Pennsylvania | Medicine | Galien Forum USA | Heart attack guidelines | |
| 2020 | Sri Radhakrishnan | Pulmonx Corporation | Chief Technical Officer | Galien Week of innovation | What is medtech innovation doing for patients with specialized needs for treatment? | |
| 2022 | Maha Radhakrishnan | Biogen | Group senior vice president & chief medical officer | Galien Forum USA | Diversity and health equity in the future creation of medicine | |
| 2021 | Charlemagne Marie Ragnag-Newende Ouedraogo | Burkina Faso | Minister of Health | Galien Forum Africa | Covid 19 lessons learned, autonomy & sovereignty of africa sub topic 5 | |
| 2022 | June Raine | MHRA | Chief Executive Officer | Galien Forum UK | Clinical trials & regulations: what have we learned from covid? | |
| 2020 | Jean-Daniel Rainhorn | Geneva University/IHEID, Switzerland | Honorary Professor in International Health & Humanitarian Action | Jerusalem Ethics Forum | Up-to-date reflection on society, medicine & reproduction | |
| 2019 | Jean-Daniel Rainhorn | Geneva University/IHEID, Switzerland | Honorary Professor in International Health & Humanitarian Action | Jerusalem Ethics Forum | Health policy & financing innovation: ethical considerations, cost & the role of the patient | |
| 2022 | Reshma Rangwala | Karyopharm Therapeutics Inc. | CMO | Galien Week of Innovation | Hematologic Cancers and Gene-based “Tumor Agnostic” Therapies How much more mileage is in store for blood-based cancer survival rates, which have been increasing steadily in recent years? And what is being done about the flip side of this success, expressed in more treatment-related morbidities, disease relapse and higher incidence | |
| 2020 | Ishu Rao | Impulse Dynamics | Medical Director | Galien Week of innovation | How much are new technologies & engineering efficiencies contributing to progress against the world’s biggest killer? | |
| 2022 | Simon Rasalingham | behold.ai | CEO and Chairman | Galien Week of Innovation | Digital Health Solution - Disease Management In what ways can these new technologies contribute to the realization of better outcomes for patients at less cost to overburdened health systems? | |
| 2012 | Guido Rasi | European Medicines Agency | Executive Director | Galien Forum USA | Ethics of innovation, under the auspices of the elie wiesel foundation for humanity | |
| 2012 | Guido Rasi | European Medicines Agency | Executive Director | Galien Forum USA | 21st century science: building partnerships, managing for success | |
| 2020 | Mads Frederik Rasmussen | Novo Nordisk A/S | Corporate Project Vice President for GLP-1, CV & Outcomes | Galien Week of innovation | Where is the growing science & its link to disease leading us in terms of new treatments for patients with unresolved chronic conditions? | |
| 2019 | Franklin Rausky | Elie Wiesel Institute, France | Director of Jewish Studies | Jerusalem Ethics Forum | Life sciences: psychiatry, humanism & totalitarianism | |
| 2022 | Lynn Ray | Olympus America Inc. | VP, GM, Global Respiratory Olympus | Galien Week of Innovation | Medical Devices and Implants – Cardiovascular and Cancer How are systems design, electronics and engineering making invasive, high-risk surgical procedures a thing of the past for these two major killers? | |
| 2017 | Vivek Reddy | Icahn School of Medicine, Mount Sinai | Leona M. & Harry B. Helmsley Charitable Trust Professor of Medicine in Cardiac Electrophysiology, | Galien Forum USA | Atrial fibrillation | |
| 2022 | Andy Richards | Congenica Ltd, Owlstone Medical, Closed Loop Medicine & ieso Digital Health | CBE I Chair | Galien Forum UK | Digital health innovation: a key driver of next generation healthcare – what & when? | |
| 2021 | Valery Ridde | IRD,Montreal-Canada | Teacher | Galien Forum Africa | « one health » & « global health » approaches: are they complementaries or contradictories in the global health security context? | |
| 2015 | Robert H. Ring | Autism Speaks | Chief Executive Officer | Galien Forum USA | Autism - the next decade | |
| 2021 | Michael Ringel | BCG | Managing Director & Senior Partner | Galien Week of innovation | Will clinical progress in therapies that promise a genetics-based cure for devastating rare diseases lead to similar downstream progress in patient access to these high-cost, high-touch treatments? | |
| 2020 | Michael Ringel | BCG | Managing Director & Senior Partner | Galien Week of innovation | Can the foundational biologic underst& ings now being brought to cancer care be leveraged to secure a targeted, more personalized approach to other conditions? | |
| 2011 | Michael Ringel | BCG | Managing Director & Senior Partner | Galien Forum USA | Drugging the undruggable» with novel approaches to small molecule design | |
| 2022 | Michael Ringel | BCG | Managing Dir Sr Partner - Moderator | Galien Week of Innovation | Biotech - Cancer Can the foundational biologic understandings now being brought to cancer care be leveraged to secure a targeted, more personalized approach to treatment, particularly in solid tumors? | |
| 2021 | Maryanne Rizk | Medable | Chief Strategy Officer | Galien Forum USA | The future is decentralized -- how the paradigm has changed & what it means for modern trials | |
| 2020 | Maryanne Rizk | IQVIA | Senior Vice President, R&D Digital Strategy | Galien Week of innovation | Will the coronavirus pandemic finally lead to an upswing in r&d to tackle neglected areas like antibiotic resistance, zoonotic transmission of pathogens & a more globally-coordinated approach to infectious diseases overall? | |
| 2019 | Maryanne Rizk | IQVIA | Senior Vice President, R&D Digital Strategy | Galien Forum USA | Digital health -orchestrating patient- centricity from molecule to market | |
| 2016 | Maryanne Rizk | Oracle Health Sciences | Senior Vice President, R&D Digital Strategy | Galien Forum USA | Molecular scissors: what can we expect from gene editing? | |
| 2015 | Maryanne Rizk | Oracle Health Sciences | Senior Vice President, R&D Digital Strategy | Galien Forum USA | Autism - the next decade | |
| 2022 | Samantha Roberts | NICE | Chief Executive Officer | Galien Forum UK | Access to innovation: optimizing health for patient populations | |
| 2021 | Antoine Rodrigue | MODJAW | Chief Executive Officer | Galien Week of innovation | In what ways can these new technologies contribute to the realization of better outcomes for patients at less cost to overburdened health systems? | |
| 2022 | Sandy Rodriguez | Roche | Vice President, Communications | Galien Webinars Series | Golden Jubilee - Best BioTech Category | |
| 2011 | Kent Rogers | UnitedHealth Group Inc | M.B.A., Senior Vice President, Industry Relations, | Galien Forum USA | Making medicines affordable | |
| 2011 | Dana Rollison | Moffitt Cancer Center | Vice President, Total Cancer Care & Chief Health Information Officer, | Galien Forum USA | The next generation of health & research informatics accelerating translational research & personalized medicine at moffitt cancer center | |
| 2013 | Maria Grazia Roncarolo | Stanford University | Professor of Pediatrics & Medicine, | Galien Forum USA | Fireside chat | delivering on the patient promise of gene therapy | |
| 2019 | Steve Rosenberg | Oracle Health Sciences | Senior Vice President & General Manager | Galien Forum USA | What’s holding back the technology revolution in clinical trials? | |
| 2013 | Steve Rosenberg | Oracle Health Sciences | Senior Vice President & General Manager, | Galien Forum USA | The marriage of technology & medicine: bringing out the best in each other | |
| 2022 | Michael Rosenblatt | Galien Forum & flagship pioneering | Co-Chair & Senior Partner | Galien Forum USA | Welcome | |
| 2022 | Michael Rosenblatt | Galien Foundation | Committee Chair | Galien Week of Innovation | Laureates Media Presentation | |
| 2021 | Michael Rosenblatt | Flagship Pioneering | Senior Partner | Galien Week of innovation | Given that many chronic diseases have an infectious origin, what learnings can be had by the most recent innovations in vaccine development technology in raising the bar on innovations to address the huge unmet need against chronic conditions that kill millions? | |
| 2021 | Michael Rosenblatt | Flagship Pioneering | Galien Forum Co-Chair Senior Partner | Galien Forum USA | Welcome | |
| 2020 | Michael Rosenblatt | Flagship Pioneering | Chief Medical Officer, Co-Chair: Galien Forum | Galien Forum USA | The promise of gene therapy | |
| 2020 | Michael Rosenblatt | Flagship Pioneering | Chief Medical Officer | Galien Forum USA | The next 50 years of innovation: where will it come from & how do we secure it? | |
| 2020 | Michael Rosenblatt | Flagship Pioneering | Chief Medical Officer | Galien Week of innovation | Where is the growing science & its link to disease leading us in terms of new treatments for patients with unresolved chronic conditions? | |
| 2020 | Michael Rosenblatt | Flagship Pioneering | Chief Medical Officer | Galien Forum USA | Making medicines affordable | |
| 2013 | Michael Rosenblatt | Merck & Co., Inc. | Executive Vice President & Chief Medical Officer | Galien Forum USA | The promise of gene therapy | |
| 2012 | Michael Rosenblatt | Merck & Co., Inc. | Executive Vice President & Chief Medical Officer | Galien Forum USA | Alzheimer's innovation & the white house 2025 m& ate:what will it take to find a treatment? | |
| 2011 | Michael Rosenblatt | Merck & Co., Inc. | Executive Vice President & Chief Medical Officer | Galien Forum USA | Perspectives on innovation, patient safety & global access thinking beyond laboratories & clinical trials | |
| 2020 | Kate Rosenbluth | Cala Health | Founding Chief Executive Officer & Chief Scientific Officer | Galien Week of innovation | How far are we from achieving the health system world of the connected patient? | |
| 2019 | Michal Rosen-Zvi | IBM, Israel | Director of Health Informatics | Jerusalem Ethics Forum | “artificial intelligence & ethics” | |
| 2014 | Hans Rosling | Karolinska Institutet, Sweden | Global Health | Galien Forum USA | A new agenda for global health | |
| 2020 | Joseph Ross | Yale School of Medicine | Medicine & Public Health | Jerusalem Ethics Forum | Tracking bioethics: transparency, trust & the industry’s social imperatives | |
| 2021 | Scott T. Rottinghaus | Alexion Pharmaceuticals | Vice President, Head of Clinical Development, Hematology & Nephrology | Galien Week of innovation | Will clinical progress in therapies that promise a genetics-based cure for devastating rare diseases lead to similar downstream progress in patient access to these high-cost, high-touch treatments? | |
| 2015 | John W. Rowe | the Columbia University Mailman School of Public Health | Julius B. Richmond Professor of Health Policy & Aging | Galien Forum USA | Us health reform: partnering, pricing & politics | |
| 2011 | Francesco Rubino | Metabolic & Diabetes Surgery Center, Weill Cornell Medical College | Associate Professor of Surgery, Director, | Galien Forum USA | A global health challenge: the obesity & diabetes epidemic where are the innovations & who will pay for them? | |
| 2020 | Marcella Ruddy | Regeneron | Vice President, Strategic Program Direction, Immunology & Inflammation | Galien Week of innovation | Where is the growing science & its link to disease leading us in terms of new treatments for patients with unresolved chronic conditions? | |
| 2021 | Rodrigo Ruiz Soto | Deciphera | Senior Vice President, Clinical Development & Translational Medicine | Galien Week of innovation | What is the state of progress in building new therapeutic & diagnostic platforms to fight major cancers & address their prevalence in vulnerable populations, including the aged, minorities, & pediatric patients? | |
| 2021 | Renee Ryan | Cala Health | Chief Executive Officer | Galien Week of innovation | How far are we from achieving the health system world of the connected patient? | |
| 2022 | Renee Ryan, | Cala Health | CEO | Galien Week of Innovation | Laureates Media Presentation | |
| 2017 | Lars Ryden | Karolinska Institute, Stockholm, Sweden | Senior Professor of Cardiology | Galien Forum USA | Atrial fibrillation | |
| 2016 | Lars Ryden | Karolinska Institute, Stockholm, Sweden | Senior Professor of Cardiology | Galien Forum USA | Diabetes mellitus & cardiovascular risk – on the rise, fall & novel possibilities with glucose lowering drugs | |
| 2015 | Lars Ryden | Karolinska Institutet, Stockholm, Sweden | Senior Professor of Cardiology | Galien Forum USA | Confronting the crisis of heart failure: innovation in pharmacology & medical devices | |
| 2016 | Michel Sadelain | Center for Cell Engineering, Memorial Sloan Kettering Cancer Center | Director | Galien Forum USA | Precision medicine: delivering on the promise | |
| 2021 | Jim Sailer | Population Council | Executive Director, Center for Biomedical Research | Galien Week of innovation | With a global pandemic raising awareness of the importance of vaccines & anti-viral/anti-microbial drugs, are private-sector r&d incentives aligned to meet these unmet medical needs? | |
| 2020 | Abdou Salam Fall | Economic & Social Transformations (LARTES) (Senegal) | Director of the Research Laboratory | Galien Forum Africa | Gender & innovations facing covid 19 sub-theme 1: gender & response to covid 19. | |
| 2019 | Ayman Salem | USA | Neurosurgeon | Jerusalem Ethics Forum | “artificial intelligence & ethics” | |
| 2021 | Papa Salif Sow | Africa Health Department, Mastercard Foundation | Director | Galien Forum Africa | Meeting of young innovators with investors | |
| 2020 | Ndeye Salimata Diop Dieng | Family, Gender & Child Protection (Senegal) | Minister of Women | Galien Forum Africa | Gender & innovations facing covid 19 sub-theme 1: gender & response to covid 19. | |
| 2021 | Macky Sall | Republic of Senegal | President | Galien Forum Africa | Inaugural Panel | |
| 2021 | Amadou Alpha Sall | Pasteur Institute - Dakar | Director | Galien Forum Africa | Innovations & ethic for global health security | |
| 2020 | Galaye Sall | Country Coordinating Mechanism of the CCM Global Fund (Senegal) | President | Galien Forum Africa | Financing the response to covid 19 | |
| 2020 | Amadou Alpha Sall | Pasteur Institute - Dakar | Director | Galien Forum Africa | Screening strategies for a person suspected of covid 19: state of play, strengths, points for improvement & recommendations. sub-theme 2: | |
| 2018 | Amadou Alpha Sall | Pasteur Institute - Dakar | Director | Galien Forum Africa | Remarkable women engage for humanity | |
| 2018 | Amadou Alpha Sall | Pasteur Institute - Dakar | Director | Galien Forum Africa | managing infectious diseases & pandemics | |
| 2019 | Bengt Samuelsson | Former President, Karolinska Institute; Former Chairman, Nobel Foundation | Nobel Laureate; | Galien Forum USA | The marriage of technology & medicine: bringing out the best in each other | |
| 2017 | Bengt Samuelsson | Karolinska institute & Former chairman of the Nobel Foundation | Nobel Laureate, Former President | Galien Forum USA | Atrial fibrillation | |
| 2016 | Bengt Samuelsson | Karolinska Institute & Former chairman of the Nobel Foundation | Nobel Laureate, Former President | Galien Forum USA | Diabetes mellitus & cardiovascular risk – on the rise, fall & novel possibilities with glucose lowering drugs | |
| 2015 | Bengt Samuelsson | Karolinska Institute & Former Chairman of the Nobel Foundation. Stockholm, Sweden | Nobel Laureate, Former President | Galien Forum USA | Confronting the crisis of heart failure: innovation in pharmacology & medical devices | |
| 2014 | Bengt Samuelsson | Karolinska institute & Former chairman of the Nobel Foundation | Nobel Laureate, Former President | Galien Forum USA | A new agenda for global health | |
| 2011 | Bengt Samuelsson | Karolinska institute & Former chairman of the Nobel Foundation | Nobel Laureate, Former President | Galien Forum USA | How will we be paying for medicine 10 years from now? (Chief Executive Officers panel) | |
| 2010 | Bengt Samuelsson | Karolinska institute & Former chairman of the Nobel Foundation | Nobel Laureate, Former President | Galien Forum USA | The changing l& scape of pharmacovigilance: the impact on medical innovation & human health | |
| 2019 | Alfred Sandrock | Biogen | Executive Vice-President & Chief Medical Officer | Galien Forum USA | Spinal muscular atrophy: charting the pathway to clinical progress | |
| 2020 | Rokia Sanogo | National Institute of Public Health of Mali, WHO | Head of the traditional medicine & Vice-president of the Advisory Committee on Traditional Medicine | Galien Forum Africa | Contribution of traditional medicine in the response against covid 19: state of play, challenges & prospects sub-theme 5: | |
| 2015 | Luca Santarelli | Roche Pharma Research & Early Development, Roche | Former Senior Vice President, Head of Neuroscience, Ophthalmology & Rare Diseases (NORD), | Galien Forum USA | Autism - the next decade | |
| 2021 | Oulimata Sarr | (West & Central Africa) International – Senegal | UN Women Dakar Regional Director | Galien Forum Africa | Socio-economic consequences, equity & gender in the global health security | |
| 2020 | Oulimata Sarr | UN Women | Regional Director | Galien Forum Africa | Gender & innovations facing covid 19 sub-theme 1: gender & response to covid 19. | |
| 2020 | Fatou Sarr Sow | Gender Laboratory (Senegal) | Director | Galien Forum Africa | Gender & innovations facing covid 19 sub-theme 1: gender & response to covid 19. | |
| 2012 | Nadeem Sarwar | Pfizer | Senior Director - Head, Population Research & Head,Cardiovascular Genetics, | Galien Forum USA | Addressing big datachallenges in genomics & personalized healthcare | |
| 2020 | George Scangos | Vir Biotechnology | Chief Executive Officer | Galien Forum USA | The future of therapeutics: what novel modalities will be drugs? what vaccines & technologies will we need? | |
| 2014 | George A. Scangos | Biogen Idec | Chief Executive Officer | Galien Forum USA | Us health reform | |
| 2022 | Tom Schall | ChemoCentryx | President, CEO, Director | Galien Week of Innovation | BioTech – Rare Diseases What is the underlying science behind clinical progress in therapies that promise a genetics-based cure for devastating rare diseases and how will this contribute to the next wave of innovations? What are the implications for continued patient access to these high-cost, high-touch 2 treatments – does the ROI calculation for rare diseases still add up? | |
| 2021 | Adam Schayowitz | Pfizer Oncology | Medicine Team Group Lead (Breast Cancer, Colorectal Cancer & Melanoma) | Galien Week of innovation | What is the state of progress in building new therapeutic & diagnostic platforms to fight major cancers & address their prevalence in vulnerable populations, including the aged, minorities, & pediatric patients? | |
| 2019 | David Schenkein | Agios Pharmaceuticals | General Partner, GV; Executive Chairman of the Board & Former Chief Executive Officer, | Galien Forum USA | Can disruptive innovation positively impact healthcare costs? | |
| 2018 | David Schenkein | Agios Pharmaceuticals | Chief Executive Officer | Galien Forum USA | Cancer in a time of disruption | |
| 2019 | Leonard S. Schleifer | Regeneron Pharmaceuticals | Founder, President & Chief Executive Officer, | Galien Forum USA | Keynote: drug pricing & access in the trump administration: consensus or confrontation? | |
| 2013 | Leonard S. Schleifer | Regeneron | Founder, President & Chief Executive Officer, | Galien Forum USA | Affordable care act us healthcare in transition: the stakes for industry | |
| 2020 | Douglas Schlichting | Eli Lilly & Company | Development Director Immunology Product Development – baricitinib rheumatoid arthritis & COVID-19 | Galien Week of innovation | The ability to claim larger health system productivity benefits from the introduction of chronic disease medicines looms in importance as these therapeutic segments become more crowded & competitive. | |
| 2014 | Corinne Schmitz | Blue-Reg pharma Consult | President | Galien Foum Monaco | Beyond the Pill : The digital transformation of the biopharmaceutical industry in progress | |
| 2016 | Jim Scholefield | Merck & Co., Inc. | Executive Vice President, Chief Information & Digital Officer | Galien Forum USA | Delivering on the patient promise of gene therapy | |
| 2020 | Rob Scott | Abbvie | Retired Chief Medical Officer | Jerusalem Ethics Forum | Tracking bioethics: transparency, trust & the industry’s social imperatives | |
| 2020 | Jessica S. Scott | Takeda Pharmaceuticals | Head of R&D Patient Engagement Office | Jerusalem Ethics Forum | Tracking bioethics: transparency, trust & the industry’s social imperatives | |
| 2022 | Rob Scott, | Alcon | Vice President, Intraocular Devices R&D | Galien Week of Innovation | Medical Devices and Implants - Other Therapeutic Areas What is Med Tech innovation doing for patients with specialized needs for treatment? | |
| 2020 | Theodore F. Search | Skipta | Chief Executive Officer | Galien Week of innovation | What are the prospects – & limitations – behind the new approaches to cancer treatments from our increased knowledge of the underlying biology behind tumor growth & proliferation? | |
| 2020 | Theodore F. Search | Skipta | Chief Executive Officer | Galien Week of innovation | Are there common links in advancing research on hematologic cancers & other rare diseases associated with uncontrolled vascular system inflammation, such as sickle cell anemia? | |
| 2021 | Penda Seck | Committee to Combat Violence against Women (CLVF) Senegal | President | Galien Forum Africa | Socio-economic consequences, equity & gender in the global health security | |
| 2020 | Annette Seck Ndiaye | PNA Senegal | Director | Galien Forum Africa | Covid 19 drug supply chain in africa: challenges & perspectives | |
| 2020 | Sandi See Tai | Pfizer Global Product Development Pfizer Inc. | Vice President, Medicine Team Lead for Amyloid, Rare Neuro & Cardiac | Galien Week of innovation | The ability to claim larger health system productivity benefits from the introduction of chronic disease medicines looms in importance as these therapeutic segments become more crowded & competitive. | |
| 2021 | Amal El Fallah Seghrouchni | Sorbone Universiti | Intelegence Articielle | Galien Webinars Series | The impact of digital technology in clinical trials: ethical considerations (french edition) | |
| 2020 | Adam Selamani | Luxembourg | Health Digital expert | Galien Forum Africa | What place for digital health & innovations? sub-theme 3: | |
| 2012 | Dennis Selkoe | Harvard Medical School; Center for Neurologic Diseases, Brigham & Women's Hospital,& Vincent & Stella Coates Professor of Neurologic Diseases, | Co-Director | Galien Forum USA | Alzheimer's innovation & the white house 2025 m& ate:what will it take to find a treatment? | |
| 2016 | Magnus Settergren | Karolinska Institutet & Karolinska University Hospital Stockholm | Associate Professor, Interventional Cardiologist, | Galien Forum USA | The marriage of technology & medicine: bringing out the best in each other | |
| 2020 | Dan Sexton | Takeda Pharmaceutical Company Limited | Strategy Lead | Galien Week of innovation | Can the foundational biologic underst& ings now being brought to cancer care be leveraged to secure a targeted, more personalized approach to other conditions? | |
| 2020 | Moussa Seydi | Clinic SMIT | Head of Department of Infectious & Tropical Diseases | Galien Forum Africa | Management of patients positive for sars-cov2: management, challenges & perspectives sub-theme 3: | |
| 2021 | Stephanie Seydoux | Global Health France | Ambassador | Galien Forum Africa | Socio-economic consequences, equity & gender in the global health security | |
| 2020 | Gaurav Shah | Rocket Pharmaceuticals, Inc | President & Chief Executive Officer | Galien Forum USA | The promise of gene therapy | |
| 2021 | Javad Shahidi | Daiichi Sankyo | Vice President, Global Oncology R&D | Galien Week of innovation | Can the foundational biologic underst& ings now being brought to cancer care be leveraged to secure a targeted, more personalized approach to other rare conditions, particularly blood-based hematologic disorders? | |
| 2020 | Javad Shahidi | Daiichi Sankyo | Vice President, Global Oncology R&D | Galien Week of innovation | Can the foundational biologic underst& ings now being brought to cancer care be leveraged to secure a targeted, more personalized approach to other conditions? | |
| 2021 | Narinder S. Shargill | Global Medical Affairs | Vice President | Galien Week of innovation | What is med tech innovation doing for patients with specialized needs for treatment? | |
| 2016 | Jonathan Sheldon | Oracle | Global Vice President, Healthcare, Health Sciences Global Business Unit, | Galien Forum USA | Precision medicine: delivering on the promise | |
| 2015 | Jonathan Sheldon | Oracle Health Sciences | Global Vice President, | Galien Forum USA | Us health reform: partnering, pricing & politics | |
| 2014 | Jonathan Sheldon | Oracle Health Sciences | Global Vice President, | Galien Forum USA | The brain initiative | |
| 2013 | Jonathan Sheldon | Oracle Health Sciences | Global Senior Director of Translational Medicine, | Galien Forum USA | Personalized medicine: effect on drug r&d & patient care | |
| 2013 | Morgan Sheng | Genentech | Vice President, Neuroscience, | Galien Forum USA | Neurodegenerative disease drug progress | |
| 2021 | Michel Sidibe | African Medicines Agency AMA-UA International – Mali | African Union Special Envoy | Galien Forum Africa | Symposium one health – one africa : a new agenda for governance & the growth of a post-covid continent | |
| 2020 | Michel Sidibe | Mali | Former Minister of Health | Galien Forum Africa | Health break | |
| 2018 | Michel Sidibe | UNAIDS | Chief Executive Officer | Galien Forum Africa | Financing africa’s healthcare | |
| 2013 | Elliott Sigal | Bristol Myers Squibb | Former Executive Vice President, Chief Scientific Officer & President, R&D | Galien Forum USA | Improving efficiency in drug development | |
| 2022 | Cynthia Silva | Outset Medical, Inc. | Clinical Affairs Outset Medical | Galien Week of Innovation | Medical Devices and Implants - Other Therapeutic Areas What is Med Tech innovation doing for patients with specialized needs for treatment? | |
| 2011 | Jonathan Silverstein | OrbiMed Advisors | Partner | Galien Forum USA | Funding innovation new trends in the healthcare m&a l& scape | |
| 2010 | Jonathan Silverstein | OrbiMed Advisors | Partner | Galien Forum USA | Biomedical innovation: funding challenges & developing public/private partnership incentives | |
| 2020 | Ute Simon | AAA ( a Novartis company) | Head Global Medical Affairs | Galien Week of innovation | What are the prospects – & limitations – behind the new approaches to cancer treatments from our increased knowledge of the underlying biology behind tumor growth & proliferation? | |
| 2019 | Nancy Simonian | Syros Pharmaceuticals | President & Chief Executive Officer | Galien Forum USA | What’s holding back the technology revolution in clinical trials? | |
| 2021 | Peter Singer | WHO DG International – Canada | Special Advisor | Galien Forum Africa | Innovations & ethic for global health security | |
| 2020 | Laksen Sirimanne | Edwards Lifesciences | Vice President, Research & Development | Galien Week of innovation | How much are new technologies & engineering efficiencies contributing to progress against the world’s biggest killer? | |
| 2022 | Laksen Sirimanne | Edwards Lifesciences | R&D Transc Heart Valve | Galien Week of Innovation | Medical Devices and Implants – Cardiovascular and Cancer How are systems design, electronics and engineering making invasive, high-risk surgical procedures a thing of the past for these two major killers? | |
| 2019 | Daniel M. Skovronsky | Eli Lilly Research Laboratories & Company | President & Chief Scientific & Medical Officer, | Galien Forum USA | What’s holding back the technology revolution in clinical trials? | |
| 2015 | Laura Slatkin | New York Collaborates for Autism | Co-Founder | Galien Forum USA | Autism - the next decade | |
| 2020 | Martha Smit | Private Pharmaceutical Sector South Africa | Life Sciences, Africa | Galien Forum Africa | Place of local production in the pharmaceutical sector sub-theme 4: | |
| 2018 | Martha Smit | Life Sciences Practice group, Johannesburg | Partner, Fasken; Member | Galien Forum Africa | Universal access to essential & others medicines | |
| 2019 | Robin Smith | STEM for Life Foundation, USA | Founder | Jerusalem Ethics Forum | Ethical considerations around patient choice & human enhancement in healthcare? | |
| 2019 | Robin Smith | STEM for Life Foundation, USA | Founder | Jerusalem Ethics Forum | “artificial intelligence & ethics” | |
| 2015 | Robin L. Smith | Neostem & Cura Foundation | Founder | Galien Forum USA | Fireside chat | delivering on the patient promise of gene therapy | |
| 2022 | Kimberly Smith | ViiV Healthcare | Sr VP Head of R&D | Galien Week of Innovation | Anti-Viral Drugs and Women’s Health With a global pandemic raising awareness of the importance of vaccines and anti-viral/anti-microbial drugs, are private-sector R&D incentives aligned to meet future contagion threats? Gauging unmet needs in women’s health therapeutics and promising new drugs in the development stage | |
| 2021 | Kim Smith-Whitley | GBT | Executive Vice President & Head of Research & Development | Galien Week of innovation | Will clinical progress in therapies that promise a genetics-based cure for devastating rare diseases lead to similar downstream progress in patient access to these high-cost, high-touch treatments? | |
| 2022 | Michael Sneed | Johnson & Johnson | Executive Vice President, Global Corporate Affairs & Chief Communication Officer | Galien Webinars Series | Golden Jubilee - Best BioTech Category | |
| 2020 | Cheikh Sokhna | Research Institute for Development (Senegal) | Director of Research | Galien Forum Africa | Clinical trials in africa sub-theme 2: | |
| 2021 | Apolline Sondo | DITD of the University Hospital – Burkina Faso | Head of the department of infectious & tropical diseases | Galien Forum Africa | Involvement of women researchers in the mhw | |
| 2020 | Apolline Sondo | Ouagadougou (Burkina Faso) | Head of the Infectious & Tropical Diseases Department SMIT | Galien Forum Africa | Management of patients positive for sars-cov2: management, challenges & perspectives sub-theme 3: | |
| 2021 | Vera Songwe | UN Economic Commission for Africa International – Cameroon | Executive Secretary | Galien Forum Africa | Symposium one health – one africa : a new agenda for governance & the growth of a post-covid continent | |
| 2022 | Harpreet Sood | Huma | VP, Primary Care & Clinical Partnerships - Moderator | Galien Week of Innovation | Digital Health Solution - Clinical Trial Management and Wellness Care Are researchers, physicians and regulators ready to embrace advanced, low-touch approaches to streamline the cumbersome infrastructure of clinical trials? And are insurers and health systems prepared to reward software- driven patient self-care technologies, particularly by recognizing prevention and wellness as an integral element of service provision? | |
| 2021 | Yaye Sophietou Diop | Speak Up Africa – Senegal | Advocacy Specialist | Galien Forum Africa | The power of youth: how can young leaders contribute to sustainable change for healthier communities? | |
| 2011 | Pascal Soriot | AstraZeneca | Chief Executive Officer | Galien Forum USA | Perspectives on innovation, patient safety & global access thinking beyond laboratories & clinical trials | |
| 2020 | Jonathan Sorof | Global Blood Therapeutics | Senior Vice President, Head of Medical Affairs | Galien Week of innovation | Will progress in therapies that promise a genetic cure for devastating rare diseases lead to similar innovations in patient access to these highcost, high-touch treatments? | |
| 2020 | Lukas K. S Sosoe | University of Luxembourg | Teacher | Galien Forum Africa | Current situation of the response, challenges & prospects.sub-theme 1: | |
| 2021 | Quentin Soulet De Brugiere | Dreem | Co-Founder & Chief Executive Officer | Galien Week of innovation | Are insurers & health systems ready to embrace & reward these new self-care technologies, particularly in recognizing prevention & wellness as an integral element of service provision? | |
| 2020 | Mohamed Soumah | Organ Transplantation & Donation Commission (Senegal) | Head of the Department of Forensic Medicine & member | Galien Forum Africa | Current situation of the response, challenges & prospects.sub-theme 1: | |
| 2021 | Khoudia Sow | UCAD Senegal | President | Galien Forum Africa | Socio-economic consequences, equity & gender in the global health security | |
| 2021 | Samba Sow | Vaccine Development Center (CVD), Minister of Health, Mali | Director General | Galien Forum Africa | Communication of crisis or risk communication & community engagement (rcce) : what respective roles ? | |
| 2020 | Papa Salif Sow | Program Development & Management, Access Operations & Emerging Markets, Africa / Geneva. GILEAD sciences | Vice President | Galien Forum Africa | Vaccine production: state of play & perspectives sub-theme 4 | |
| 2020 | Mouhamadou Sow | Teranga Pharma «Ensuring the pharmaceutical sovereignty of Senegal» | Managing Director | Galien Forum Africa | Place of local production in the pharmaceutical sector sub-theme 4: | |
| 2020 | Jeffrey Spaeder | IQVIA | Chief Medical & Scientific Officer & Senior Vice President | Galien Forum USA | The future of therapeutics: what novel modalities will be drugs? what vaccines & technologies will we need? | |
| 2019 | Jeffrey Spaeder | IQVIA | Chief Medical & Scientific Officer & Senior Vice President | Galien Forum USA | What’s holding back the technology revolution in clinical trials? | |
| 2013 | Reisa Sperling | Harvard Medical School Department of Neurology, Brigham & Women’s Hospital | Neurology | Galien Forum USA | Neurodegenerative disease drug progress | |
| 2020 | Sam Spigelman | Janssen Research & Development, LLC | Senior Global Medical Affairs Leader | Galien Week of innovation | What are the prospects – & limitations – behind the new approaches to cancer treatments from our increased knowledge of the underlying biology behind tumor growth & proliferation? | |
| 2022 | Sanjay Srivastava | Accenture | Managing Director LifeSciences Moderator | Galien Week of Innovation | Solid Tumor Cancers What is the state of progress in extending cell-based gene therapies to fight solid tumor cancers? How successful has the pharma industry been in building new therapeutic and diagnostic platforms to fight major cancers and address their prevalence in vulnerable populations, including the aged, minorities, and pediatric patients? | |
| 2021 | Nagaraja Srivatsan | IQVIA | Senior Vice President & Chief Digital Officer, R&DS Technology Solutions | Galien Webinars Series | The impact of digital technologies in transforming & accelerating vaccine trials, development & delivery – lessons from covid-22 | |
| 2021 | Nagaraja Srivatsan | IQVIA | Senior Vice President & Chief Digital Officer, R&DS Technology Solutions | Galien Webinars Series | The impact of digital technologies in transforming & accelerating vaccine trials, development & delivery – lessons from covid-19 part 6 | |
| 2021 | Nagaraja Srivatsan | IQVIA | Senior Vice President & Chief Digital Officer, R&DS Technology Solutions | Galien Week of innovation | Are insurers & health systems ready to embrace & reward these new self-care technologies, particularly in recognizing prevention & wellness as an integral element of service provision? | |
| 2022 | Neil Stahl | Regeneron | EVP, Research and Development | Galien Week of Innovation | Laureates Media Presentation | |
| 2014 | Jay Stamatis | AbbVie | Vice President, Corporate Strategy Office; Head of Business Development & Acquisitions, | Galien Forum USA | Pioneers for a cure: the role of innovation & entrepreneurship in cancer research | |
| 2015 | Glenn D. Steele Jr. | Geisinger Health System | Chairman, xG Health Solutions; Former Chief Executive Officer | Galien Forum USA | Us health reform: partnering, pricing & politics | |
| 2015 | Glenn D. Steele Jr. | Geisinger Health System | Chairman, xG Health Solutions; Former Chief Executive Officer | Galien Forum USA | Delivering on the patient promise of gene therapy | |
| 2014 | Steven H. Stein | Novartis Oncology US | Senior Vice President, US Clinical Development & Medical Affairs, | Galien Forum USA | Cancer immunotherapeutics | |
| 2021 | Sally Stephens | Medicines360 | Corporate Strategy, Business Development, Marketing/Sales, & the Developing Countries Program | Galien Week of innovation | Given that many chronic diseases have an infectious origin, what learnings can be had by the most recent innovations in vaccine development technology in raising the bar on innovations to address the huge unmet need against chronic conditions that kill millions? | |
| 2012 | Scot Stevens | UPMC CancerCenter & UPCI,Director Personalized Medicine Technology, | Chief Information Officer | Galien Forum USA | Addressing big datachallenges in genomics & personalized healthcare | |
| 2020 | Paul Stoffels | Johnson & Johnson | Vice Chairman of the Executive Committee & Chief Scientific Officer - | Galien Forum USA | Covid-19 vaccines: the path to the holy grail | |
| 2022 | Jayme Strauss | Viz.ai | Chief Clinical Officer | Galien Week of Innovation | Digital Health Solution - Disease Management In what ways can these new technologies contribute to the realization of better outcomes for patients at less cost to overburdened health systems? | |
| 2012 | Eliane Strosberg | Art & Science - Belgium | Professor | Galien Forum USA | Art & science: from anatomy to genetics | |
| 2015 | Lorenz Studer | The Center for Stem Cell Biology Developmental Biology Program, The Memorial Sloan-Kettering Cancer Center | Director | Galien Forum USA | Untangling the web of neurodegeneration: how far & how soon? | |
| 2021 | Harrison Suhnfor | H&S Technologies – Cameroun | Young Innovators | Galien Forum Africa | Meeting of young innovators with investors | |
| 2021 | Mark Sullivan | Medicines Development for Global Health | Founder & Managing Director | Galien Week of innovation | With a global pandemic raising awareness of the importance of vaccines & anti-viral/anti-microbial drugs, are private-sector r&d incentives aligned to meet these unmet medical needs? | |
| 2020 | Mark Sullivan | Medicines Development for Global Health | Founder & Managing Director | Galien Week of innovation | Will the coronavirus pandemic finally lead to an upswing in r&d to tackle neglected areas like antibiotic resistance, zoonotic transmission of pathogens & a more globally-coordinated approach to infectious diseases overall? | |
| 2012 | Anthony Sun | Aisling Capital | Partner | Galien Forum USA | The changing face of chinese healthcare | |
| 2022 | Sally Sussman | Pfizer | Chief Corporate Affairs Officer, Executive Vice President | Galien Webinars Series | Golden Jubilee - Best Vaccine Category | |
| 2020 | Soumya Swaminathan | World Health Organization | Chief Scientist | Jerusalem Ethics Forum | Societal, legal & ethical challenges around access to covid-19 vaccines | |
| 2015 | Julie Sweet | Accenture | Chief Executive Officer & Chair of the Board | Galien Forum USA | Bioengineering for better health: what future for targeted drug delivery? | |
| 2020 | Abdou Aziz Sy | Sabodala Gold | Managing Director | Galien Forum Africa | Impact of the covid 19 pandemic on the natural resources sector sub-theme 2: | |
| 2021 | Cheikna Sylla | CODES & Honorary Director of the UFR of Health Sciences of Thies – Senegal | President | Galien Forum Africa | Conference on reform in health training | |
| 2011 | Kevin Tabb | Stanford Hospital & Clinics | Chief Medical Officer | Galien Forum USA | Perspectives on innovation, patient safety & global access thinking beyond laboratories & clinical trials | |
| 2022 | Ramita Tandon | Walgreens | Chief Clinical Trials Office | Galien Week of Innovation | Best Incubator/Accelerator/ equity - Clinical Trial Management and Wellness Care An innovator’s connection to a leadership accelerator, incubator or private equity organization is a strong indicator of success. Financial support is part of the commitment, as are experience and connections. How do these investment and counseling groups help start-ups with their clinical trial design, navigate regulatory and payer system complexities or build a go-to marketing plan? Beyond access to cash, what makes the innovator’s connection to an accelerator, incubator or private equity group success critical? | |
| 2018 | Hong Tang | Pasteur Institute of Shanghai | Director | Galien Forum Africa | Remarkable women engage for humanity | |
| 2018 | Hong Tang | Pasteur Institute of Shanghai | Director | Galien Forum Africa | managing infectious diseases & pandemics | |
| 2021 | Conrad Tankou | GIC Space | Chief Executive Officer | Galien Forum Africa | Leadership & innovation, meet the winners of the africa young innovators award for health | |
| 2010 | Mary Tanner | Peter J. Solomon Company | Managing Director | Galien Forum USA | Biomedical innovation: funding challenges & developing public/private partnership incentives | |
| 2022 | Marc Taub | Abbott | Divisional VP Technical Operations | Galien Week of Innovation | Laureates Media Presentation | |
| 2015 | Marti Taylor | OneFifteen | President & Chief Executive Officer | Galien Forum USA | Bioengineering for better health: what future for targeted drug delivery? | |
| 2020 | Alain Tehindrazanarivelo | African Regional Expert Committee on Traditional Medicine (Madagascar) | Neurologist & member | Galien Forum Africa | Contribution of traditional medicine in the response against covid 19: state of play, challenges & prospects sub-theme 5: | |
| 2021 | Pamela Tenaerts | Medable, Inc | Chief Scientific Officer | Galien Week of innovation | How far are we from achieving the health system world of the connected patient? | |
| 2015 | Marc Tessier-Lavigne | The Rockefeller University, New York, | President, Professor Laboratory of Brain Development & Repair | Galien Forum USA | Untangling the web of neurodegeneration: how far & how soon? | |
| 2015 | Marc Tessier-Lavigne | The Rockefeller University, New York, | President, Professor Laboratory of Brain Development & Repair | Galien Forum USA | Delivering on the patient promise of gene therapy | |
| 2014 | Marc Tessier-Lavigne | The Rockefeller University, New York, | President, Professor Laboratory of Brain Development & Repair | Galien Forum USA | Pioneers for a cure: the role of innovation & entrepreneurship in cancer research | |
| 2013 | Marc Tessier-Lavigne | The Rockefeller University, New York, | President, Professor Laboratory of Brain Development & Repair | Galien Forum USA | Presentation of the pershing square sohn prize for young investigators in cancer research in new york city | |
| 2013 | Marc Tessier-Lavigne | The Rockefeller University, New York, | President, Professor Laboratory of Brain Development & Repair | Galien Forum USA | Neurodegenerative disease drug progress | |
| 2021 | Sanskriti Thakur | Medable | Chief Growth Officer | Galien Week of innovation | What is the state of progress in building new therapeutic & diagnostic platforms to fight major cancers & address their prevalence in vulnerable populations, including the aged, minorities, & pediatric patients? | |
| 2021 | Sanskriti Thakur | Medable | Chief Growth Officer | Jerusalem Ethics Forum | Inclusive medicine: how modern research amplifies outcomes for patient access, inclusion & diversity | |
| 2022 | Sans Thakur | Medable | Chief Growth Officer Moderator | Galien Week of Innovation | Chronic and Autoimmune Disorders Chronic non-communicable diseases now account for three quarters of annual deaths worldwide, with a fast rising percentage taking place in low and middle income countries. With this in mind, how important is incentivizing more industry investment in costly clinical trials and other research targeting key areas of unmet need in major chronic conditions like CVD? Will a better understanding of the common molecular signatures that underlie many serious autoimmune disorders result in more progress in therapeutic interventions, including prevention? | |
| 2018 | Ibrahima Thiaw | Sahel | Special Advisor | Galien Forum Africa | The health consequences of climate change | |
| 2018 | Mame Thierno Dieng | Senegal | Minister of the Environment | Galien Forum Africa | The health consequences of climate change | |
| 2012 | William Thies | Alzheimer's Association | Chief Medical & Scientific Officer | Galien Forum USA | Alzheimer's innovation & the white house 2025 m& ate:what will it take to find a treatment? | |
| 2021 | Elizabeth H.Z. Thompson | Horizon | Research & Development | Galien Week of innovation | Can the foundational biologic underst& ings now being brought to cancer care be leveraged to secure a targeted, more personalized approach to other rare conditions, particularly blood-based hematologic disorders? | |
| 2016 | Craig Thompson | Memorial Sloan-Kettering Cancer Center , | President & Chief Executive Officer | Galien Forum USA | Promise - & politics - in the fight against cancer | |
| 2020 | Mads Krogsgaard Thomsen | Novo Nordisk A/S | Executive Vice President & Chief Scientific Officer | Galien Forum USA | The future of therapeutics: what novel modalities will be drugs? what vaccines & technologies will we need? | |
| 2018 | Madeleine Thomson | Wellcome Trust | Head of Climate Impacts | Galien Forum Africa | The health consequences of climate change | |
| 2011 | Nancy Thornberry | Kallyop | Chief Executive Officer | Galien Forum USA | The gut microbiome: opportunities & challenges | |
| 2020 | Ramon Tiu | Astellas Pharma Global Development Global Medical Leader, Gilteritinib Program | Executive Medical Director | Galien Week of innovation | Are there common links in advancing research on hematologic cancers & other rare diseases associated with uncontrolled vascular system inflammation, such as sickle cell anemia? | |
| 2022 | Jaya L. Tiwari | XVIVO Perfusion | Clinical & Regulatory Affairs | Galien Week of Innovation | Biotech - Chronic/Autoimmune Disorders and Vaccines Given that many chronic diseases have an infectious origin, what learnings can be had by the most recent innovations in vaccine development technology in raising the bar on innovations to address the huge unmet need against conditions that kill millions? | |
| 2011 | Eric Topol | Scripps Research Translational Institute, Author, Deep Learning | Executive Vice President & Chair of Innovative Medicine, Director & Founder | Galien Forum USA | The marriage of technology & medicine: bringing out the best in each other | |
| 2021 | Emma Toure Cuq | URGOTech Inc. | Chief Scientific Officer | Galien Week of innovation | Are insurers & health systems ready to embrace & reward these new self-care technologies, particularly in recognizing prevention & wellness as an integral element of service provision? | |
| 2021 | Coumba Toure Kane | University of Sine Saloum – Senegal | IRESSEF, Chancellor | Galien Forum Africa | Covid 19 lessons learned, autonomy & sovereignty of africa sub topic 7 | |
| 2014 | Olivia Tournay Flatto | Pershing Square Sohn Cancer Research Alliance | Executive Director | Galien Forum USA | Pioneers for a cure: the role of innovation & entrepreneurship in cancer research | |
| 2015 | Kevin J. Tracey | The Feinstein Institute for Medical Researc | President | Galien Forum USA | Bioengineering for better health: what future for targeted drug delivery? | |
| 2019 | Tomasz Trafny | Vatican | Official of the Pontifical Council for Culture | Jerusalem Ethics Forum | Ethical considerations around patient choice & human enhancement in healthcare? | |
| 2019 | Tomasz Trafny | Pontifical Council for Culture, Vatican | Head of Science & Faith Department | Jerusalem Ethics Forum | “artificial intelligence & ethics” | |
| 2022 | Thomas Triomphe | Sanofi-Pasteur MSD | VP, Vaccines | Galien Webinars Series | Golden Jubilee - Best Vaccine Category | |
| 2014 | Nathaniel Turner | Flatiron Health, Inc. | Co-Founder | Galien Forum USA | The future of digital health | |
| 2014 | Stephen J. Ubl | PhRMA | President & Chief Executive Officer | Galien Forum USA | Keynote: drug pricing & access in the trump administration: consensus or confrontation? | |
| 2021 | Marie Chantal Umunyana | Women Innovators Incubator program | Participant | Galien Forum Africa | Women & stem in the global health security context | |
| 2021 | J.P. Urbanski | Baylis Medical | Director of Strategic Marketing | Galien Week of innovation | How are systems design, electronics & engineering making invasive, high-risk surgical procedures a thing of the past? | |
| 2022 | J.P. Urbanski | Boston Scientific | Baylis Medical | Dir Strategic Mkg Cardiology Baylis | Galien Week of Innovation | Medical Devices and Implants – Cardiovascular and Cancer How are systems design, electronics and engineering making invasive, high-risk surgical procedures a thing of the past for these two major killers? | |
| 2021 | Juan Pablo Uribe | Global Financing Facility GFF International – Colombia | Director | Galien Forum Africa | Covid 19 lessons learned, autonomy & sovereignty of africa sub topic 8 | |
| 2022 | Giovanna Usvardi | Chiesi Group | Head of Global Communication & Public Affairs | Galien Webinars Series | Golden Jubilee - Best Orphan Rare Category | |
| 2014 | Roy Vagelos | Prix Galien USA; Regeneron Pharmaceuticals ; Merck & Co., Inc | Chairman | Galien Forum USA | Us health reform | |
| 2013 | Roy Vagelos | Prix Galien USA; Regeneron Pharmaceuticals ; Merck & Co., Inc | Chairman | Galien Forum USA | Keynote: drug pricing & access in the trump administration: consensus or confrontation? | |
| 2013 | Roy Vagelos | Prix Galien USA; Regeneron Pharmaceuticals ; Merck & Co., Inc | Chairman | Galien Forum USA | Intro | |
| 2013 | Roy Vagelos | Prix Galien USA; Regeneron Pharmaceuticals ; Merck & Co., Inc | Chairman | Galien Forum USA | Affordable care act us healthcare in transition: the stakes for industry | |
| 2012 | Roy Vagelos | Prix Galien USA; Regeneron Pharmaceuticals ; Merck & Co., Inc | Chairman | Galien Forum USA | Welcome | |
| 2012 | Roy Vagelos | Prix Galien USA; Regeneron Pharmaceuticals ; Merck & Co., Inc | Chairman | Galien Forum USA | Panel: “looking back, moving forward” | |
| 2022 | Patrick Vallance | Government | Government Chief Scientific Adviser | Galien Forum UK | Access to innovation: optimizing health for patient populations | |
| 2022 | Jérôme Van Biervliet | VIB | Managing Director | Galien Week of Innovation | Best Incubator/Accelerator/ equity - Disease Management Incubators and accelerators are pivotal in developing innovative solutions to address humanity’s most pressing health challenges. Why are academic institutions, major medical centers, and significant life science companies launching incubators and accelerators to offer guidance to biotech, digital health, health information, and medical device start-ups? Beyond financial resources, how are these groups working to advance ideas into the marketplace, and what is their impact? | |
| 2022 | Filip Van den Wyngaert | Sanofi | MSc Global Head TTP | Galien Week of Innovation | BioTech – Rare Diseases What is the underlying science behind clinical progress in therapies that promise a genetics-based cure for devastating rare diseases and how will this contribute to the next wave of innovations? What are the implications for continued patient access to these high-cost, high-touch 2 treatments – does the ROI calculation for rare diseases still add up? | |
| 2022 | Lisette Van Gemert | University of Twente. | Professor | Galien Forum Netherlands | #VALUE! | |
| 2022 | Roderick Van Grieken | The Netherlands Debate Institute | Founder & Director | Galien Forum Netherlands | #VALUE! | |
| 2020 | Katherine Vandebelt | Oracle Health Science | Global Vice President, Clinical Innovation | Galien Week of innovation | The ability to claim larger health system productivity benefits from the introduction of chronic disease medicines looms in importance as these therapeutic segments become more crowded & competitive. | |
| 2022 | Ashkan Vaziri | BioSensics | Founder, CEO | Galien Week of Innovation | Digital Health Solution - Disease Management In what ways can these new technologies contribute to the realization of better outcomes for patients at less cost to overburdened health systems? | |
| 2021 | Rajeev Venkayya | Takeda Pharmaceuticals Ltd. | President, Global Vaccines Unit | Jerusalem Ethics Forum | Highly prevalent neglected diseases: developing medicines & building infrastructure for the rest of the world | |
| 2013 | Rajeev Venkayya | Takeda Pharmaceuticals Ltd. | President, Global Vaccines Unit | Galien Forum USA | Preparing for the next pandemic: development & delivery of new wave innovations in vaccines | |
| 2021 | Michele Verschoore | L’Oreal Research & Innovation (France) | Medical Director | Galien Forum Africa | Involvement of women researchers in the mhw | |
| 2019 | Michele Verschoore | L’Oreal Research & Innovation (France) | Medical Director | Jerusalem Ethics Forum | Personalized genomics medicine: the value of knowing | |
| 2016 | Philip Vickers | Shire plc | Global Head, Research & Development | Galien Forum USA | Precision medicine: delivering on the promise | |
| 2014 | Christopher A. Viehbacher | Sanofi & Chairman Genzyme | Chief Executive Officer | Galien Forum USA | Us health reform | |
| 2022 | Pam Vig | Mirum Pharmaceuticals, Inc. | Head of R&D | Galien Week of Innovation | Rare Genetic Diseases Will progress in therapies that promise a genetic cure for devastating rare diseases lead to similar innovations in patient access to these high-cost, high-touch treatments? | |
| 2022 | Michael Vincent | Pfizer Inc. | SVP CSO In & Immuno | Galien Week of Innovation | Chronic and Autoimmune Disorders Chronic non-communicable diseases now account for three quarters of annual deaths worldwide, with a fast rising percentage taking place in low and middle income countries. With this in mind, how important is incentivizing more industry investment in costly clinical trials and other research targeting key areas of unmet need in major chronic conditions like CVD? Will a better understanding of the common molecular signatures that underlie many serious autoimmune disorders result in more progress in therapeutic interventions, including prevention? | |
| 2013 | Bert Vogelstein | Johns Hopkins School of Medicine | Professor of Oncology | Galien Forum USA | Keynote Personalized medicine: effect on drug r&d & patient care | |
| 2019 | Andrew C. Von Eschenbach | Samaritan Health Initiatives, Inc., USA | President | Jerusalem Ethics Forum | Health policy & financing innovation: ethical considerations, cost & the role of the patient | |
| 2019 | Andrew C. Von Eschenbach | Samaritan Health Initiatives, Inc., USA | President | Jerusalem Ethics Forum | Dominion over all of creation: progress & responsibility | |
| 2019 | Andrew C. Von Eschenbach | Samaritan Health Initiatives, Inc., USA | President | Jerusalem Ethics Forum | 2020/2030 agenda “facing the next ethical challenges” | |
| 2014 | Robert H. Vonderheide | Perelman School of Medicine, University of Pennsylvania | Hanna Wise Professor of Cancer Research , | Galien Forum USA | Cancer immunotherapeutics | |
| 2019 | Michel Vounatsos | Biogen inc | Chief Executive Officer & Director | Galien Forum USA | The gut microbiome: opportunities & challenges | |
| 2015 | Michel Vounatsos | Biogen | Chief Executive Officer | Galien Forum USA | Delivering on the patient promise of gene therapy | |
| 2018 | Salimata Wade | University Cheikh Anta Diop - Senegal | Nutritionist | Galien Forum Africa | Addressing chronic malnutrition | |
| 2022 | Mel Walker | MW Consulting | Biotech/Digital Health Adviser | Galien Forum UK | Access to innovation: optimizing health for patient populations | |
| 2022 | Mark Walport | Imperial College, London UK | Honorary Distinguished Professor of Medicine | Galien Forum UK | Welcome Remarks | |
| 2014 | Sihong Wang | City University of New York City College | Prize Winner & Associate Professor of Biomedical Engineering, | Galien Forum USA | Pioneers for a cure: the role of innovation & entrepreneurship in cancer research | |
| 2021 | Rhoda Wanyenze | School of Public Health & College of Health Sciences, Makerere University – Uganda | Dean | Galien Forum Africa | Covid 19 lessons learned, autonomy & sovereignty of africa sub topic 9 | |
| 2020 | Majesty Ihou Wateba | Health Sciences of the University of Lome (Togo) | Minister of Health & Dean of the Faculty | Galien Forum Africa | Socio-economic impact of the covid 19 pandemic sub-theme 5 | |
| 2017 | Ryan Watts | Denali Therapeutics | Co-founder, President & Chief Executive Officer | Galien Forum USA | Addressing unmet medical needs with early-stage life science venture capital | |
| 2015 | Ryan Watts | Denali Therapeutics | Co-founder, President & Chief Executive Officer | Galien Forum USA | Untangling the web of neurodegeneration: how far & how soon? | |
| 2021 | Scott C. Weaver | University of Texas Medical Branch | John Sealy Distinguished University Chair in Human Infections & Immunity Chair, Department of Microbiology & Immunology Director, Institute for Human Infections & Immunity; & Scientific Director Galveston National Laboratory GVN Center Director | Jerusalem Ethics Forum | Highly prevalent neglected diseases: developing medicines & building infrastructure for the rest of the world | |
| 2021 | Iain Webb | Bayer | Head of US Medical Affairs Oncology | Galien Week of innovation | Will the success of novel, gene-based therapies in advancing survival timelines in blood & bone marrow cancers be repeated in the solid tumor setting, with therapies that address each tumor’s individual genetic profile rather than association with its geographic location in the body? | |
| 2021 | Iain Webb | Bayer | Head of US Medical Affairs Oncology | Galien Week of innovation | What is the state of progress in building new therapeutic & diagnostic platforms to fight major cancers & address their prevalence in vulnerable populations, including the aged, minorities, & pediatric patients? | |
| 2015 | Christophe Weber | Takeda Pharmaceutical Company Limited | PharmD, Representative Director, President & Chief Executive Officer, | Galien Forum USA | How will we be paying for medicine 10 years from now? (Chief Executive Officers panel) | |
| 2022 | Michelle Weese | Bristol-Myers Squibb | EVP, Corporate Affairs | Galien Webinars Series | Golden Jubilee - Best BioTech Category | |
| 2020 | Tal Wenderow | VOCALIS HEALTH | Chief Executive Officer | Galien Webinars Series | The digital health enterprise: start-up trends & the culture of big pharma | |
| 2011 | Robert M. Wenham | Moffitt Cancer Center | Principal Investigator, Total Cancer Care Programs of Gynecologic Oncology & Experimental Therapeutics | Galien Forum USA | The next generation of health & research informatics accelerating translational research & personalized medicine at moffitt cancer center | |
| 2019 | Steve Whitehead | NIH National Institute for Allergies & Infectious Diseases | Senior Associate Scientist, Laboratory of Infectious Diseases, | Galien Forum USA | Preparing for the next pandemic: development & delivery of new wave innovations in vaccines | |
| 2018 | Marion Wiesel | The Elie Wiesel Foundation for Humanity New York | Chair | Galien Forum Africa | Remarkable women engage for humanity | |
| 2012 | Elie Wiesel | Author & Peace Nobel Prize Laureate | Professor | Galien Forum USA | Ethics of innovation, under the auspices of the elie wiesel foundation for humanity | |
| 2022 | Roy Wiesner | aMoon Fund | Managing Director | Galien Week of Innovation | Best Incubator/Accelerator/ equity - Disease Management Incubators and accelerators are pivotal in developing innovative solutions to address humanity’s most pressing health challenges. Why are academic institutions, major medical centers, and significant life science companies launching incubators and accelerators to offer guidance to biotech, digital health, health information, and medical device start-ups? Beyond financial resources, how are these groups working to advance ideas into the marketplace, and what is their impact? | |
| 2020 | Roy Wiesner | aMoon | Managing Director | Galien Webinars Series | The digital health enterprise: start-up trends & the culture of big pharma | |
| 2022 | Chris Williams | Sanofi | Head of Corporate Communications & Brand | Galien Webinars Series | Golden Jubilee - Best Pharmaceutical Category | |
| 2021 | Alisa Wilson | Accenture | Managing Director, Life Sciences | Galien Week of innovation | Can the foundational biologic underst& ings now being brought to cancer care be leveraged to secure a targeted, more personalized approach to other rare conditions, particularly blood-based hematologic disorders? | |
| 2011 | Ron Winslow | WSJ | Senior Medical & Health Care Writer | Galien Forum USA | A global health challenge: the obesity & diabetes epidemic where are the innovations & who will pay for them? | |
| 2021 | Pascale Witz | Sanofi et PDG de GE Pharmaceutical Diagnostic | Founder & CEO | Galien Webinars Series | The impact of digital technology in clinical trials: ethical considerations (french edition) | |
| 2015 | Amanda Woerman | Institute for Neurodegenerative Diseases, (UCSF) | Assistant Professor of Neurology | Galien Forum USA | Closing symposium: treating neurodegenerative disease: the potential of prion-based therapies | |
| 2020 | Cen Xu | Amgen Neuroscience | Executive Director | Galien Week of innovation | Where is the growing science & its link to disease leading us in terms of new treatments for patients with unresolved chronic conditions? | |
| 2022 | George Yancopoulos | Regeneron | Co-Founder, president and chief scientific officer | Galien Forum USA | CEO Panel | |
| 2020 | George Yancopoulos | Regeneron Pharmaceuticals | President & Chief Scientific Officer - | Galien Forum USA | Immunology from both sides: oncology & autoimmune disease | |
| 2017 | George Yancopoulos | Regeneron Pharmaceuticals | President, & Chief Scientific Officer, | Galien Forum USA | Inflammatory skin diseases & mechanistic interconnections to other inflammation disorders | |
| 2021 | Nadim Yared | CVRx | President & Chief Executive Officer | Galien Week of innovation | How are systems design, electronics & engineering making invasive, high-risk surgical procedures a thing of the past? | |
| 2018 | Yazdan Yazdanpanah | Inserm | Professor | Galien Forum Africa | managing infectious diseases & pandemics | |
| 2018 | Yazdan Yazdanpanah | Inserm | Professor | Galien Forum Africa | Remarkable women engage for humanity | |
| 2021 | Ashley Yegin | Takeda | Global Medical Unit Head, Rare Disease/HAE | Galien Week of innovation | Will clinical progress in therapies that promise a genetics-based cure for devastating rare diseases lead to similar downstream progress in patient access to these high-cost, high-touch treatments? | |
| 2014 | Krishna Yeshwant | Google Ventures | General Partner | Galien Forum USA | The future of digital health | |
| 2021 | Tal Zaks | Moderna | Chief Medical Officer | Galien Webinars Series | The impact of digital technologies in transforming & accelerating vaccine trials, development & delivery – lessons from covid-23 | |
| 2022 | Nafeez Zawahir | Publicis | Chief Medical Officer - Moderator | Galien Week of Innovation | Laureates Media Presentation | |
| 2011 | Jide Zeitlan | Keffi Group | Chief Executive Officer | Galien Forum USA | Funding innovation new trends in the healthcare m&a l& scape | |
| 2014 | Elias Zerhouni | Sanofi | President, Global R&D. | Galien Forum USA | A new agenda for global health | |
| 2015 | Feng Zhang | Massachusetts Institute of Technology | Professor | Galien Forum USA | Delivering on the patient promise of gene therapy | |
| 2021 | Eyal Zimlichman | ARC Innovation Program | Founder & Director | Galien Webinars Series | The incubators of innovation: academic medical centers as digital health champions | |
| 2016 | Bernard Zinman | Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital Sinai Centre for Diabetes. Mount Sinai Hospital, Toronto, Ontario | Senior Scientist Director of the Leadership | Galien Forum USA | Diabetes mellitus & cardiovascular risk – on the rise, fall & novel possibilities with glucose lowering drugs | |
| 2013 | Huda Zoghbi | Baylor College of Medicine | Professor | Galien Forum USA | Personalized medicine: effect on drug r&d & patient care | |
| 2022 | Lynne Zydowsky | Alexandria summit; chief of science, Alexandria real estate equities, inc./Alexandria venture investments | Chief Science Officer | Galien Forum USA | Mental health in America, a public health crisis | |
| 2021 | Lynne Zydowsky | Alexandria Real Estate Equities, Inc./ Alexandria Venture Investments | Chief Science Officer | Galien Forum USA | Combating the opioid crisis in america | |
| 2020 | Lynne Zydowsky | Alexandria Real Estate Equities, Inc./ Alexandria Venture Investments ; Co-Founder, Alexandria Summit | Chief Science Officer | Galien Forum USA | Covid-19 vaccines: the path to the holy grail | |
| 2018 | Lynne Zydowsky | Alexandria Real Estate Equities, Inc./ Alexandria Venture Investments ; Co-Founder, Alexandria Summit | Chief Science Officer | Galien Forum USA | Cancer in a time of disruption | |
| 2017 | Lynne Zydowsky | Alexandria Real Estate Equities, Inc./ Alexandria Venture Investments ; Co-Founder, Alexandria Summit | Chief Science Officer | Galien Forum USA | Addressing unmet medical needs with early-stage life science venture capital | |
| 2014 | Lynne Zydowsky | Alexandria Real Estate Equities, Inc./ Alexandria Venture Investments ; Co-Founder, Alexandria Summit | Chief Science Officer | Galien Forum USA | The future of digital health | |
| 2011 | Lynne Zydowsky | Alexandria Real Estate Equities, Inc./ Alexandria Venture Investments ; Co-Founder, Alexandria Summit | Chief Science Officer | Galien Forum USA | A global health challenge: the obesity & diabetes epidemic where are the innovations & who will pay for them? | |
| 2014 | Thierry Zylberberg | Orange Healthcare | Executive Vice President | Galien Foum Monaco | Beyond the Pill : The digital transformation of the biopharmaceutical industry in progress | |
| 2023 | Jane Adam | St. George’s NHS Trust | NICE Technology Appraisal Committee and Consultant, | Galien Forum UK | What is the role of the NHS in public sector innovation? | |
| 2023 | Lucy Chappell | Department of Health & Social Care (DHSC) | Chief Scientific Adviser | Galien Forum UK | What is the role of the NHS in public sector innovation? | |
| 2023 | Ara Darzi of Denham | Imperial College London | Co-Director, Institute of Global Health Innovation, | Galien Forum UK | impact of AI / Digital on healthcare | |
| 2023 | Luisa Freitas Dos Santos | GSK | Vice President - Global Clinical Supply Chain, | Galien Forum UK | Driving resilience in global medical supply chains | |
| 2023 | Will Gibbs | Octopus Ventures | Healthtech Partner, | Galien Forum UK | impact of AI / Digital on healthcare | |
| 2023 | Alison Holland | Medable | Executive GM, Digital and Decentralized Solutions, | Galien Forum UK | impact of AI / Digital on healthcare | |
| 2023 | Sarah Justine Kerruish | Kheiron Medical Technologies | Chief Strategy Officer, | Galien Forum UK | impact of AI / Digital on healthcare | |
| 2023 | Stephanie Kuku | World Health Organization’s Department of Digital Health and Innovation | Health Technology Director, Senior Consultant, Hardian Health & Senior Adviser and Consultant, | Galien Forum UK | impact of AI / Digital on healthcare | |
| 2023 | Ravi Limaye | Wockhardt UK | CEO / Managing Director, | Galien Forum UK | Driving resilience in global medical supply chains | |
| 2023 | Murray Lumpkin | Bill & Melinda Gates Foundation | Lead for Global Regulatory Systems Initiatives | Galien Forum UK | Access to innovation: exploring solutions to global challenges. | |
| 2023 | Deusdedit Mubangizi | World Health Organization | Head of Prequalification Unit | Galien Forum UK | Access to innovation: exploring solutions to global challenges. | |
| 2023 | Munir Pirmohamed | University of Liverpool | David Weatherall Chair of Medicine, | Galien Forum UK | Driving resilience in global medical supply chains | |
| 2023 | Sam Roberts | National Institute for Health and Care Excellence | Chief Executive Officer | Galien Forum UK | Access to innovation: exploring solutions to global challenges. | |
| 2023 | Roland Sinker | Cambridge University Hospitals NHS Foundation Trust | Chief Executive | Galien Forum UK | What is the role of the NHS in public sector innovation? | |
| 2023 | Helen Stokes Lampard | Academy of Medical Royal Colleges | Chair | Galien Forum UK | What is the role of the NHS in public sector innovation? | |
| 2023 | Steffen Thirstrup | European Medicines Agency | Chief Medical Officer | Galien Forum UK | Access to innovation: exploring solutions to global challenges. | |
| 2023 | Per Troein | IQVIA | Vice President Strategic Partners, | Galien Forum UK | Driving resilience in global medical supply chains | |
| 2023 | Mel Walker | Biotech/Digital Health Adviser | Galien Forum UK | Access to innovation: exploring solutions to global challenges. | ||
| 2023 | Bruce Warner | NHS | Deputy Chief Pharmaceutical Officer for England, | Galien Forum UK | Driving resilience in global medical supply chains | |
| 2023 | Matthieu Leclerc-Chalvet | Therapixel | CEO | Galien Week of innovation | What factors have contributed to the slower than anticipated take-up of digital health offerings in the management of chronic disease? Is AI going to finally tip the scale and lead to universal adoption of “connected health” strategies focused on digital therapeutics? | |
| 2023 | Rich Brancaccio | Revibe Technologies | Founder, Chief Innovation Officer | Galien Week of innovation | What factors have contributed to the slower than anticipated take-up of digital health offerings in the management of chronic disease? Is AI going to finally tip the scale and lead to universal adoption of “connected health” strategies focused on digital therapeutics? | |
| 2023 | anam Shetty | Evolve Medical Systems | Founder, CEO | Galien Week of innovation | What factors have contributed to the slower than anticipated take-up of digital health offerings in the management of chronic disease? Is AI going to finally tip the scale and lead to universal adoption of “connected health” strategies focused on digital therapeutics? | |
| 2023 | Rebecca Wilkins | Abbott - NeuroSphere Virtual Clinic | Divisional Vice President, Research & Development | Galien Week of innovation | What factors have contributed to the slower than anticipated take-up of digital health offerings in the management of chronic disease? Is AI going to finally tip the scale and lead to universal adoption of “connected health” strategies focused on digital therapeutics? | |
| 2023 | Sharief Taraman | Cognoa | CEO | Galien Week of innovation | What factors have contributed to the slower than anticipated take-up of digital health offerings in the management of chronic disease? Is AI going to finally tip the scale and lead to universal adoption of “connected health” strategies focused on digital therapeutics? | |
| 2023 | Shailja Dixit | Curio | CEO | Galien Week of innovation | What factors have contributed to the slower than anticipated take-up of digital health offerings in the management of chronic disease? Is AI going to finally tip the scale and lead to universal adoption of “connected health” strategies focused on digital therapeutics? | |
| 2023 | Eric Dessertenne | Biocorp | CEO | Galien Week of innovation | What factors have contributed to the slower than anticipated take-up of digital health offerings in the management of chronic disease? Is AI going to finally tip the scale and lead to universal adoption of “connected health” strategies focused on digital therapeutics? | |
| 2023 | Alexander Riftine | IntelleWave | President, CEO | Galien Week of innovation | What factors have contributed to the slower than anticipated take-up of digital health offerings in the management of chronic disease? Is AI going to finally tip the scale and lead to universal adoption of “connected health” strategies focused on digital therapeutics? | |
| 2023 | Mette Dyhrberg | Mymee | Founder, CEO | Galien Week of innovation | What factors have contributed to the slower than anticipated take-up of digital health offerings in the management of chronic disease? Is AI going to finally tip the scale and lead to universal adoption of “connected health” strategies focused on digital therapeutics? | |
| 2023 | Eran Orr | XRHealth | CEO | Galien Week of innovation | What factors have contributed to the slower than anticipated take-up of digital health offerings in the management of chronic disease? Is AI going to finally tip the scale and lead to universal adoption of “connected health” strategies focused on digital therapeutics? | |
| 2023 | Ryan Brewster | NoviGuide | NoviGuide Clinical Consultant | Galien Week of innovation | What factors have contributed to the slower than anticipated take-up of digital health offerings in the management of chronic disease? Is AI going to finally tip the scale and lead to universal adoption of “connected health” strategies focused on digital therapeutics? | |
| 2023 | MaryAnn Rizk | Rizk Management Advisors | CEO - Moderator | Galien Week of innovation | What factors have contributed to the slower than anticipated take-up of digital health offerings in the management of chronic disease? Is AI going to finally tip the scale and lead to universal adoption of “connected health” strategies focused on digital therapeutics? | |
| 2023 | Chrissa McFarlane | Patientory, Inc | Founder, CEO | Galien Week of innovation | Are health system payers and insurers prepared to reward software-driven patient self-care applications, particularly by recognizing prevention and wellness as an integral element of service -- and reimbursement -- provision? | |
| 2023 | Roy Cohen | Behavidence | CEO | Galien Week of innovation | Are health system payers and insurers prepared to reward software-driven patient self-care applications, particularly by recognizing prevention and wellness as an integral element of service -- and reimbursement -- provision? | |
| 2023 | Eric Snyder | Hyperion | Director, Informatics / Technology Innovation | Galien Week of innovation | Are health system payers and insurers prepared to reward software-driven patient self-care applications, particularly by recognizing prevention and wellness as an integral element of service -- and reimbursement -- provision? | |
| 2023 | Michelle Longmire | Medable | Co-Founder, CEO | Galien Week of innovation | Are health system payers and insurers prepared to reward software-driven patient self-care applications, particularly by recognizing prevention and wellness as an integral element of service -- and reimbursement -- provision? | |
| 2023 | Darcy Forman | Science 37 | Chief Delivery Officer | Galien Week of innovation | Are health system payers and insurers prepared to reward software-driven patient self-care applications, particularly by recognizing prevention and wellness as an integral element of service -- and reimbursement -- provision? | |
| 2023 | Zahid Ali Ashraf | TECHMEDO | Founder, CEO | Galien Week of innovation | Are health system payers and insurers prepared to reward software-driven patient self-care applications, particularly by recognizing prevention and wellness as an integral element of service -- and reimbursement -- provision? | |
| 2023 | Marisa Cruz | Empatica | Chief Medical Officer | Galien Week of innovation | Are health system payers and insurers prepared to reward software-driven patient self-care applications, particularly by recognizing prevention and wellness as an integral element of service -- and reimbursement -- provision? | |
| 2023 | Joe DeVivo | Butterfly Network, Inc | President, Chairman, Chief Executive Officer | Galien Week of innovation | Are health system payers and insurers prepared to reward software-driven patient self-care applications, particularly by recognizing prevention and wellness as an integral element of service -- and reimbursement -- provision? | |
| 2023 | Madeline Naylor | Skipta | CR, CTM - Moderator | Galien Week of innovation | Are health system payers and insurers prepared to reward software-driven patient self-care applications, particularly by recognizing prevention and wellness as an integral element of service -- and reimbursement -- provision? | |
| 2023 | Steven Lester, M.D. | Mayo Clinic and Arizona State University MedTech Accelerator | Founder, Chief Medical Officer | Galien Week of innovation | Incubator and accelerators are pivotal in developing innovative solutions to addressing humanity’s most pressing health care challenges. Why are academic institutes, major medical centers/ hospitals, and the top 10 pharma companies launching incubators and accelerator ventures to offer guidance to biotech, digital health, health information, and medical device start-ups, often under their own umbrella? Beyond financial and intellectual resources, how are these groups working to advance ideas into the marketplace, and what is their actual clinical impact? | |
| 2023 | Gene D. Morse, PharmD | Center for Integrated Global Biomedical Sciences by University at Buffalo | Director, Center for Integrated Global Biomedical Sciences | Galien Week of innovation | Incubator and accelerators are pivotal in developing innovative solutions to addressing humanity’s most pressing health care challenges. Why are academic institutes, major medical centers/ hospitals, and the top 10 pharma companies launching incubators and accelerator ventures to offer guidance to biotech, digital health, health information, and medical device start-ups, often under their own umbrella? Beyond financial and intellectual resources, how are these groups working to advance ideas into the marketplace, and what is their actual clinical impact? | |
| 2023 | Danina Kapetanovic | OROT CONNECTED HEALTH INCUBATOR BY CIUSSS WEST CENTRAL MONTREAL | Chief Innovation Officer | Galien Week of innovation | Incubator and accelerators are pivotal in developing innovative solutions to addressing humanity’s most pressing health care challenges. Why are academic institutes, major medical centers/ hospitals, and the top 10 pharma companies launching incubators and accelerator ventures to offer guidance to biotech, digital health, health information, and medical device start-ups, often under their own umbrella? Beyond financial and intellectual resources, how are these groups working to advance ideas into the marketplace, and what is their actual clinical impact? | |
| 2023 | Konrad Dobschuetz | NHS Innovation Accelerator | National Director | Galien Week of innovation | Incubator and accelerators are pivotal in developing innovative solutions to addressing humanity’s most pressing health care challenges. Why are academic institutes, major medical centers/ hospitals, and the top 10 pharma companies launching incubators and accelerator ventures to offer guidance to biotech, digital health, health information, and medical device start-ups, often under their own umbrella? Beyond financial and intellectual resources, how are these groups working to advance ideas into the marketplace, and what is their actual clinical impact? | |
| 2023 | Gil Bashe | FINN Partners | Managing Partner, Chair Global Health Purpose - Moderator | Galien Week of innovation | Incubator and accelerators are pivotal in developing innovative solutions to addressing humanity’s most pressing health care challenges. Why are academic institutes, major medical centers/ hospitals, and the top 10 pharma companies launching incubators and accelerator ventures to offer guidance to biotech, digital health, health information, and medical device start-ups, often under their own umbrella? Beyond financial and intellectual resources, how are these groups working to advance ideas into the marketplace, and what is their actual clinical impact? | |
| 2023 | Isaac Middelmann | EIT Health Venture Centre of Excellence (VCoE) | Managing Director (ad interim) | Galien Week of innovation | An innovator’s connection to a leadership accelerator, incubator, or private equity organization is a strong indicator of success. Financial support is part of the commitment, as are experience and business connections. How do these investment and counseling groups help start-ups with their clinical trial design, navigate regulatory and payer system complexities, or build a go to marketing plan? Beyond access to cash, what makes the innovator’s connection to an incubator, accelerator, or private equity group so critical to eventual success in the market? | |
| 2023 | Christopher Hentschel | Cube Labs | Chief Scientific Officer | Galien Week of innovation | An innovator’s connection to a leadership accelerator, incubator, or private equity organization is a strong indicator of success. Financial support is part of the commitment, as are experience and business connections. How do these investment and counseling groups help start-ups with their clinical trial design, navigate regulatory and payer system complexities, or build a go to marketing plan? Beyond access to cash, what makes the innovator’s connection to an incubator, accelerator, or private equity group so critical to eventual success in the market? | |
| 2023 | Robert Karanja, PhD | Villgro Africa | Co-Founder | Galien Week of innovation | An innovator’s connection to a leadership accelerator, incubator, or private equity organization is a strong indicator of success. Financial support is part of the commitment, as are experience and business connections. How do these investment and counseling groups help start-ups with their clinical trial design, navigate regulatory and payer system complexities, or build a go to marketing plan? Beyond access to cash, what makes the innovator’s connection to an incubator, accelerator, or private equity group so critical to eventual success in the market? | |
| 2023 | Mati Gill | AION Labs | CEO | Galien Week of innovation | An innovator’s connection to a leadership accelerator, incubator, or private equity organization is a strong indicator of success. Financial support is part of the commitment, as are experience and business connections. How do these investment and counseling groups help start-ups with their clinical trial design, navigate regulatory and payer system complexities, or build a go to marketing plan? Beyond access to cash, what makes the innovator’s connection to an incubator, accelerator, or private equity group so critical to eventual success in the market? | |
| 2023 | Ron Cohen | Acorda Therapeutics | President, CEO - Moderator | Galien Week of innovation | An innovator’s connection to a leadership accelerator, incubator, or private equity organization is a strong indicator of success. Financial support is part of the commitment, as are experience and business connections. How do these investment and counseling groups help start-ups with their clinical trial design, navigate regulatory and payer system complexities, or build a go to marketing plan? Beyond access to cash, what makes the innovator’s connection to an incubator, accelerator, or private equity group so critical to eventual success in the market? | |
| 2023 | Jim Lee | Incyte Corp. | Group Vice President, Head Inflammation and AutoImmunity | Galien Week of innovation | Gastrointestinal and adenocarcinoma cancers represent more than a quarter of all cancers. What are the epidemiological, cellular and molecular factors that are driving this trend, particularly among younger populations – and how is research science responding? | |
| 2023 | Lamine Mbow | Boehringer Ingelheim | SVP, Global Head of Cancer Immunology BI - Moderator | Galien Week of innovation | Gastrointestinal and adenocarcinoma cancers represent more than a quarter of all cancers. What are the epidemiological, cellular and molecular factors that are driving this trend, particularly among younger populations – and how is research science responding? | |
| 2023 | Patrice Lee | Pfizer Inc. | Vice President, Pharmacology, Toxicology and Exploratory Development | Galien Week of innovation | Assessing the current state of scientific progress in understanding the basic evolution of cancer as well as nominee experience in moving promising drug targets into clinical trials, regulatory approvals and market acceptance. | |
| 2023 | Susan Pandya | Servier Pharmaceuticals | Head of Cancer Metabolism Global Development Oncology & Immuno-Oncology | Galien Week of innovation | Assessing the current state of scientific progress in understanding the basic evolution of cancer as well as nominee experience in moving promising drug targets into clinical trials, regulatory approvals and market acceptance. | |
| 2023 | Robert Consalvo | H1 | Senior Director of Strategic Commercial Engagement - Moderator | Galien Week of innovation | Assessing the current state of scientific progress in understanding the basic evolution of cancer as well as nominee experience in moving promising drug targets into clinical trials, regulatory approvals and market acceptance. | |
| 2023 | Josh Bauml | Janssen Pharmaceutical Companies of Johnson & Johnson | Global Medical Head Amivantamab NSCLC Program | Galien Week of innovation | Assessing the current state of scientific progress in understanding the basic evolution of cancer as well as nominee experience in moving promising drug targets into clinical trials, regulatory approvals and market acceptance. | |
| 2023 | Lewis Warrington, MD | Ironshore | Chief Medical Officer | Galien Week of innovation | CNS drugs often take longer to develop and have lower success rates than other types of drug candidates. What strategies are nominees developing to “de-risk” novel CNS therapies and speed the pathway to clinical and market success? | |
| 2023 | Machelle Manuel, PhD | Amylyx Pharmaceuticals, Inc. | Vice President, Head Global Medical Affairs | Galien Week of innovation | CNS drugs often take longer to develop and have lower success rates than other types of drug candidates. What strategies are nominees developing to “de-risk” novel CNS therapies and speed the pathway to clinical and market success? | |
| 2023 | Hugh Marston | Boehringer Ingelheim | Head of Global CNS Diseases - Moderator | Galien Week of innovation | CNS drugs often take longer to develop and have lower success rates than other types of drug candidates. What strategies are nominees developing to “de-risk” novel CNS therapies and speed the pathway to clinical and market success? | |
| 2023 | Jessica Federer | Chief Digital Officer - Moderator | Galien Week of innovation | With a global pandemic raising awareness of the importance of vaccines and anti-viral medicines, are private-sector R&D incentives aligned to meet growing market needs? Gauging unmet needs in women’s health therapeutics and promising new trends in research. | ||
| 2023 | Jared Baeten | Gilead Sciences, Inc. | Vice President, Clinical Development, HIV Franchise Head | Galien Week of innovation | With a global pandemic raising awareness of the importance of vaccines and anti-viral medicines, are private-sector R&D incentives aligned to meet growing market needs? Gauging unmet needs in women’s health therapeutics and promising new trends in research. | |
| 2023 | Francisco Leon | Sanofi | Chief Scientific Officer & Co-Founder, Provention Bio | Galien Week of innovation | Given the complex biological and genetic interrelationships that characterize autoimmune, metabolic and aged-based genetic disorders, how has research science progressed in ensuring patients with these conditions can benefit from a more personalized approach to treatment? | |
| 2023 | Paulo Fontoura | Genentech | SVP and Global Head of Neuroscience and I2O | Galien Week of innovation | Given the complex biological and genetic interrelationships that characterize autoimmune, metabolic and aged-based genetic disorders, how has research science progressed in ensuring patients with these conditions can benefit from a more personalized approach to treatment? | |
| 2023 | Mike Vincent | Pfizer Inc. | Senior Vice President, Chief Scientific Officer, Inflammation & Immunology (I&I) | Galien Week of innovation | Given the complex biological and genetic interrelationships that characterize autoimmune, metabolic and aged-based genetic disorders, how has research science progressed in ensuring patients with these conditions can benefit from a more personalized approach to treatment? | |
| 2023 | Michael Ringel | Boston Consulting Group (BCG) | Managing Director, Senior Partner - Moderator | Galien Week of innovation | Given the complex biological and genetic interrelationships that characterize autoimmune, metabolic and aged-based genetic disorders, how has research science progressed in ensuring patients with these conditions can benefit from a more personalized approach to treatment? | |
| 2023 | Bill Mezzanotte | CSL / uniQure | EVP, Head of Research and Development | Galien Week of innovation | Will progress in medicines that promise a cure for devastating rare diseases lead to similar innovations on patient access to these increasingly high-cost, high-touch therapies? | |
| 2023 | Arup amanik | Boehringer Ingelheim | Corporate Vice President | Galien Week of innovation | Will progress in medicines that promise a cure for devastating rare diseases lead to similar innovations on patient access to these increasingly high-cost, high-touch therapies? | |
| 2023 | Monica Kumar | Sanofi | Global Project Head | Galien Week of innovation | Will progress in medicines that promise a cure for devastating rare diseases lead to similar innovations on patient access to these increasingly high-cost, high-touch therapies? | |
| 2023 | Bahija Jallal | Immunocore | CEO | Galien Week of innovation | Will progress in medicines that promise a cure for devastating rare diseases lead to similar innovations on patient access to these increasingly high-cost, high-touch therapies? | |
| 2023 | Kevin Brubacher | Bionest Partners, Accenture | Managing Director - Moderator | Galien Week of innovation | Will progress in medicines that promise a cure for devastating rare diseases lead to similar innovations on patient access to these increasingly high-cost, high-touch therapies? | |
| 2023 | Tonya Resutek | Olympus America Inc. | Executive Director for Respiratory Marketing | Galien Week of innovation | How are MedTech innovations like precision robotic engineering, connected devices, 3D printing and AI changing clinical workflows, costs and patient outcomes in cancer? | |
| 2023 | David Webster | Body Vision Medical | CEO | Galien Week of innovation | How are MedTech innovations like precision robotic engineering, connected devices, 3D printing and AI changing clinical workflows, costs and patient outcomes in cancer? | |
| 2023 | David Brachman | GT Medical Technologies, Inc. | Co-Founder and Chief Technology Officer | Galien Week of innovation | How are MedTech innovations like precision robotic engineering, connected devices, 3D printing and AI changing clinical workflows, costs and patient outcomes in cancer? | |
| 2023 | Madeline Naylor | Skipta | Wellness Care - Moderator | Galien Week of innovation | How are MedTech innovations like precision robotic engineering, connected devices, 3D printing and AI changing clinical workflows, costs and patient outcomes in cancer? | |
| 2023 | Jason Spees | Impulse Dynamics | CEO | Galien Week of innovation | What do MedTech manufacturers require to ensure that patients continue to benefit from safer, less invasive innovations in CVD, still the number one cause of death worldwide? | |
| 2023 | Laksen Sirimanne | Edwards Lifesciences | Senior Vice President, THV Research and Development | Galien Week of innovation | What do MedTech manufacturers require to ensure that patients continue to benefit from safer, less invasive innovations in CVD, still the number one cause of death worldwide? | |
| 2023 | Matt Thompson | ENDOLOGIX LLC | CEO, President | Galien Week of innovation | What do MedTech manufacturers require to ensure that patients continue to benefit from safer, less invasive innovations in CVD, still the number one cause of death worldwide? | |
| 2023 | Anew Easton | Terumo Aortic | Senior Global Product Manager | Galien Week of innovation | What do MedTech manufacturers require to ensure that patients continue to benefit from safer, less invasive innovations in CVD, still the number one cause of death worldwide? | |
| 2023 | Robert Consalvo | H1 | Senior Director of Strategic Commercial Engagement - Moderator | Galien Week of innovation | What do MedTech manufacturers require to ensure that patients continue to benefit from safer, less invasive innovations in CVD, still the number one cause of death worldwide? | |
| 2023 | Steven Eror | Solo-Dex, Inc. | Chief Executive Officer | Galien Week of innovation | What are the next frontiers of patient care offered by MedTech devices and diagnostics in your therapeutic area? | |
| 2023 | Jennifer Sipple | Outset Medical, Inc. | Vice President, Marketing | Galien Week of innovation | What are the next frontiers of patient care offered by MedTech devices and diagnostics in your therapeutic area? | |
| 2023 | Arthur Rascon | Valencia Technologies Corporation | Chief Executive Officer | Galien Week of innovation | What are the next frontiers of patient care offered by MedTech devices and diagnostics in your therapeutic area? | |
| 2023 | Gil Bashe | FINN Partners | Managing Partner Chair Global Health Purpose | Galien Week of innovation | What are the next frontiers of patient care offered by MedTech devices and diagnostics in your therapeutic area? | |
| 2023 | Megan O’Meara | Seagen Inc. | Senior Vice President, Head of Clinical Development | Galien Week of innovation | What are the latest estimations of progress in your respective fields of cancer research, i.e. hematologic and solid tumor cancers? What does the future hold for immunotherapy, precision medicine, cancer vaccines and cancer prevention? | |
| 2023 | Michael Vasconcelles, M.D., PhD | ImmunoGen, Inc. | Exec VP, Research, Development, and Medical Affairs | Galien Week of innovation | What are the latest estimations of progress in your respective fields of cancer research, i.e. hematologic and solid tumor cancers? What does the future hold for immunotherapy, precision medicine, cancer vaccines and cancer prevention? | |
| 2023 | Lusong Lu | BeiGene | SVP, External Innovation | Galien Week of innovation | What are the latest estimations of progress in your respective fields of cancer research, i.e. hematologic and solid tumor cancers? What does the future hold for immunotherapy, precision medicine, cancer vaccines and cancer prevention? | |
| 2023 | Kailash Swarna | Accenture | Managing Director - Moderator | Galien Week of innovation | What are the latest estimations of progress in your respective fields of cancer research, i.e. hematologic and solid tumor cancers? What does the future hold for immunotherapy, precision medicine, cancer vaccines and cancer prevention? | |
| 2023 | Jordan Schecter | The Janssen Pharmaceutical Companies of Johnson & Johnson and Legend Biotech USA Inc | Vice President for Cellular Therapy | Galien Week of innovation | What are the latest estimations of progress in your respective fields of cancer research, i.e. hematologic and solid tumor cancers? What does the future hold for immunotherapy, precision medicine, cancer vaccines and cancer prevention? | |
| 2023 | Eric Richards, MS, MPH | Daiichi Sankyo & AstraZeneca | Senior Vice President, Head of Global Regulatory Affairs | Galien Week of innovation | What are the latest estimations of progress in your respective fields of cancer research, i.e. hematologic and solid tumor cancers? What does the future hold for immunotherapy, precision medicine, cancer vaccines and cancer prevention? | |
| 2023 | Rachel Kobos, MD | The Janssen Pharmaceutical Companies of Johnson & Johnson | Vice President Oncology Research & Development | Galien Week of innovation | What are the latest estimations of progress in your respective fields of cancer research, i.e. hematologic and solid tumor cancers? What does the future hold for immunotherapy, precision medicine, cancer vaccines and cancer prevention? | |
| 2023 | Nafeez Zawahir, MD | Razorfish Health | Chief Medical Officer - Moderator | Galien Week of innovation | In the aftermath of the Covid-19 pandemic, what is the state of the vaccine business model? Will climate change, urbanization and an aging population require more investments in fighting a growing incidence of infectious diseases? | |
| 2023 | Alejana Gurtman | Pfizer Inc. | SVP, Vaccine Clinical Research and Development | Galien Week of innovation | In the aftermath of the Covid-19 pandemic, what is the state of the vaccine business model? Will climate change, urbanization and an aging population require more investments in fighting a growing incidence of infectious diseases? | |
| 2023 | Jane Parnes | Amgen USA | Executive Medical Director | Galien Week of innovation | As more complex conditions respond to improvements in our under- standing of the biology behind disease, what can patients expect to see in the form of new treatments in your respective therapeutic areas of expertise? | |
| 2023 | Amy Sehnert | Bristol Myers Squibb | Vice President, Head of Cardiomyopathy and Heart Failure Clinical Development | Galien Week of innovation | As more complex conditions respond to improvements in our under- standing of the biology behind disease, what can patients expect to see in the form of new treatments in your respective therapeutic areas of expertise? | |
| 2023 | Amir Kalali | CNS Summit, Co-Chair Decentralized Trial Research Alliance | Chairman, Chief Curator - Moderator | Galien Week of innovation | As more complex conditions respond to improvements in our under- standing of the biology behind disease, what can patients expect to see in the form of new treatments in your respective therapeutic areas of expertise? | |
| 2023 | Michael Rosenblatt, MD | Galien Forum | Prix Galien Committee Chair (Categories: Pharma, Biotech, Rare/Orphan) and Co-Chair of the Galien Forum; Former Dean of Tufts University School of Medicine, Former Chief Medical Officer of Merck & Co. Inc. | Galien Forum USA | Challenges to Individual and Public Health | |
| 2023 | Sue Desmond-Hellmann, MD, MPH | Galien Forum | Former Chief Executive Officer of the Bill & Melinda Gates Foundation. Co-Chair of the Galien Forum | Galien Forum USA | Challenges to Individual and Public Health | |
| 2023 | John Maraganore, PhD | Alnylam Pharmaceuticals | Former and Founding CEO | Galien Forum USA | Tomorrow’s Innovation Imperative: Conceiving, Creating and Building BioPharma Companies | |
| 2023 | Sangeeta N. Bhatia, MD, PhD | Massachusetts Institute of Technology | John J. and Dorothy Wilson Professor; Electrical Engineering and Computer Science, Institute for Medical Engineering and Science, Massachusetts Institute of Technology | Galien Forum USA | Tomorrow’s Innovation Imperative: Conceiving, Creating and Building BioPharma Companies | |
| 2023 | Adam Koppel, MD, PhD | Bain Capital Life Sciences | Partner | Galien Forum USA | Tomorrow’s Innovation Imperative: Conceiving, Creating and Building BioPharma Companies | |
| 2023 | Mike Nally | Flagship Pioneering | Chief Executive Officer, Generate Biomedicines; CEO-Partner | Galien Forum USA | Tomorrow’s Innovation Imperative: Conceiving, Creating and Building BioPharma Companies | |
| 2023 | Daphne Zohar | PureTech Health | Founder & Chief Executive Officer, Member of the Board of Directors | Galien Forum USA | Tomorrow’s Innovation Imperative: Conceiving, Creating and Building BioPharma Companies | |
| 2023 | Jeffrey Shaman, PhD | Columbia University | Professor and Director of the Climate and Health Program | Galien Forum USA | Climate Change and Public Health | |
| 2023 | Gwen W. Collman, PhD, FISEE | National Institutes of Health | Director, Office of Scientific Coordination, Planning and Evaluation; National Institute of Environmental Health Sciences | Galien Forum USA | Climate Change and Public Health | |
| 2023 | Ruxana aghia Akli | The Janssen Pharmaceutical Companies of Johnson & Johnson | Global Head, Global Public Health R&D | Galien Forum USA | Climate Change and Public Health | |
| 2023 | Jessica Fanzo | The Columbia Climate School | Professor of Climate; Director, Food for Humanity Initiative | Galien Forum USA | Climate Change and Public Health | |
| 2023 | Andy Haines | London School of Hygiene & Tropical Medicine | Professor of Environmental Change and Public Health | Galien Forum USA | Climate Change and Public Health | |
| 2023 | Joel S. Marcus | Alexandria Real Estate Equities, Inc./Alexandria Venture Investments; Co-Founder, Alexandria Summit; Board Director, Navy SEAL Foundation and National Medal of Honor Museum; Co-Founder, OneFifteen | Executive Chairman & Founder | Galien Forum USA | A National Imperative to Combat Mental Illness and Addiction | |
| 2023 | Lynne Zydowsky, PhD | Alexandria Real Estate Equities, Inc./ Alexandria Venture Investments; President & Co-Founder, Alexandria Summit | Chief of Science | Galien Forum USA | A National Imperative to Combat Mental Illness and Addiction | |
| 2023 | Robin King | The Navy Seal Foundation | CEO | Galien Forum USA | A National Imperative to Combat Mental Illness and Addiction | |
| 2023 | Representative Seth Moulton | Massachusetts’ Sixth Congressional District; U.S. Marine Corps (Ret.) | Member of Congress | Galien Forum USA | A National Imperative to Combat Mental Illness and Addiction | |
| 2023 | Representative Michael Waltz | Florida’s Sixth Congressional District; U.S. Army Green Beret (Ret.); National Guard (Ret.) | Member of Congress | Galien Forum USA | A National Imperative to Combat Mental Illness and Addiction | |
| 2023 | Michael Rosenblatt, MD | Galien Forum | Prix Galien Committee Chair (Categories: Pharma, Biotech, Rare/Orphan) and Co-Chair of the Galien Forum; Former Dean of Tufts University School of Medicine, Former Chief Medical Officer of Merck & Co. Inc. | Galien Forum USA | Exclusive fireside chat featuring Alex Gorsky, former Chairman& CEO, Johnson & Johnso | |
| 2023 | Alex Gorsky | Johnson & Johnson | Former Chairman and CEO | Galien Forum USA | Exclusive fireside chat featuring Alex Gorsky, former Chairman& CEO, Johnson & Johnso | |
| 2023 | Bernard Poussot | Roche Holding & Cargill Inc. Former Chairman & CEO, Wyeth; Prix Galien Committee Chair (Categories: Medtech, Digital Health, IAE and StartUp) | Board Member | Galien Forum USA | Prix Galien Awards Ceremony - Categories: Best Medical Technology, Best Digital Health Solution, Best Incubator/Accelerator/Equity and Best StartUp | |
| 2023 | Mikael Dolsten | Pfizer Research and Development | Chief Scientific Officer & President | Galien Forum USA | Obesity Science & Treatment Breakthroughs | |
| 2023 | Stephen L. Gough | Novo Nordisk | Global Chief Medical Officer and Senior Vice President of Global Medical Affairs | Galien Forum USA | Obesity Science & Treatment Breakthroughs | |
| 2023 | Lee M. Kaplan, MD, PhD | Geisel School of Medicine at Dartmouth | Professor of Medicine and Chief of the Section on Obesity Medicine | Galien Forum USA | Obesity Science & Treatment Breakthroughs | |
| 2023 | Joe Nadglowski | Obesity Action Coalition | President & CEO | Galien Forum USA | Obesity Science & Treatment Breakthroughs | |
| 2023 | Daniel M. Skovronsky, MD, PhD | Eli Lilly and Company | Executive Vice President, Chief Scientific and Medical Officer, and President, Lilly Research Laboratories | Galien Forum USA | Obesity Science & Treatment Breakthroughs | |
| 2023 | Søren Tullin | Boehringer Ingelheim | Senior Vice President & Global Head of Cardio Metabolic Disease Research | Galien Forum USA | Obesity Science & Treatment Breakthroughs | |
| 2023 | James J. Collins | Broad Institute of MIT and Harvard | Termeer Professor of Medical Engineering & Science Professor | Galien Forum USA | AI’s Impact on Personal — and Public Health, Now & in the Future | |
| 2023 | Regina Barzilay | MIT | School of Engineering Distinguished Professor for AI and Health | Galien Forum USA | AI’s Impact on Personal — and Public Health, Now & in the Future | |
| 2023 | Eric Horvitz | Microsoft | Chief Scientific Officer | Galien Forum USA | AI’s Impact on Personal — and Public Health, Now & in the Future | |
| 2023 | Ariel Katz | H1 | CEO & Co-founder | Galien Forum USA | AI’s Impact on Personal — and Public Health, Now & in the Future | |
| 2023 | Steve Quake | Chan Zuckerberg Initiative | Head of Science | Galien Forum USA | AI’s Impact on Personal — and Public Health, Now & in the Future | |
| 2023 | Lieven Van der Veken | McKinsey & Company | Senior Partner | Galien Forum USA | AI’s Impact on Personal — and Public Health, Now & in the Future | |
| 2023 | Petra Jantzer, PhD | Accenture | Senior Managing Director, Global Life Sciences Lead | Galien Forum USA | Science Meets Society: Balancing Innovation, Equity and Public Health in a Post-COVID World | |
| 2023 | Michael Rosenblatt, MD | Galien Forum | Prix Galien Committee Chair (Categories: Pharma, Biotech, Rare/Orphan) and Co-Chair of the Galien Forum; Former Dean of Tufts University School of Medicine, Former Chief Medical Officer of Merck & Co. Inc. | Galien Forum USA | Science Meets Society: Balancing Innovation, Equity and Public Health in a Post-COVID World | |
| 2023 | Albert Bourla | Pfizer | Chairman & CEO | Galien Forum USA | Science Meets Society: Balancing Innovation, Equity and Public Health in a Post-COVID World | |
| 2023 | Michael J. Dowling | Northwell Health | President & CEO | Galien Forum USA | Science Meets Society: Balancing Innovation, Equity and Public Health in a Post-COVID World | |
| 2023 | David R. Epstein | Seagen | CEO | Galien Forum USA | Science Meets Society: Balancing Innovation, Equity and Public Health in a Post-COVID World | |
| 2023 | David A. Ricks | Eli Lilly and Company | Chair & CEO | Galien Forum USA | Science Meets Society: Balancing Innovation, Equity and Public Health in a Post-COVID World | |
| 2021 | Robert Bradway | Amgen | Chairman & Chief Executive Officer | Galien Forum USA | CEO Session | |
| 2024 | Michael Rosenblatt | Galien Forum | MD, Prix Galien Awards Committee Chair | Galien Webinars Series | Biotech, Pharma, Rare/Orphan Diseases | |
| 2024 | Amy Sehnert | Bristol Myers Squibb | VP, Global Program Lead | Galien Webinars Series | Biotech, Pharma, Rare/Orphan Diseases | |
| 2024 | Ruth Gimeno | Eli Lilly and Company | Group VP Diabetes & Metabolic Research | Galien Webinars Series | Biotech, Pharma, Rare/Orphan Diseases | |
| 2024 | Stephen Gough | Novo Nordisk | Global Chief Medical Officer, SVP | Galien Webinars Series | Biotech, Pharma, Rare/Orphan Diseases | |
| 2024 | Janine Lamar | Boehringer Ingelheim | Global Spesolimab Lead | Galien Webinars Series | Biotech, Pharma, Rare/Orphan Diseases | |
| 2024 | Paul Monahan | CSL Behring | Executive Director, Senior Clinical Fellow, R&D, Hematology | Galien Webinars Series | Biotech, Pharma, Rare/Orphan Diseases | |
| 2024 | Matt Kapusta | UniQure | CEO | Galien Webinars Series | Biotech, Pharma, Rare/Orphan Diseases | |
| 2024 | Bernard Poussot | The Galien Foundation | Prix Galien Committee Chair | Galien Webinars Series | Digital Health, Medtech, Accelerator/Incubator/Equity, Startup | |
| 2024 | Michelle Longmire | Medable | Co-Founder and CEO | Galien Webinars Series | Digital Health, Medtech, Accelerator/Incubator/Equity, Startup | |
| 2024 | Robert Karanja | Villgro Africa | Co-Founder, Chief Innovation Office | Galien Webinars Series | Digital Health, Medtech, Accelerator/Incubator/Equity, Startup | |
| 2024 | Representative | Guardant Health | Galien Webinars Series | Digital Health, Medtech, Accelerator/Incubator/Equity, Startup | ||
| 2024 | Lamine Mbow | Boehringer Ingelheim | PhD | Galien Webinars Series | Digital Health, Medtech, Accelerator/Incubator/Equity, Startup | |
| 2024 | Oded Kraft | GrayMatters Health | Co-Founder & CEO | Galien Webinars Series | Digital Health, Medtech, Accelerator/Incubator/Equity, Startup | |
| 2024 | Representative | Tessera Therapeutics | Galien Webinars Series | Digital Health, Medtech, Accelerator/Incubator/Equity, Startup | ||
| 2024 | Representative | Volta Medical | Galien Webinars Series | Digital Health, Medtech, Accelerator/Incubator/Equity, Startup | ||
| 2024 | Shri Anil KHANNA | Modi Prix Galien India | Galien Forum Coordinator - Modi Prix Galien India Committee Member. Sr. Vice President, GM Modi Science Foundation, New Delhi | Modi Prix Galien India | Welcome remarks | |
| 2024 | Professor Manju SHARMA | Modi Prix Galien India | Modi Prix Galien India Committee Chair Former Secretary to the Govt. of India, Department of Biotechnology. Chair New Initiative, NASI, Allahabad | Modi Prix Galien India | Opening remarks | |
| 2024 | Dr Saurabh JAIN | Indegene | Vice President | Modi Prix Galien India | Scaling up genAI in life sciences: from pilots to production | |
| 2024 | Sridhar ANJANAPPA | Infusion Systems Software R&D, Baxter Innovations and Business Solutions Pvt. Ltd | Sr. Manager | Modi Prix Galien India | Scaling up genAI in life sciences: from pilots to production | |
| 2024 | Anirudh RANGANATHAN | Sekkei Bio | Co-founder | Modi Prix Galien India | Scaling up genAI in life sciences: from pilots to production | |
| 2024 | Suresh SUBRAMANIAN | EY India | Partner and Life Sciences Leader | Modi Prix Galien India | Scaling up genAI in life sciences: from pilots to production | |
| 2024 | Sanskriti THAKUR | World economic Forum Strategy Council | Chairwoman, Generational health Pioneer | Modi Prix Galien India | Generational health is not possible without women’s health | |
| 2024 | Amira GHOUAIBI | World Economic Forum | Head Global Alliance for Women's Health | Modi Prix Galien India | Generational health is not possible without women’s health | |
| 2024 | Sampada | Astellas Pharma India | General Manager & Managing Director | Modi Prix Galien India | Generational health is not possible without women’s health | |
| 2024 | Aishwarya RAVI | Pfizer | Pharmaceutical Scientist | Modi Prix Galien India | Generational health is not possible without women’s health | |
| 2024 | Niveditha | Egon Zehnder | Lead of Healthcare/Life Sciences Pratice | Modi Prix Galien India | Generational health is not possible without women’s health | |
| 2024 | Krishna SARMA | Corporate Law Group | Managing Partner | Modi Prix Galien India | Addressing pandemics through partnerships | |
| 2024 | Thomas CUENI | International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) | Director General | Modi Prix Galien India | Addressing pandemics through partnerships | |
| 2024 | Sudharshan JAIN | Indian Pharmaceutical Alliance (IPA) | IGBA Representative and Secretary General | Modi Prix Galien India | Addressing pandemics through partnerships | |
| 2024 | Vignesh SHIVNATH | Dr Reddy’s Laboratories | Director, Business Development & Alliance Managemen | Modi Prix Galien India | Addressing pandemics through partnerships | |
| 2024 | Jasdeep Singh SOOD | Jubilant Pharma, Generics | SVP, President | Modi Prix Galien India | Addressing pandemics through partnerships | |
| 2024 | Rajinder SURI | Developing Countries Vaccine Manufacturers Network (DCVMN) | CEO | Modi Prix Galien India | Addressing pandemics through partnerships | |
| 2024 | Stuti JALAN | Crosshairs & Women Inspiring | Founder, Storyteller | Curator & Speaker Tedx | Modi Prix Galien India | The next frontier in global medicine: advancements in medicine | |
| 2024 | Shuchin BAJAJ | Ujala Cygnus Hospitals | Founder Director | Modi Prix Galien India | The next frontier in global medicine: advancements in medicine | |
| 2024 | Pushpanjali R. CHAWLA | Pivotul Consulting Services | Founder | Modi Prix Galien India | The next frontier in global medicine: advancements in medicine | |
| 2024 | Shailja MITTAL | Qurex | Co-Founder | Modi Prix Galien India | The next frontier in global medicine: advancements in medicine | |
| 2024 | Peter PUSHPARAJ | AI Nexus Healthcare India | CEO & Director | Modi Prix Galien India | The next frontier in global medicine: advancements in medicine | |
| 2024 | Pr Sir Munir Pirmohamed | University of Liverpool | UK Galien Forum Chair; David Weatherall Chair of Medicine, University of Liverpool, Liverpool; NHS Chair of Pharmacogenetics | Galien Forum UK | Introduction | |
| 2024 | Dr Mel Walker | BioPharma Futures | Life Sciences Strategic Advisor and Managing Director | Galien Forum UK | No decision for me without me: Putting Patients at the heart of drug development | |
| 2024 | Robyn Bent | FDA | Director of CDER’s Patient-Focused Drug Development (PFDD) Program | Galien Forum UK | No decision for me without me: Putting Patients at the heart of drug development | |
| 2024 | Dr Sarah Gheuens | Agios Pharmaceuticals | Chief Medical Officer, Head of R&D | Galien Forum UK | No decision for me without me: Putting Patients at the heart of drug development | |
| 2024 | Dr Maria Mavris | European Medicines Agency | Patient Liaison | Galien Forum UK | No decision for me without me: Putting Patients at the heart of drug development | |
| 2024 | Elizabeth Vroom | World Duchenne Organization | Co-founder and chair | Galien Forum UK | No decision for me without me: Putting Patients at the heart of drug development | |
| 2024 | Dame June Raine | Medicines and Healthcare products Regulatory Agency | Chief Executive | Galien Forum UK | Introducing New Technologies: Optimising pathways to improve population health | |
| 2024 | Pr Gary Ford | ealth Innovation Oxford and Thames Valley | Chief Executive Officer | Galien Forum UK | Introducing New Technologies: Optimising pathways to improve population health | |
| 2024 | Hilary Hutton-Squire | Gilead Sciences | Vice President, Head of Global Value and Access | Galien Forum UK | Introducing New Technologies: Optimising pathways to improve population health | |
| 2024 | Sir Harpal Kumar | BioPharma Business & Europe, GRAIL, LLC | President | Galien Forum UK | Introducing New Technologies: Optimising pathways to improve population health | |
| 2024 | Dr Hakim Yadi | Closed Loop Medicine | CEO | Galien Forum UK | Introducing New Technologies: Optimising pathways to improve population health | |
| 2024 | Dr Miles Congreve | Isomorphic Labs | Chief Scientific Officer | Galien Forum UK | Can we use artificial intelligence to design new drugs? | |
| 2024 | Lord Prior of Brampton | Deputy Chairman UK and Global Senior Advisor at Lazard, Chairman of Protas; Chairman of the Cambridge Life Sciences Council and Chairman of Tympa Health | Galien Forum UK | Innovation in R&D: The Birth of Breakthroughs | ||
| 2024 | Tamsin Berry | Population Health Partners | Co-founder and partner | Galien Forum UK | Innovation in R&D: The Birth of Breakthroughs | |
| 2024 | Dr Joep Muijrers | Gilde Healthcare | General Partner | Galien Forum UK | Innovation in R&D: The Birth of Breakthroughs | |
| 2024 | Dr Matthias Müllenbeck | SVP, Head Global Business Development & Alliance Management | Galien Forum UK | Innovation in R&D: The Birth of Breakthroughs | ||
| 2024 | Dr Jane Osbourn | Alchemab Therapeutics Ltd | CSO | Galien Forum UK | Innovation in R&D: The Birth of Breakthroughs | |
| 2024 | Dr Vin Diwakar | National Director for Transformation (interim) | Galien Forum UK | Data Driven Medicine: The NHS as a strategic partner in Life Sciences | ||
| 2024 | Dr Michelle Longmire | Medable | CEO and Co-Founder | Galien Forum UK | Data Driven Medicine: The NHS as a strategic partner in Life Sciences | |
| 2024 | Pr Andrew Morris | University of Edinburgh | Director, Health Data Research UK & Professor of Medicine and Vice Principal Data Science | Galien Forum UK | Data Driven Medicine: The NHS as a strategic partner in Life Sciences | |
| 2024 | Dr Adrian Rabe | Boehringer Ingelheim Ltd. | Head of RWE Centre of Excellence | Galien Forum UK | Data Driven Medicine: The NHS as a strategic partner in Life Sciences | |
| 2024 | Richard Stephens | MY data & UK Cancer Research Advocates Forum | Patient partner | Galien Forum UK | Data Driven Medicine: The NHS as a strategic partner in Life Sciences | |
| 2024 | Ming Tang | NHS England | Chief Data and Analytics Officer | Galien Forum UK | Data Driven Medicine: The NHS as a strategic partner in Life Sciences | |
| 2024 | Dr Walid AMARA | GHT Grand Paris Nord Est | Cardiologist and Electrophysiologist - Chief Department / Arrythmias Management Team | Galien Forum International | ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING | |
| 2024 | Dr Andrea NATALE | HCA Healthcare | Executive Medical Director, Texas Cardiac Arrhythmia Institute at St. David’s Medical Center, Austin, Texas, U.S.A. National Medical Director, Cardiac Electrophysiology | Galien Forum International | ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING | |
| 2024 | Dr Matias NORDABY | Boehringer Ingelheim | Associated Therapeutic Area Head - Cardio-Renal-Metabolic Therapeutic Area | Galien Forum International | ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING | |
| 2024 | Dr Pierre SABOURET | European Atherosclerosis Society Member | President of the National College of French Cardiologists, Senior Researcher at Sorbonne University-Heart Institute-Paris | Galien Forum International | ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING | |
| 2024 | Pr Jean-Marc AYOUBI | Foch Hospital - Simone Veil Faculty of Medicine - Université Paris Saclay | Head of Department Gynaecology-Obstetrics & Reproductive Medicine | Galien Forum International | WOMEN’S HEALTH: FERTILITY PRESERVATION | |
| 2024 | Pr Attilio DI SPIEZIO SARDO | Napoli | Surgeon specializing in gynecology and obstetrics, and an expert in minimally invasive gynecological surgery, | Galien Forum International | WOMEN’S HEALTH: FERTILITY PRESERVATION | |
| 2024 | Pr Rene FRYDMAN | Foch Hospital | Obstetrician, Gynecologist - Department of Reproductive Medicine and Obstetric Gynecology | Galien Forum International | WOMEN’S HEALTH: FERTILITY PRESERVATION | |
| 2024 | Pr Laura RIENZI | University of Urbino., Roma | enior clinical embryologist- Scientific Director GENERA PMA, IVI-RMA Global Research Alliance. Associate Professor | Galien Forum International | WOMEN’S HEALTH: FERTILITY PRESERVATION | |
| 2024 | Dr Michèle VERSCHOORE | Dermatologist, Skin Scientific Expert, Former Medical Director of L’Oréal | Galien Forum International | WOMEN’S HEALTH: FERTILITY PRESERVATION | ||
| 2024 | Pr Olivier CHOSIDOW | La Pitie-Salpetriere University Hospital - Paris, France / French Society of Dermatology / Chairman of the Infectiology and Sexually Transmitted Infections Working Group (GrIDIST) | Dermatologist | Galien Forum International | WHAT’S NEW IN THE TREATMENT OF INFECTIOUS, ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES? | |
| 2024 | Pr Paolo GISONDI | University of Verona, Verona, Italy | Dermatology and Venereology | Galien Forum International | WHAT’S NEW IN THE TREATMENT OF INFECTIOUS, ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES? | |
| 2024 | Pr Celeste LEBBE | niversité Paris Cite, AP-HP Dermato-oncology, Cancer Institute APHP Nord Paris Cite, INSERM U976, Saint Louis Hospital, Paris, France | Head of the Dermato oncology Unit | Galien Forum International | WHAT’S NEW IN THE TREATMENT OF INFECTIOUS, ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES? | |
| 2024 | Rev Andrea CIUCCI | Vatican | Pontifical Academy for Life | Jerusalem Ethics Forum | ARTIFICIAL INTELLIGENCE AND ETHICS | |
| 2024 | Mauro FERRARI | University of Washington, Seattle WA, USA | Professor of Pharmaceutics | Jerusalem Ethics Forum | ARTIFICIAL INTELLIGENCE AND ETHICS | |
| 2024 | Pr Alberto E. TOZZI | Bambino Gesù Children’s Hospital, Roma, Italy | Pediatrician and Epidemiologist | Jerusalem Ethics Forum | ARTIFICIAL INTELLIGENCE AND ETHICS | |
| 2024 | Pr Arnold MUNNICH | Foch Hospital | Geneticist, Department of Reproductive Medicine and Obstetric Gynecology | Jerusalem Ethics Forum | GENE THERAPY | |
| 2024 | Dr William MEZZANOTTE | CSL | Executive Vice President, Head of R&D | Jerusalem Ethics Forum | GENE THERAPY | |
| 2024 | Pr Giuseppe NOVELLI | Dipartimento di Oncoematologia, Rome | Direttore U.O.C. Laboratorio Genetica Medica | Jerusalem Ethics Forum | GENE THERAPY | |
| 2024 | Pr Michaela SEMERARO | Necker hospital - Paris, France | Pediatrician specialized in Gene Therapy and Immunology, responsible of the Center of Clinical Investigation | Jerusalem Ethics Forum | GENE THERAPY | |
| 2024 | Dr Filippo SURACE | Gruppo Surace | Serial Entrepreneur, Surgeon, Inventor, Founder and CEO of Cube Labs, CEO | Jerusalem Ethics Forum | BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE | |
| 2024 | Dr Işıl GüNEY | Ulysses Advisory Group | Molecular Biologist, Partner BioScience Managers, Partner and Co-founder | Jerusalem Ethics Forum | BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE | |
| 2024 | Yossi BORNSTEIN | Israel Life Science | CEO and Founder of Shizim Group, Founder | Jerusalem Ethics Forum | BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE | |
| 2024 | Dr Chris HENTSCHEL | Molecular Biologist, Former CEO of Medicines for Malaria Venture, Former CEO of MRC Collaborative Center, Former CSO of Centocor | Jerusalem Ethics Forum | BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE | ||
| 2024 | Mario MARAZZITI | Italian Parliament | Italian Politician and Journalist, Member of Italian Parliament, Human Rights Leader, Health Diplomacy Leader, Community of Sant’Egidio | Jerusalem Ethics Forum | BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE | |
| 2024 | Satish MODI | Chairman Modi Global Enterprises, Chairman Gujar Mal Modi Science Foundation, Philanthropist, Author | Jerusalem Ethics Forum | BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE | ||
| 2024 | Dr Philippe DOUSTE BLAZY | United Unions Fund Unitlife | Chair of the United Unions Fund Unitlife, Former French Minister of Health, Culture and Foreign Affairs, Professor of Public Health, cardiologist | Jerusalem Ethics Forum | ETHICAL CHALLENGES IN LIFE SCIENCES | |
| 2024 | Michael Rosenblatt | Bain Capital Life Sciences and Flagship Pioneering | Galien Forum Co-Chair; Prix Galien Committee Chair (Categories: Pharma, Biotech, Rare/Orphan); Advisory Partner, Ascenta Capital; Senior Advisor | Galien Forum USA | OPENING REMARKS | |
| 2024 | Phillip A. Sharp | MIT | Nobel Laureate; Galien Forum Co-Chair; Institute Professor and Professor of Biology Emeritus, Koch Institute for Integrative Cancer Research | Galien Forum USA | OPENING REMARKS | |
| 2024 | Julie Louise Gerberding | Foundation for the National Institutes of Health | President and Chief Executive Officer | Galien Forum USA | WOMEN’S HEALTH / GENERATIONAL HEALTH | |
| 2024 | Diana W. Bianchi | NIH | Director, Eunice Kennedy Shriver, National Institute of Child Health and Human Development | Galien Forum USA | WOMEN’S HEALTH / GENERATIONAL HEALTH | |
| 2024 | Mary-Ann Etiebet | Vital Strategies | President and Chief Executive Officer | Galien Forum USA | WOMEN’S HEALTH / GENERATIONAL HEALTH | |
| 2024 | Elizabeth I. O. Garner | American Medical Women’s Association | Former Chief Scientific Officer, Ferring US; Immediate Past President, | Galien Forum USA | WOMEN’S HEALTH / GENERATIONAL HEALTH | |
| 2024 | Sandra Milligan | Organon | President, Aspira Women's Health | Galien Forum USA | WOMEN’S HEALTH / GENERATIONAL HEALTH | |
| 2024 | Sans Thakur | TOWER Capital Group and the pioneer of Generational Health | Founder and Chairwoman | Galien Forum USA | WOMEN’S HEALTH / GENERATIONAL HEALTH | |
| 2024 | Rohit Aggarwala | City of New York | Chief Climate Officer | Galien Forum USA | CLIMATE CHANGE & HEALTH | |
| 2024 | John Balbus | Office of Climate Change and Health Equity, U.S. Department of Health and Human Services | Deputy Assistant Secretary for Climate Change and Health Equity and Director | Galien Forum USA | CLIMATE CHANGE & HEALTH | |
| 2024 | Awa Marie Coll-Seck | Republic of Senegal | Chair of the Galien Africa; Former Senior Minister to the President of the Republic of Senegal; Former Minister of Health | Galien Forum USA | CLIMATE CHANGE & HEALTH | |
| 2024 | Ruxandra Draghia-Akli | INTREPID Alliance | Executive Leader in Life Sciences Innovation and Global Health; Chair of the Scientific Advisory Board, | Galien Forum USA | CLIMATE CHANGE & HEALTH | |
| 2024 | Jodi Sherman | Yale | Co-Chair, Lancet Commission on Sustainable Healthcare | Galien Forum USA | CLIMATE CHANGE & HEALTH | |
| 2024 | Ezekiel J. Emanuel | University of Pennsylvania | Vice Provost for Global Initiatives; Co-Director, Healthcare Transformation Institute; Diane v.S. Levy and Robert M. Levy University Professor; Perelman School of Medicine and The Wharton School | Galien Forum USA | BIOPHARMA PRESSURE POINTS: PBMS, PRICING, ACCESS, AND THE GLOBAL SUPPLY CHAIN | |
| 2024 | Ariel Katz | H1 | Co-founder and Chief Executive Officer | Galien Forum USA | BIOPHARMA PRESSURE POINTS: PBMS, PRICING, ACCESS, AND THE GLOBAL SUPPLY CHAIN | |
| 2024 | Daniel Mendelson | JPMorgan Chase & Co. | Chief Executive Officer, Morgan Health | Galien Forum USA | BIOPHARMA PRESSURE POINTS: PBMS, PRICING, ACCESS, AND THE GLOBAL SUPPLY CHAIN | |
| 2024 | John M. O'Brien | National Pharmaceutical Council | President and Chief Executive Officer | Galien Forum USA | BIOPHARMA PRESSURE POINTS: PBMS, PRICING, ACCESS, AND THE GLOBAL SUPPLY CHAIN | |
| 2024 | Janet Woodcock | U.S. Food & Drug Administration | Former Principal Deputy Commissioner | Galien Forum USA | BIOPHARMA PRESSURE POINTS: PBMS, PRICING, ACCESS, AND THE GLOBAL SUPPLY CHAIN | |
| 2024 | Joel S. Marcus | Alexandria Summit | Executive Chairman & Founder, Alexandria Real Estate Equities, Inc./Alexandria Venture Investments; Co-Founde | Galien Forum USA | IMMUNOLOGY & INFLAMMATION - A CORNERSTONE OF TREATING HUMAN DISEASE | |
| 2024 | Lynne Zydowsky | Alexandria Summit | Chief of Science, Alexandria Real Estate Equities, Inc./Alexandria Venture Investments; President & Co-Founder | Galien Forum USA | IMMUNOLOGY & INFLAMMATION - A CORNERSTONE OF TREATING HUMAN DISEASE | |
| 2024 | Steve Harr | Sana Biotechnology | President and Chief Executive Officer | Galien Forum USA | IMMUNOLOGY & INFLAMMATION - A CORNERSTONE OF TREATING HUMAN DISEASE | |
| 2024 | Thomas J. Lynch Jr. | Fred Hutchinson Cancer Center | President and Director, Raisbeck Endowed Chair | Galien Forum USA | IMMUNOLOGY & INFLAMMATION - A CORNERSTONE OF TREATING HUMAN DISEASE | |
| 2024 | Priya Singhal | Biogen | Executive Vice President, Head of Development | Galien Forum USA | IMMUNOLOGY & INFLAMMATION - A CORNERSTONE OF TREATING HUMAN DISEASE | |
| 2024 | Michael Rosenblatt | Bain Capital Life Sciences and Flagship Pioneering | Galien Forum Co-Chair; Prix Galien Committee Chair (Categories: Pharma, Biotech, Rare/Orphan)Advisory Partner, Ascenta Capital; Senior Advisor | Galien Forum USA | EXCLUSIVE FIRESIDE CHAT FEATURING NOUBAR AFEYAN, CEO OF FLAGSHIP PIONEERING | |
| 2024 | Noubar Afeyan | Moderna | Founder and Chief Executive Officer, Flagship Pioneering and Co-founder & Chairman | Galien Forum USA | EXCLUSIVE FIRESIDE CHAT FEATURING NOUBAR AFEYAN, CEO OF FLAGSHIP PIONEERING | |
| 2024 | Kenneth C. Frazier | General Catalyst | Prix Galien Committee Chair (Categories: Medtech, Digital Health, IAE and Startup); Retired Chairman and Chief Executive Officer, Merck & Co., Inc.; Chairman, Health Assurance Initiatives | Galien Forum USA | TRIBUTE TO BERNARD POUSSOT FOLLOWED BY AWARDS CEREMONY FOR THE CATEGORIES: BEST MEDICAL TECHNOLOGY, BEST DIGITAL HEALTH SOLUTION, BEST INCUBATOR/ACCELERATOR/EQUITY AND BEST STARTUP | |
| 2024 | Phillip A. Sharp | MIT | Nobel Laureate; Galien Forum Co-Chair; Institute Professor and Professor of Biology Emeritus, Koch Institute for Integrative Cancer Research | Galien Forum USA | BIG BIOTECH - WHERE IS IT GOING? | |
| 2024 | Ray Dehaies | Amgen | Senior Vice President Global Research Emeritus | Galien Forum USA | BIG BIOTECH - WHERE IS IT GOING? | |
| 2024 | Pushkal Garg | Alnylam | Chief Medical Officer and Executive Vice President, Development & Medical Affairs | Galien Forum USA | BIG BIOTECH - WHERE IS IT GOING? | |
| 2024 | Jane Grogan | Biogen | Executive Vice President and Head of Research | Galien Forum USA | BIG BIOTECH - WHERE IS IT GOING? | |
| 2024 | George D. Yancopoulos | Regeneron | Board Co-Chair, President and Chief Scientific Officer | Galien Forum USA | BIG BIOTECH - WHERE IS IT GOING? | |
| 2024 | Alan Moses | Joslin Diabetes Center | Independent Pharmaceutical/Biotechnology Consultant; Former Global CMO, Novo Nordisk A/S; Board of Directors | Galien Forum USA | FROM NASH TO MASH | |
| 2024 | Stephen L. Gough | Novo Nordisk | Global Chief Medical Officer and Senior Vice-President of Global Medical Affairs | Galien Forum USA | FROM NASH TO MASH | |
| 2024 | Mark Hartman | Eli Lilly and Company | Vice President of Medical, Lilly Research Laboratories | Galien Forum USA | FROM NASH TO MASH | |
| 2024 | Anthony Hollenberg | Boston University Chobanian and Avedisian School Medicine | President of Boston Medical Center and Professor of Medicine | Galien Forum USA | FROM NASH TO MASH | |
| 2024 | Jeff McIntyre | Global Liver Institute (GLI) | Vice President, Liver Health Programs, | Galien Forum USA | FROM NASH TO MASH | |
| 2024 | Ira Tabas | Columbia University Irving Medical Center | Richard J. Stock Professor and Vice-Chair of Research, Department of Medicine | Galien Forum USA | FROM NASH TO MASH | |
| 2024 | Søren Tullin | Boehringer Ingelheim | Senior Vice President and Global Head of CardioMetabolic Diseases Research | Galien Forum USA | FROM NASH TO MASH | |
| 2024 | Petra Jantzer | Accenture | Senior Managing Director, Global Life Sciences Lead | Galien Forum USA | CEO PANEL | |
| 2024 | Michael Rosenblatt | Bain Capital Life Sciences and Flagship Pioneering | Galien Forum Co-Chair; Prix Galien Committee Chair (Categories: Pharma, Biotech, Rare/Orphan)Advisory Partner, Ascenta Capital; Senior Advisor | Galien Forum USA | CEO PANEL | |
| 2024 | Noubar Afeyan | Moderna | Founder and Chief Executive Officer, Flagship Pioneering; Co-founder & Chairman | Galien Forum USA | CEO PANEL | |
| 2024 | John F. Crowley | Biotechnology Innovation Organization (BIO) | President and Chief Executive Officer | Galien Forum USA | CEO PANEL | |
| 2024 | Chris Viehbacher | Biogen | President and Chief Executive Officer | Galien Forum USA | CEO PANEL | |
| 2024 | Mikael Dolsten | Pfizer Research & Development | Chief Scientific Officer and President | Galien Forum USA | mRNA VS. GENE THERAPY | |
| 2024 | Katherine High | CRISPR Therapeutics | Professor Emerita at the Perelman School of Medicine at the University of Pennsylvania; Co-founder, Spark Therapeutics; Board Director, | Galien Forum USA | mRNA VS. GENE THERAPY | |
| 2024 | Kate Jeffrey | Moderna Inc. | Vice President, Immune Therapeutics and Genomic Sciences, Research & Early Development | Galien Forum USA | mRNA VS. GENE THERAPY | |
| 2024 | Zhen Li | ADARx Pharmaceuticals | President and Chief Executive Officer | Galien Forum USA | mRNA VS. GENE THERAPY | |
| 2024 | Kinnari Patel | Rocket Pharmaceuticals | President, Head of Research & Development and Chief Operating Officer | Galien Forum USA | mRNA VS. GENE THERAPY | |
| 2024 | Isaac Kohane | Harvard Medical School | Marion V. Nelson Professor & Chair, Department of Biomedical Informatics, Editor-in-Chief NEJM AI | Galien Forum USA | ARTIFICIAL INTELLIGENCE IN HEALTHCARE: MANAGING THE LEARNING CURVE FOR PATIENTS & SOCIETY | |
| 2024 | Ajay Gannerkote | Ultrasound | Global President and Head of Siemens Healthineers | Galien Forum USA | ARTIFICIAL INTELLIGENCE IN HEALTHCARE: MANAGING THE LEARNING CURVE FOR PATIENTS & SOCIETY | |
| 2024 | John D. Halamka | Mayo Clinic Platform | President | Galien Forum USA | ARTIFICIAL INTELLIGENCE IN HEALTHCARE: MANAGING THE LEARNING CURVE FOR PATIENTS & SOCIETY | |
| 2024 | Michelle Longmire | Co-founder and Chief Executive Officer | Medable | Galien Forum USA | ARTIFICIAL INTELLIGENCE IN HEALTHCARE: MANAGING THE LEARNING CURVE FOR PATIENTS & SOCIETY | |
| 2024 | Chris Mansi | Viz.ai | Co-founder and Chief Executive Officer | Galien Forum USA | ARTIFICIAL INTELLIGENCE IN HEALTHCARE: MANAGING THE LEARNING CURVE FOR PATIENTS & SOCIETY | |
| 2024 | Erika Stanzl | McKinsey | Digital & Analytics R&D Leader, Life Sciences Practice | Galien Forum USA | ARTIFICIAL INTELLIGENCE IN HEALTHCARE: MANAGING THE LEARNING CURVE FOR PATIENTS & SOCIETY | |
| 2024 | Amanda Gunn | Norstella | Sr Analyst, RWD Health Informatics | Galien Week of Innovation | Best Biotechnology Product | |
| 2024 | Neeraj Chawla | Accenture | Managing Director, Life Sciences Technology | Galien Week of Innovation | Best Biotechnology Product | |
| 2024 | Kailash Swarna | Accenture | Managing Director & Global Lead of Clinical Development for Life Sciences R&D, | Galien Week of Innovation | Best Biotechnology Product | |
| 2024 | Shelby Lipton | Argenx | General Manager, VYVGART and Global Commercial Lead | Galien Week of Innovation | Best Biotechnology Product | |
| 2024 | Lusong Luo | BeiGene | Senior VP, External Innovation | Galien Week of Innovation | Best Biotechnology Product | |
| 2024 | Mark Rutstein | Daiichi Sankyo, Inc. | Global Head of Oncology Clinical Development | Galien Week of Innovation | Best Biotechnology Product | |
| 2024 | Tahamtan (Tahi) Ahmadi | Genmab and AbbVie | Executive Vice President, Chief Medical Officer | Galien Week of Innovation | Best Biotechnology Product | |
| 2024 | Len Friedland | GSK Vaccines | Vice President, Director Scientific Affairs and Public Health | Galien Week of Innovation | Best Biotechnology Product | |
| 2024 | David Altarac | Innoviva Specialty Therapeutics | Chief Medical Officer | Galien Week of Innovation | Best Biotechnology Product | |
| 2024 | Deepu Madduri | Johnson & Johnson Services, Inc. | Senior Director, Compound Development Team Leader | Galien Week of Innovation | Best Biotechnology Product | |
| 2024 | Christoph Heuck | Johnson & Johnson | Vice President, Global Medical Head for Talquetamab, Innovative Medicine | Galien Week of Innovation | Best Biotechnology Product | |
| 2024 | Katherine Chastain | Johnson & Johnson Services, Inc. | Executive Medical Director | Galien Week of Innovation | Best Biotechnology Product | |
| 2024 | Heather Platt | Merck & Co Inc. | Section Head, Pneumococcal Vaccines, Merck Research Laboratories | Galien Week of Innovation | Best Biotechnology Product | |
| 2024 | Ana Sanchez | MGI Tech | Senior Product Manager | Galien Week of Innovation | Best Biotechnology Product | |
| 2024 | Iona Munjal | Pfizer | Executive Director, Vaccines Clinical R&D | Galien Week of Innovation | Best Biotechnology Product | |
| 2024 | Martha Brown | Boehringer Ingelheim | Executive Director, Research Coordination, | Galien Week of Innovation | Best Solution for Rare / Orphan Diseases | |
| 2024 | Ralph Torbay | Immunocore | SVP, Commercial | Galien Week of Innovation | Best Solution for Rare / Orphan Diseases | |
| 2024 | Fern Lazar | Finn Partner | Global Health Practice Leader | Galien Week of Innovation | Best Medical Product | |
| 2024 | Steven Lester | Mayo Clinic | Founder, CMO | Galien Week of Innovation | Best Medical Product | |
| 2024 | Amanda DePalma | Siemens Healthineers | Board of Directors SVP, Head of Corporate and Regional Marketing, Ultrasound | Galien Week of Innovation | Best Medical Product | |
| 2024 | Santosh Prabhu | Abbott | Divisional Vice President of Product Development for Abbott's Structural Heart Business | Galien Week of Innovation | Best Medical Product | |
| 2024 | George Yao | Alcon, Inc. | Franchise Head, R&D Vision Care | Galien Week of Innovation | Best Medical Product | |
| 2024 | Russ Joseph | Edwards Lifesciences | THV Research and Development | Galien Week of Innovation | Best Medical Product | |
| 2024 | David Taylor | Edwards Lifesciences | Senior Vice President, R&D | Galien Week of Innovation | Best Medical Product | |
| 2024 | Mike Blue | HistoSonics | CEO and President | Galien Week of Innovation | Best Medical Product | |
| 2024 | Ishu V. Rao | Impulse Dynamics | Medical Director | Galien Week of Innovation | Best Medical Product | |
| 2024 | Ali Dianaty | Medtronic | Senior Vice President, Product Innovation and Operations | Galien Week of Innovation | Best Medical Product | |
| 2024 | Jason Fontana | Medtronic | General Manager of the Renal Denervation (RDN) Business and Vice President of CRDN Global Marketing | Galien Week of Innovation | Best Medical Product | |
| 2024 | Hiten Chawla | Medtronic | Vice President | Galien Week of Innovation | Best Medical Product | |
| 2024 | Samuel Mazin | RefleXion Medical | Co-founder and CTO | Galien Week of Innovation | Best Medical Product | |
| 2024 | Vishal Jayakumar | Smith & Nephew, Inc. | SVP Robotics & Enabling Technologies R&D, Global Research and Development | Galien Week of Innovation | Best Medical Product | |
| 2024 | Myra Cocker | Siemens Healthineers | Global Director of Clinical Science, Cardiovascular | Galien Week of Innovation | Best Digital Health Solution | |
| 2024 | Stan Tsvirko | Novartis | Executive Director, Medical Intelligence and Technology | Galien Week of Innovation | Best Digital Health Solution | |
| 2024 | Elaine Brennan | Northwell Health | Executive Director, Global Strategic Partnerships | Galien Week of Innovation | Best Digital Health Solution | |
| 2024 | Adam Shain | Aptar Digital Health | VP of Patient Solutions | Galien Week of Innovation | Best Digital Health Solution | |
| 2024 | Elizabeth Schwarzbach | BigHat Biosciences | Chief Business Officer | Galien Week of Innovation | Best Digital Health Solution | |
| 2024 | Jennifer Guild | Clinical ink | Senior Program Director | Galien Week of Innovation | Best Digital Health Solution | |
| 2024 | Dennis P. Wall | Cognoa | Founder & Chief officer of Science and Innovation | Galien Week of Innovation | Best Digital Health Solution | |
| 2024 | David Crowley | Empatica | Program Manager Pharma Partnerships | Galien Week of Innovation | Best Digital Health Solution | |
| 2024 | Avie Luthra | MyPsychAdmin | Psychiatrist Consultant | Galien Week of Innovation | Best Digital Health Solution | |
| 2024 | Yogendra Bobra | Omnyk Inc. | CEO | Galien Week of Innovation | Best Digital Health Solution | |
| 2024 | Chrissa McFarlane | Patientory, Inc. | Chief Executive Officer | Galien Week of Innovation | Best Digital Health Solution | |
| 2024 | Rajarshi Banerjee | Perspectum | CEO | Galien Week of Innovation | Best Digital Health Solution | |
| 2024 | David Stoffel | RapidAI | Chief Business Officer | Galien Week of Innovation | Best Digital Health Solution | |
| 2024 | Pau Herrero | Roche Diagnostics | Lead Research Engineer | Galien Week of Innovation | Best Digital Health Solution | |
| 2024 | Zahid Ali Ashraf | Techmedo | Founder & CEO | Galien Week of Innovation | Best Digital Health Solution | |
| 2024 | Jamie Stern | Viz.ai | Sr. Director of Clinical Strategy and Care Pathway Programs | Galien Week of Innovation | Best Digital Health Solution | |
| 2024 | Ikechukwu Anoke | Zuri Health | Founder and CEO | Galien Week of Innovation | Best Digital Health Solution | |
| 2024 | Antoine Robilliard | Withings | VP Health Solutions | Galien Week of Innovation | Best Digital Health Solution | |
| 2024 | Scott DeWire | Boehringer Ingelheim | Executive Director Global Business Development & Licensing | Galien Week of Innovation | Best Incubator / Accelerator /Equity | |
| 2024 | Omar Perez | Cedars-Sinai Accelerator | Manager, Business Development & Strategic Alliances | Galien Week of Innovation | Best Incubator / Accelerator /Equity | |
| 2024 | Annie Thériault | Cross-Border Impact Ventures | Managing Partner | Galien Week of Innovation | Best Incubator / Accelerator /Equity | |
| 2024 | Christopher Hentschel | Cube Labs | Chief Scientific Officer | Galien Week of Innovation | Best Incubator / Accelerator /Equity | |
| 2024 | Isaac Middelmann | EIT Health | Managing Director (ad interim) | Galien Week of Innovation | Best Incubator / Accelerator /Equity | |
| 2024 | Marianne Khalil | McGill Dobson Centre for Entrepreneurship | Senior Manager | Galien Week of Innovation | Best Incubator / Accelerator /Equity | |
| 2024 | Danina Kapetanovic | OROT | Chief Innovation Officer/Founder and Head | Galien Week of Innovation | Best Incubator / Accelerator /Equity | |
| 2024 | Linxin Gu | TechConnect Venture Studio | Founder and CEO | Galien Week of Innovation | Best Incubator / Accelerator /Equity | |
| 2024 | Devin Dunn | TMC Innovation | Head, HealthTech Accelerator | Galien Week of Innovation | Best Incubator / Accelerator /Equity | |
| 2024 | MaryAnne Rizk | Amazon Web Services (AWS) | Managing Director, Global Head of Life Sciences Clinical Strategy | Galien Week of Innovation | Best Pharmaceutical Product | |
| 2024 | Gil Bashe | Finn Partners | Chair Global Health and Purpose | Galien Week of Innovation | Best Pharmaceutical Product | |
| 2024 | Laura Williams | Ardelyx, Inc. | Chief Medical Officer | Galien Week of Innovation | Best Pharmaceutical Product | |
| 2024 | Alex Scott | Eisai Inc. | Executive Vice President, Integrity and Chief Administrative Officer | Galien Week of Innovation | Best Pharmaceutical Product | |
| 2024 | Jared Baeten | Gilead Sciences, Inc. | Vice President, HIV Clinical Development | Galien Week of Innovation | Best Pharmaceutical Product | |
| 2024 | Mahadi Baig | Johnson & Johnson | Global Medical Head | Galien Week of Innovation | Best Pharmaceutical Product | |
| 2024 | Peter Radovich | Mirum Pharmaceuticals, Inc. | President and Chief Operating Officer | Galien Week of Innovation | Best Pharmaceutical Product | |
| 2024 | Mahesh Patel | Merck Research Laboratories | Vice President in Global Clinical Development | Galien Week of Innovation | Best Pharmaceutical Product | |
| 2024 | Dushen Chetty | Novartis Oncology | Vice President, Global Program Head, Prostate Cancer | Galien Week of Innovation | Best Pharmaceutical Product | |
| 2024 | Koshika Soma | Pfizer | Senior Vice President, Medicine Team Lead, Core Dermatology | Galien Week of Innovation | Best Pharmaceutical Product | |
| 2024 | Jennifer Hammond | Pfizer | Development Head, Antivirals | Galien Week of Innovation | Best Pharmaceutical Product | |
| 2024 | Terrie Curran | Phathom Pharmaceuticals | President & CEO | Galien Week of Innovation | Best Pharmaceutical Product | |
| 2025 | Shri Ani Khanna | Modi Prix Galien India - GM Modi Science Foundation, New Delhi | Galien Forum Coordinator - Committee Member. Sr. Vice President | Modi Prix Galien India | Welcome & Opening Remarks | |
| 2025 | Rhythma KAUL | HT Media Ltd | Health Editor | Modi Prix Galien India | Prioritizing Obesity Care in India | |
| 2025 | Seema CHHABRA | Patient Advocate Obesity Management | Modi Prix Galien India | Prioritizing Obesity Care in India | ||
| 2025 | Dr Ratna DEVI | DakshamA Health - PAIR (Patient Academy for Innovation and Research) - WHO Geneva | CEO - Director - Steering Committee Member NCD Labs | Modi Prix Galien India | Prioritizing Obesity Care in India | |
| 2025 | Dr Chandrakant LAHARIYA, MBBS, MD, DNB | ‘Centre for Health: The Specialty Practice’ in New Delhi, India. | Founder and chief physician | Modi Prix Galien India | Prioritizing Obesity Care in India | |
| 2025 | Dr Rajendra Pratap GUPTA, PhD. | Health Parliament｜Academy of Digital Health Sciences | Founder | Modi Prix Galien India | Prioritizing Obesity Care in India | |
| 2025 | Mel Walker | Access InVivo | Life Sciences Strategic Advisor and CEO | Galien Forum UK | Advances in international HTA collaboration: How will joint clinical assessments impact patient access to medicines in Europe? | |
| 2025 | Steffen Thirstrup | European Medicines Agency | Chief Medical Officer | Galien Forum UK | Advances in international HTA collaboration: How will joint clinical assessments impact patient access to medicines in Europe? | |
| 2025 | Niklas Hedberg | EU Member States Coordination Group under HTAR | Chief Pharmacist at the Swedish national governmental authority, the Dental and Pharmaceuticals Benefits Agency and Co-Chair | Galien Forum UK | Advances in international HTA collaboration: How will joint clinical assessments impact patient access to medicines in Europe? | |
| 2025 | Sam Roberts | NICE | Chief Executive | Galien Forum UK | Advances in international HTA collaboration: How will joint clinical assessments impact patient access to medicines in Europe? | |
| 2025 | Valentina Strammiello | European Patients Forum | Director of Strategic Initiatives | Galien Forum UK | Advances in international HTA collaboration: How will joint clinical assessments impact patient access to medicines in Europe? | |
| 2025 | Greg Rossi | AstraZeneca | Senior Vice President Head of Oncology Europe and Canada | Galien Forum UK | Advances in international HTA collaboration: How will joint clinical assessments impact patient access to medicines in Europe? | |
| 2025 | Dame June Raine | Medicines and Healthcare products Regulatory Agency | Former Chief Executive Officer | Galien Forum UK | Advances in individualised medicine: Are breakthrough therapies for ultra rare diseases within reach? | |
| 2025 | Matthew Wood | University of Oxford, Oxford-Harrington Rare Disease Centre, Case Western Reserve University School of Medicine | Professor of Neuroscience, Deputy Head Medical Sciences Division (Innovation), Director and Chief Scientific Officer, Adjunct Professor of Medicine | Galien Forum UK | Advances in individualised medicine: Are breakthrough therapies for ultra rare diseases within reach? | |
| 2025 | Gregory Friberg | BioMarin Pharmaceutical | Chief Research & Development Officer | Galien Forum UK | Advances in individualised medicine: Are breakthrough therapies for ultra rare diseases within reach? | |
| 2025 | Janet Woodcock | U.S. Food and Drug Administration | Former Director of the Center for Drug Evaluation and Researc and Principal Deputy Commissioner | Galien Forum UK | Advances in individualised medicine: Are breakthrough therapies for ultra rare diseases within reach? | |
| 2025 | Dan O’Connor | The Association of the British Pharmaceutical Industry | Director Regulatory and Early Access Policy | Galien Forum UK | Advances in individualised medicine: Are breakthrough therapies for ultra rare diseases within reach? | |
| 2025 | François Houÿez | European Organisation for Rare Diseases (EURORDIS) | Treatment Information and Access Director / Health Policy Advisor | Galien Forum UK | Advances in individualised medicine: Are breakthrough therapies for ultra rare diseases within reach? | |
| 2025 | Tony Wood | GSK | Chief Scientific Officer | Galien Forum UK | Keynote | |
| 2025 | Naveed Sattar | University of Glasgow, and Chair of Obesity Healthcare Goals Programme | Professor of Cardiometabolic Medicine | Galien Forum UK | Advances in treatment for obesity and its co-morbidities: Global challenges and opportunities for prevention and population health | |
| 2025 | Simon Griffin | University of Cambridge | Professor of General Practice | Galien Forum UK | Advances in treatment for obesity and its co-morbidities: Global challenges and opportunities for prevention and population health | |
| 2025 | Vicki Mooney | European Coalition for People living with Obesity | Executive Director | Galien Forum UK | Advances in treatment for obesity and its co-morbidities: Global challenges and opportunities for prevention and population health | |
| 2025 | Rachel Batterham | Eli Lilly and Company | Senior Vice President of International Medical Affairs | Galien Forum UK | Advances in treatment for obesity and its co-morbidities: Global challenges and opportunities for prevention and population health | |
| 2025 | Melanie Davies | University of Leicester | Professor of Diabetes Medicine | Galien Forum UK | Advances in treatment for obesity and its co-morbidities: Global challenges and opportunities for prevention and population health | |
| 2025 | Kathryn Abel | Fellow Academy of Medical Sciences | Mental Health Mission Co-Chair; European Research Council Fellow and National Institutes of Health Research Senior Investigator | Galien Forum UK | Advances in the treatment of symptoms in mental health/mood disorders: How can healthcare systems deliver solutions at scale to address the global mental health crisis? | |
| 2025 | Vanessa Pinfold | McPin Foundation and Chair of the Alliance of Mental Health Research Funders | Co-Founder/Research Director | Galien Forum UK | Advances in the treatment of symptoms in mental health/mood disorders: How can healthcare systems deliver solutions at scale to address the global mental health crisis? | |
| 2025 | Catherine Owen Adams | Acadia Pharma | CEO | Galien Forum UK | Advances in the treatment of symptoms in mental health/mood disorders: How can healthcare systems deliver solutions at scale to address the global mental health crisis? | |
| 2025 | Sanket Shah | Otsuka Precision Health | President & Board Member | Galien Forum UK | Advances in the treatment of symptoms in mental health/mood disorders: How can healthcare systems deliver solutions at scale to address the global mental health crisis? | |
| 2025 | Michael Browning | University of Oxford | Lead of Mood Disorders Translational Research Collaboration, Honorary Consultant Psychiatrist and Professor of Computational Psychiatry | Galien Forum UK | Advances in the treatment of symptoms in mental health/mood disorders: How can healthcare systems deliver solutions at scale to address the global mental health crisis? | |
| 2025 | Andrew Grill | Actionable Futurist and Bestselling Author of Digitally Curious | Galien Forum UK | Advances in the treatment of symptoms in mental health/mood disorders: How can healthcare systems deliver solutions at scale to address the global mental health crisis? | ||
| 2025 | Lawrence Tallon | Medicines and Healthcare products Regulatory Agency (MHRA) | Chief Executive Officer | Galien Forum UK | Keynote |
TOP SCIENTISTS & KOL